| scientific journal | Q5633421 |
| P495 | country of origin | United States of America | Q30 |
| P582 | end time | 1991-01-01 | |
| P571 | inception | 1979-01-01 | |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| P407 | language of work or name | English | Q1860 |
| P123 | publisher | University of Chicago Press | Q1814982 |
| P1476 | title | Reviews of Infectious Diseases |
| Q37904948 | "Contribution to the Question of Pneumotyphus": a discussion of the original article by J. Ritter in 1880. |
| Q40835060 | "Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation. |
| Q68472636 | 1989 sexually transmitted diseases treatment guidelines. A symposium. Atlanta, Georgia, 28-29 March 1989 |
| Q37888935 | 1989 sexually transmitted diseases treatment guidelines. Introduction |
| Q28334253 | 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex |
| Q39632280 | 4-Quinolones in the treatment of infections of the central nervous system. |
| Q43520620 | A Case Report of Escherichia vulneris Urosepsis |
| Q67830391 | A Case of Human Endocarditis Due to Streptococcus suis in North America |
| Q40161635 | A Critical Review of Antibiotic Prophylaxis in Orthopedic Surgery |
| Q41213224 | A Glimpse of the Early History of the Cephalosporins |
| Q45128802 | A Morphogenetic Study on Host-Pathogen Interactions Is Needed for Success in Genetic Analysis of Microbial Pathogenicity and the Pathogenesis of Infections |
| Q67911738 | A New Case of Meningitis Due to Pasteurella multocida |
| Q71101985 | A Program for Surveillance of Hospital-Acquired Infections in a General Hospital: A Two-Year Experience |
| Q40176276 | A Rat Model of Unilateral Utero-Tubo-Ovarian Abscess |
| Q40161623 | A Reevaluation of the Roles of the O2-Dependent and O2-Independent Microbicidal Systems of Phagocytes |
| Q40133157 | A Review of the Parasite Cellular Mechanisms Involved in the Pathogenesis of Amebiasis |
| Q45975218 | A Sri Lankan man with eosinophilia, wheezing, and cough. |
| Q44374396 | A case of group B streptococcal pyomyositis. |
| Q70163498 | A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis |
| Q35194826 | A cloned DNA fragment for identification of Mycobacterium tuberculosis. |
| Q39264549 | A community-based study of acute respiratory tract infection in Thai children |
| Q39264556 | A community-based study of acute respiratory tract infections in children in Uruguay |
| Q70742249 | A comparative study of bacampicillin hydrochloride given twice a day and amoxicillin given three times a day for treatment of skin and soft tissue infections: preliminary observations |
| Q48665159 | A comparative study of bacampicillin hydrochloride, penicillin V, and amoxicillin in the treatment of acute tonsillitis and/or pharyngitis due to beta-hemolytic streptococci. |
| Q71407500 | A comparison of the serologic responses to oral and injectable trivalent poliovirus vaccines |
| Q43584435 | A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients |
| Q70601364 | A convergent approach to the synthesis of lipid A |
| Q69091658 | A critique of semiautomated susceptibility systems |
| Q70410626 | A double-blind study comparing cefonicid with cefazolin as prophylaxis in patients undergoing total hip or knee replacement |
| Q48408604 | A history of the Infectious Diseases Society of America. |
| Q43207705 | A hospital-based study of acute viral infections of the respiratory tract in Thai children, with emphasis on laboratory diagnosis |
| Q49090889 | A memorial minute: Eli Chernin, 1924-1990. |
| Q44444107 | A model of Acanthamoeba keratitis in the rat. |
| Q93561625 | A model of the structural organization of rubella virions |
| Q39158220 | A molecular strategy for the study of bacterial invasion |
| Q72873783 | A multi-center, double-blind comparison of ketoconazole and griseofulvin in the treatment of infections due to dermatophytes |
| Q41454529 | A new generation of beta-lactam antibiotics: anticipating future developments and needs |
| Q38717783 | A perspective on the treatment of Lyme borreliosis. |
| Q39606845 | A potential role for the major iron-regulated protein expressed by pathogenic Neisseria species |
| Q43725797 | A program of outpatient parenteral antibiotic therapy for serious pediatric bacterial infections. |
| Q41978936 | A quantitative bacterial plaque assay for the enumeration of viable Acanthamoeba cells. |
| Q70159419 | A randomized comparative study of sulbactam plus ampicillin vs. metronidazole plus cefotaxime in the management of acute appendicitis in children |
| Q69892153 | A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections |
| Q53780766 | A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. |
| Q70159391 | A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections |
| Q40251618 | A review of human salmonellosis: I. Infective dose. |
| Q40181097 | A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. |
| Q39193560 | A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. |
| Q40258397 | A review of positive blood cultures: identification and source of microorganisms and patterns of sensitivity to antibiotics. |
| Q40273627 | A review of the current impact of measles in the People's Republic of China |
| Q40328775 | A review of the methods of identification and differentiation of mycobacteria. |
| Q40266054 | A review of the morphological and biochemical features of the attachment process in infections with Mycoplasma pneumoniae. |
| Q40868838 | A review: "Studies in Pyroplasmosis hominis ('spotted fever' or 'tick fever' of the Rocky Mountains)" by Louis B. Wilson and William M. Chowning, published in The Journal of Infectious Diseases 1:31-57, 1904. |
| Q69601600 | A role for the infection control specialist in child day care? |
| Q67006785 | A seminar on infant botulism: held at the Center for Disease Control, Atlanta, Georgia, September 7 and 8, 1978 |
| Q34160125 | A study of nonbacterial agents of acute lower respiratory tract infection in Thai children |
| Q45013168 | A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media. |
| Q46253787 | A successful eradication campaign. Global eradication of smallpox |
| Q71407403 | A taxonomic point |
| Q43609578 | A three-year study of positive blood cultures, with emphasis on prognosis |
| Q39634872 | A tribute to toilet paper |
| Q70601373 | A two-step mechanism for the interaction of Re lipopolysaccharide with erythrocyte membranes |
| Q52400909 | A unique tribute to Theobald Smith, 1915. |
| Q38983131 | A. Conan Doyle, Sherlock Holmes, and murder by tropical infection |
| Q41291145 | AIDS and Biomedical Research Funding: Comparative Analysis |
| Q39681866 | AIDS and the social sciences: review of useful knowledge and research needs |
| Q34687331 | AIDS in the pre-AIDS era. |
| Q39788583 | AIDS: has the problem been adequately assessed? |
| Q67936842 | Abdominal Abscess Due to Cardiobacterium hominis and Clostridium bifermentans |
| Q40330822 | Abnormal phagocyte chemotaxis: pathophysiology, clinical manifestations, and management of patients. |
| Q31041696 | Abnormalities of the nervous system in Lyme disease: response to antimicrobial therapy |
| Q38593723 | Abortion and perinatal sepsis associated with campylobacter infection |
| Q72775820 | Absence of beta-lactamase-inducing effect of moxalactam |
| Q68090883 | Absolute CD4 lymphocyte counts and the risk of opportunistic pulmonary infection |
| Q41200734 | Absorption of Botulinal Toxin from the Gastrointestinal Tract |
| Q72775870 | Absorption, excretion, and clinical efficacy of moxalactam in pediatric patients |
| Q37754453 | Acanthamoeba and disinfection of soft contact lenses |
| Q70183208 | Acanthamoeba keratitis following penetrating keratoplasty in a patient without other identifiable risk factors |
| Q44197932 | Acanthamoeba keratitis: clinical signs and analysis of outcome |
| Q54380573 | Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase. |
| Q39681811 | Achromobacter xylosoxidans bacteremia |
| Q40079267 | Acquired Immune Deficiency Syndrome (AIDS): Speculations About Its Etiology and Comparative Immunology |
| Q69411471 | Actinobacillus actinomycetemcomitans infection |
| Q39538026 | Actinobacillus actinomycetemcomitans prosthetic valve endocarditis. |
| Q38579437 | Actinomycetoma in the United States |
| Q39681823 | Actinomycosis of the central nervous system. |
| Q40775770 | Actions of complement on Junin virus |
| Q39681909 | Activated leukocytes and the hemostatic system. |
| Q71339968 | Activation of Hageman factor by lipopolysaccharides of Bacteroides fragilis, Bacteroides vulgatus, and Fusobacterium mortiferum |
| Q38280951 | Activation of the immune coagulation system by murine hepatitis virus strain 3. |
| Q46533354 | Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia |
| Q45792641 | Active diffusion of adsorbed mycoplasmal virus L3 on Acholeplasma laidlawii cell membranes. |
| Q43796880 | Active surveillance for toxic shock syndrome in the United States, 1986. |
| Q40216494 | Activity of cefsulodin and other agents against Pseudomonas aeruginosa |
| Q43883452 | Activity of imipenem against Pseudomonas and Bacteroides species. |
| Q39507034 | Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models |
| Q45126639 | Activity of sulbactam/ampicillin in screening and discriminative animal models of infection |
| Q37908263 | Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro. |
| Q72775838 | Activity, Stability, and Pharmacology of the Epimers of Moxalactam |
| Q40247829 | Acute and persistent viral infections of differentiated nerve cells |
| Q37918342 | Acute appendicitis complicating infectious mononucleosis: case report and review |
| Q38121839 | Acute bacterial sialadenitis: a study of 29 cases and review |
| Q40764263 | Acute human immunodeficiency virus infection temporally associated with rhabdomyolysis, acute renal failure, and nephrosis |
| Q39742192 | Acute infectious diarrhea among children in day care: epidemiology and control. |
| Q39260313 | Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh |
| Q43207711 | Acute lower respiratory tract infections in hospitalized patients with diarrhea in Dhaka, Bangladesh. |
| Q68021100 | Acute neurologic deterioration in a young man |
| Q54415389 | Acute otitis media caused by Branhamella catarrhalis: biology and therapy. |
| Q40758893 | Acute respiratory disease in Spain: seven years of experience |
| Q44268802 | Acute respiratory disease in Spain: some epidemiologic concerns. |
| Q38663760 | Acute respiratory infection in children of developing countries: challenge of the 1990s |
| Q39742183 | Acute respiratory infections in day care |
| Q39264527 | Acute respiratory tract infection in children in Idikan Community, Ibadan, Nigeria: severity, risk factors, and frequency of occurrence. |
| Q39264544 | Acute respiratory tract infections among a birth cohort of children from Cali, Colombia, who were studied through 17 months of age. |
| Q39601003 | Acute ureteral colic from an obstructing renal aspergilloma |
| Q69796458 | Additional case of liver abscess due to Streptococcus milleri |
| Q36461157 | Adenovirus vectors as potential vaccines against herpes simplex virus. |
| Q70183191 | Adherence characteristics of three strains of Acanthamoeba |
| Q70183180 | Adherence of Acanthamoeba castellanii cysts and trophozoites to extended wear soft contact lenses |
| Q70183185 | Adherence of Acanthamoeba to soft contact lenses |
| Q39728879 | Adherence of Candida species to host tissues and plastic surfaces |
| Q41676351 | Adherence of Helicobacter pylori to gastric carcinoma cells: analysis by flow cytometry |
| Q39694777 | Adherence of Staphylococcus aureus to squamous epithelium: role of fibronectin and teichoic acid. |
| Q38535225 | Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis |
| Q45852951 | Administration of zidovudine for treatment of infection due to human immunodeficiency virus |
| Q40792703 | Adoption of thermometry into clinical practice in the United States |
| Q68349817 | Advances in the management of HIV disease: focus on didanosine (ddI). A symposium. Houston, Texas, 18 September 1989. Proceedings |
| Q33362630 | Adventures among viruses. III. The puzzle of the common cold. 1950. |
| Q40161647 | Adverse Effects of Rifampin |
| Q37918336 | Adverse antibiotic effects associated with renal insufficiency |
| Q39632285 | Adverse effects of the fluoroquinolones. |
| Q40244037 | Adverse metabolic effects of antiparasitic drugs. |
| Q33388345 | Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins |
| Q33484021 | Adverse reactions to trimethoprim-sulfamethoxazole |
| Q33483246 | Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients |
| Q37404564 | Adverse virus-drug interactions |
| Q40195142 | Aeromonas hydrophila and Plesiomonas shigelloides as causes of intestinal infections |
| Q71809976 | Aerosolized measles vaccine--will it open the window? |
| Q39759545 | After empiric therapy: what to do until the granulocyte comes back |
| Q71102092 | Agents of Mycobacterial Variations |
| Q36840006 | Alteration of Cutaneous Staphylococcal Flora as a Consequence of Antimicrobial Prophylaxis |
| Q69491261 | Alteration of proteins reacting with antibody to toxic shock syndrome toxin 1 by endogenous proteases of Staphylococcus aureus |
| Q28295954 | Alternaria infection in a patient with acquired immunodeficiency syndrome: case report and review of invasive alternaria infections |
| Q39538136 | Alternating phenotypic expression of two classes of Trichomonas vaginalis surface markers |
| Q70676557 | Alternatives to water chlorination |
| Q40131311 | Amebiasis: Nutritional Implications |
| Q40133162 | Amebiasis: host-pathogen biology |
| Q39439467 | Amebiasis: introduction, current status, and research questions |
| Q93561620 | Amebic liver abscess: a therapeutic approach |
| Q68099558 | Amino acid sequence, active-site residue, and effect of suicide inhibitors on cephalosporinase of Citrobacter freundii GN346 |
| Q34028160 | Amphotericin B: 30 years of clinical experience |
| Q41200812 | An Evaluation of Pertussis Vaccine |
| Q72873818 | An Evaluation of Two Years of Clinical Experience with Ketoconazole |
| Q46040653 | An Orthotopic Heart Transplant Recipient with Subacute Meningitis |
| Q67994458 | An aerial baiting system for the distribution of attenuated or recombinant rabies vaccines for foxes, raccoons, and skunks |
| Q68868402 | An annotated bibliography of toxic shock syndrome |
| Q70183127 | An auxotrophic live oral Shigella flexneri vaccine: development and testing |
| Q52397925 | An enzyme from bacteria able to destroy penicillin. 1940. |
| Q53949240 | An epidemiologic approach to pneumococcal disease. |
| Q72775824 | An evaluation of the toxicity of moxalactam in laboratory animals |
| Q49128080 | An experimental investigation of the rôle of the blood fluids in connection with phagocytosis. 1903. |
| Q70140181 | An office model of outpatient parenteral antibiotic therapy |
| Q28287908 | An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections |
| Q34993203 | An outbreak of human and canine blastomycosis |
| Q70744633 | An overview of pharmacokinetics |
| Q39753132 | An overview of the response of bacteria to beta-lactam antibiotics |
| Q70744650 | An overview: evaluation of cefonicid in infections of the urinary tract, lower respiratory tract, and skin and soft tissue |
| Q37557315 | An unusual cause of cervical lymphadenitis: Kikuchi-Fujimoto disease. |
| Q28267095 | Anaerobes as Normal Oral Flora |
| Q40176193 | Anaerobes in Burn-Wound Infections |
| Q40176179 | Anaerobes in Liver Abscess |
| Q40176154 | Anaerobes in infections of the head and neck and ear, nose, and throat |
| Q38143787 | Anaerobes: problems and controversies in bacteriology, infections, and susceptibility testing. |
| Q40176242 | Anaerobic Bacterial Diseases Now and Then: Where Do We Go From Here? |
| Q40176200 | Anaerobic Infections in Childhood |
| Q40176162 | Anaerobic Mediastinitis |
| Q40176150 | Anaerobic Oral and Dental Infection |
| Q40793805 | Anaerobic bacteremia in a general hospital: retrospective five-year analysis |
| Q67830405 | Anaerobic bacteremia: declining rate over a 15-year period |
| Q68021092 | Anaerobic bacteremia: decreasing rate over a 15-year period |
| Q44725518 | Anaerobic bacteria and bacterial infections: perspectives on treatment and resistance in Italy. |
| Q40176184 | Anaerobic bacteria in bone and joint infections |
| Q43421206 | Anaerobic osteomyelitis of long bones |
| Q38522396 | Analysis of 1,186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial Therapy |
| Q31146465 | Analysis of Clinical, Epidemiologic, and Laboratory Data on Chronic Fatigue Syndrome |
| Q40798987 | Analysis of Q fever in Uruguay. |
| Q59807051 | Analysis of Toxic Shock Syndrome Isolates Producing Staphylococcal Enterotoxins B and Cl with Use of Southern Hybridization and Immunologic Assays |
| Q50207956 | Analysis of lipid A from Salmonella minnesota R595 lipopolysaccharide by chemical methods and nuclear magnetic resonance |
| Q68380975 | Anatomy for epidemiologists |
| Q68703375 | Angiostrongyliasis in Australia |
| Q39550165 | Angiostrongylus (Parastrongylus) eosinophilic meningitis |
| Q41200748 | Animal Models for the Study of Infant Botulism |
| Q38208834 | Animal lentivirus replication and reverse transcriptase inhibitors |
| Q38143777 | Animal model system for studying virulence of and host response to Bacteroides fragilis |
| Q39510133 | Animal models for acquired immunodeficiency syndrome |
| Q38612218 | Animal models for toxic shock syndrome: overview. |
| Q39550228 | Animal models in the pathogenesis and treatment of rabies. |
| Q39817216 | Animal models of Reye's syndrome |
| Q43212522 | Animal-to-human disease transmission. |
| Q44319048 | Anorectal Infections in Patients with Malignant Diseases |
| Q68442212 | Another case of AIDS in the pre-AIDS era |
| Q67250201 | Antibacterial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime |
| Q39849293 | Antibacterial activity of imipenem: the first thienamycin antibiotic |
| Q40337643 | Antibacterial therapy for acute otitis media: a critical analysis. |
| Q46169845 | Antibiotic Misuse in Two Clinical Situations: Positive Blood Culture and Administration of Aminoglycosides |
| Q36840031 | Antibiotic Prophylaxis in Clean Surgery: Peripheral Vascular Surgery, Noncardiovascular Thoracic Surgery, Herniorrhaphy, and Mastectomy |
| Q36840022 | Antibiotic Prophylaxis in Trauma: Penetrating Abdominal Injuries and Open Fractures |
| Q57077300 | Antibiotic Tolerance Among Clinical Isolates of Bacteria |
| Q71102007 | Antibiotic Use on the Surgical Services of Two Jerusalem Hospitals, as Determined by Surveillance and Influenced by an Intervention Program |
| Q38579077 | Antibiotic combinations in experimental infections in animals |
| Q43853965 | Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. |
| Q54374113 | Antibiotic prophylaxis after exposure to antibiotic-resistant Mycobacterium tuberculosis. |
| Q71603548 | Antibiotic prophylaxis in cancer patients: regimens of oral, nonabsorbable antibiotics for prevention of infection during induction of remission |
| Q36840021 | Antibiotic prophylaxis in orthopedic surgery |
| Q70410614 | Antibiotic prophylaxis in surgery |
| Q39753141 | Antibiotic resistance in Haemophilus influenzae: epidemiology, mechanisms, and therapeutic possibilities |
| Q40251613 | Antibiotic resistance in anaerobic bacteria: molecular biology and clinical aspects. |
| Q40330812 | Antibiotic resistance of Salmonella in Europe and the United States |
| Q40337568 | Antibiotic synergism and antimicrobial combinations in clinical infections |
| Q37404699 | Antibiotic therapy for postcesarean endomyometritis |
| Q38744923 | Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy. |
| Q70463755 | Antibiotic treatment for control of tree diseases associated with mycoplasma-like organisms |
| Q69091665 | Antibiotic use and antibiotic resistance worldwide. Report of a study sponsored by the Fogarty International Center of the National Institutes of Health, 1983-1986 |
| Q54572401 | Antibiotic-Associated Colitis: Effects of Antibiotics on Clostridium difficile and the Disease in Hamsters |
| Q66899571 | Antibiotic-Associated Pseudomembranous Colitis |
| Q38016836 | Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 1966-1988. |
| Q40310234 | Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects. |
| Q38684693 | Antibiotics in the management of shigellosis in children: what role for the quinolones? |
| Q71052032 | Antibiotics: the medium is the message |
| Q41200794 | Antibodies to Streptococcal Carbohydrate: Substitutes for the Myeloma Proteins |
| Q70601389 | Antibodies to lipid A: occurrence in humans |
| Q34283609 | Antibody Response of Patients with Hodgkin's Disease to Protein and Polysaccharide Antigens |
| Q39858764 | Antibody Response to Anaerobic Bacteria |
| Q40775859 | Antibody response in Crimean-Congo hemorrhagic fever |
| Q38663807 | Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade |
| Q70296086 | Antifungal Action of Rifampin |
| Q38016840 | Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. |
| Q37918384 | Antifungal prophylaxis in bone marrow transplantation |
| Q71102094 | Antigenic Relationships among Mycobacterial Species Studied by Modified-Rocket and Crossed Immunoelectrophoresis |
| Q44756621 | Antigenic Variation of Poliovirus Studied by Means of Monoclonal Antibodies |
| Q72737370 | Antigenic characterization of poliovirus type 3 using monoclonal antibodies |
| Q38348818 | Antigenic determinants of the cholera/coli family of enterotoxins. |
| Q67994472 | Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies |
| Q37899920 | Antigenic structure of surface-exposed regions of the major outer-membrane protein of Chlamydia trachomatis. |
| Q39538123 | Antigenic variation of surface proteins of Borrelia species |
| Q45796079 | Antigenicity and Reactogenicity of Influenza A/USSR/77 Virus Vaccine in Children -- A Multicentered Evaluation of Dosage and Safety |
| Q37903858 | Antigens of Chlamydia trachomatis. |
| Q41846855 | Antigens of Onchocerca volvulus. |
| Q67250194 | Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of Synergy |
| Q40176219 | Antimicrobial Agent-Associated Colitis and Diarrhea: Historical Background and Clinical Aspects |
| Q36840010 | Antimicrobial Prophylaxis for Appendectomy and Colorectal Surgery |
| Q40139589 | Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use |
| Q40176230 | Antimicrobial Susceptibility Testing of Anaerobic Bacteria |
| Q54513123 | Antimicrobial Susceptibility Tests with Cefotaxime and Correlation with Clinical Bacteriologic Response |
| Q38593653 | Antimicrobial agents and the medical journal: trends in publishing, 1936-1983. |
| Q68886659 | Antimicrobial agents in the prevention of travelers' diarrhea |
| Q38616078 | Antimicrobial drugs, microorganisms, and phagocytes |
| Q72113270 | Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux |
| Q39737870 | Antimicrobial prophylaxis of travelers' diarrhea: a selected summary. |
| Q54562723 | Antimicrobial prophylaxis: a critique of recent trials. |
| Q38143785 | Antimicrobial susceptibility testing of anaerobic bacteria: review and update on the role of the National Committee for Clinical Laboratory Standards. |
| Q39632254 | Antimicrobial therapy for enteric infections and typhoid fever: state of the art. |
| Q39737885 | Antimicrobial therapy for infectious diarrhea |
| Q37754392 | Antimicrobial therapy for shigellosis |
| Q44077210 | Antimicrobial therapy for travelers' diarrhea |
| Q43582692 | Antisecretory and antiinflammatory properties of bismuth subsalicylate |
| Q38675539 | Antisporozoite vaccine for malaria: experimental basis and current status. |
| Q37557400 | Antituberculous immunity: new solutions to an old problem. |
| Q28281567 | Antiviral activity and mechanism of action of ganciclovir |
| Q38745078 | Antiviral chemotherapy for infection with human immunodeficiency virus |
| Q38186811 | Antiviral cytotoxic T lymphocyte induction and vaccination |
| Q39538012 | Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine. |
| Q44046176 | Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype |
| Q71102081 | Application of Pyrolysis Mass Spectrometry to the Classification and Identification of Mycobacteria |
| Q44163867 | Application of immunoassay methods in the serodiagnosis of human filariasis |
| Q36445036 | Applications of computerized microscopic image analysis in infectious diseases |
| Q39643629 | Approaches to an understanding of pathogenetic mechanisms in AIDS. |
| Q40121838 | Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses |
| Q70220560 | Approaches to the Development of New Poliovirus Vaccines Based on Molecular Genetics |
| Q69192155 | Approaches to the development of new antituberculosis drugs |
| Q50221237 | Are We Ready for a National Salmonella Control Program? |
| Q40304157 | Arthritis in disease due to Neisseria meningitidis. |
| Q36631315 | Ascariasis: host-pathogen biology |
| Q40244059 | Ascariasis: nutritional implications |
| Q34172009 | Aspects of chemistry in the development of the 4-quinolone antibacterial agents |
| Q39316484 | Aspects of rubella infection in Brazil |
| Q37404559 | Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review |
| Q43489013 | Aspergillus clavatus endocarditis involving a normal aortic valve following coronary artery surgery |
| Q38616083 | Aspergillus endocarditis in patients without prior cardiovascular surgery: report of a case in a liver transplant recipient and review |
| Q68021123 | Aspiration pneumonia |
| Q45832300 | Assessing and Modeling Heterosexual Spread of the Human Immunodeficiency Virus in the United States |
| Q37704044 | Assessment of depression in patients with chronic fatigue syndrome |
| Q40315057 | Assessment of the antibody response to pneumococcal vaccine in high-risk populations |
| Q70924131 | Assessment of the pneumococcal polysaccharide vaccine. Boston, Massachusetts, October 6, 1980 |
| Q70147066 | Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay |
| Q42984672 | Association Between Hepatitis C Virus and Mixed Cryoglobulinemia |
| Q44204902 | Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology |
| Q37696686 | Asymptomatic bacteriuria in patients with diabetes mellitus |
| Q40209343 | Attachment by mycoplasmas and its role in disease |
| Q40161666 | Attachment of Streptococcus pyogenes to Mammalian Cells |
| Q71621921 | Attachment of mycoplasmas to host cell membranes |
| Q71102057 | Atypical mycobacterial infections in children |
| Q40075802 | Autoimmune Mechanisms in the Pathogenesis of Rheumatic Fever |
| Q39821311 | Available rubella serologic tests |
| Q69983822 | Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli |
| Q28328526 | Aztreonam in the treatment of gram-negative bacterial meningitis |
| Q44142048 | Aztreonam monotherapy as prophylaxis in transurethral resection of the prostate: a multicenter study |
| Q70226007 | Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections |
| Q69923767 | Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections |
| Q40814262 | Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients |
| Q42225508 | Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria |
| Q39838026 | Aztreonam therapy for serious gram-negative bacillary infections |
| Q54697082 | Aztreonam versus gentamicin for short-term prophylaxis in biliary and gastric surgery. |
| Q54441894 | Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests. |
| Q70226000 | Aztreonam: the expanding clinical profile. A symposium. Sicily, Italy May 1988 and Jerusalem, Israel, June 1989 |
| Q67294876 | Bacampicillin vs. amoxicillin for treatment of acute infections of the urinary tract |
| Q64934301 | Bacillus cereus panophthalmitis: source of the organism. |
| Q38232972 | Bacillus species infections in neonates |
| Q40748898 | Bacteremia and septic arthritis caused by Moraxella catarrhalis |
| Q43636363 | Bacteremia caused by Aeromonas species in hospitalized cancer patients |
| Q68021081 | Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital |
| Q70172391 | Bacteremia due to Corynebacterium jeikeium in a patient with AIDS |
| Q67830394 | Bacteremia due to Erysipelothrix rhusiopathiae in immunocompromised hosts without endocarditis |
| Q54312278 | Bacteremia due to Escherichia coli: a study of 861 episodes. |
| Q40328782 | Bacteremia due to Staphylococcus aureus in patients with cancer: report on 45 cases in adults and review of the literature. |
| Q40762362 | Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features |
| Q37404534 | Bacteremia in granulocytopenic patients in a tertiary-care general hospital |
| Q52267717 | Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. |
| Q69612211 | Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study |
| Q39694734 | Bacteremia with Anaerobiospirillum succiniciproducens |
| Q37947312 | Bacteremic disease due to Haemophilus influenzae capsular type f in adults: report of five cases and review. |
| Q68074447 | Bacteremic pneumonia due to group C streptococci |
| Q36711005 | Bacteria and viruses induce production of interferon in the cerebrospinal fluid of children with acute meningitis: a study of 57 cases and review |
| Q40161661 | Bacterial Adherence in the Mouth |
| Q36525465 | Bacterial Adhesion: Genetics, Biogenesis, and Role in Pathogenesis of Fimbrial Adhesins of Escherichia coli |
| Q40108314 | Bacterial Endotoxins and Pathogenesis |
| Q67936832 | Bacterial Infection as a Complication of Liver Transplantation: Epidemiology and Risk Factors |
| Q40091949 | Bacterial Virulence and Pathogenesis: An Overview |
| Q40161690 | Bacterial Virulence and the Inflammatory System |
| Q39537943 | Bacterial active-site serine penicillin-interactive proteins and domains: mechanism, structure, and evolution |
| Q39463268 | Bacterial adherence in the pathogenesis of urinary tract infection: a review |
| Q39681877 | Bacterial adherence: the attachment of group A streptococci to mucosal surfaces |
| Q39660486 | Bacterial colonization and infection resulting from multiplication of a single organism |
| Q46920506 | Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea |
| Q71339971 | Bacterial flora of the vagina: quantitative study |
| Q33397287 | Bacterial infection as a presenting manifestation of visceral leishmaniasis |
| Q39830836 | Bacterial pathogens of increasing significance in hospital-acquired infections. |
| Q39632296 | Bacterial resistance to fluoroquinolones |
| Q38286341 | Bacterial resistance to quinolones: mechanisms and clinical importance. |
| Q37988786 | Bacterial tracheitis: report of eight new cases and review |
| Q40337556 | Bactericidal synergism between beta-lactams and aminoglycosides: mechanism and possible therapeutic implications |
| Q39858754 | Bacteriophages of Bacteroides |
| Q40310216 | Bacteriophages of Streptococcus pneumoniae |
| Q69923771 | Bacteriuria and excess mortality: what should the next steps be? |
| Q39694744 | Bacteroides fragilis meningitis |
| Q43678854 | Bacteroides fragilis meningitis: report of two cases |
| Q37817860 | Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection |
| Q41641718 | Basis for Lack of Drug Susceptibility of Atypical Mycobacteria |
| Q68309673 | Bellagio conference on the pathogenesis and prevention of pneumonia in children in developing countries. Bellagio, Italy, 21-25 August 1989 |
| Q69947922 | Benefit-cost aspects of rubella immunization |
| Q52400390 | Benjamin Waterhouse and the introduction of vaccination. By John B. Blake, 1957. |
| Q69710777 | Beta-hemolytic group C streptococci and pharyngitis |
| Q39828277 | Beta-hemolytic group F streptococcal bacteremia: a study and review of the literature |
| Q41213167 | Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story |
| Q68320135 | Beta-lactamase inhibition: therapeutic implication in infectious diseases. St. Philip, Barbados, 20-21 January 1989 |
| Q37404691 | Beta-lactamase inhibition: therapeutic implications in infectious diseases--an overview |
| Q39681873 | Beyond the political model of reporting: nonspecific symptoms in media communication about AIDS. |
| Q40176173 | Biliary Tract Infection with Anaerobes and the Presence of Free Bile Acids in Bile |
| Q50178484 | Biliary pharmacokinetics of sulbactam plus ampicillin in humans |
| Q41182419 | Billroth and Penicillium |
| Q40216490 | Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents. |
| Q70477362 | Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile |
| Q68099557 | Biochemical characterization of type A and type B beta-lactamase from Enterobacter cloacae |
| Q39759562 | Biochemistry of C3 and related thiolester proteins in infection and inflammation |
| Q44115354 | Biographical memoir of Theobald Smith, 1859-1934. |
| Q41200787 | Biography of Charles H. Rammelkamp, Jr |
| Q40134665 | Biohazards of Investigations on the Transmissible Spongiform Encephalopathies |
| Q39130231 | Biological implications of polyparasitism |
| Q39550212 | Biology, ecology, and control of the vampire bat. |
| Q68930504 | Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori |
| Q38143710 | Bismuth subsalicylate: history, chemistry, and safety |
| Q69710771 | Blastocystis hominis as a human pathogen |
| Q69659200 | Blastocystis hominis infection in humans |
| Q39538036 | Blastocystis hominis: an organism in search of a disease |
| Q68703370 | Blastocystis in immunodeficiency diseases |
| Q37557217 | Blastomycosis in Africa: clinical features, diagnosis, and treatment |
| Q43636941 | Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients |
| Q39750242 | Blood cultures: issues and controversies |
| Q39538068 | Bone and joint infections caused by Kingella kingae: six cases and review of the literature |
| Q40803913 | Bone and joint infections in intravenous drug abusers. |
| Q40176213 | Botulism and Tetanus: Selected Epidemiologic and Microbiologic Aspects |
| Q69705954 | Botulism in China |
| Q40298571 | Botulism in the United States--1977. From the Center for Disease Control |
| Q41200773 | Botulism: From van Ermengem to the Present. A Comment |
| Q71339947 | Brain abscess and cerebritis |
| Q48694541 | Brain abscess caused by Listeria monocytogenes. |
| Q39592647 | Brain abscess due to Listeria monocytogenes: case report and literature review |
| Q48511049 | Brain abscesses due to Pseudallescheria boydii associated with primary non-Hodgkin's lymphoma of the central nervous system: a case report and literature review |
| Q39599569 | Branhamella catarrhalis respiratory infections |
| Q40176208 | Breast feeding and toxigenic intestinal infections: missing links in crib death? |
| Q44023125 | Bronchiolitis Obliterans-Organizing Pneumonia Associated with Cryptococcus neoformans Infection |
| Q37988789 | Brucella endocarditis: the role of combined medical and surgical treatment. |
| Q39694761 | Brucellar meningitis. |
| Q39833220 | Brucellar spondylitis: a detailed analysis based on current findings. |
| Q43910235 | Brucellosis: an unusual diagnosis for a seronegative patient with abscesses, osteomyelitis, and ulcerative colitis. |
| Q30457021 | Campylobacter pylori: its link to gastritis and peptic ulcer disease. |
| Q70527493 | Can infectious diseases be eradicated? A report on the International Conference on the Eradication of Infectious Diseases |
| Q43324097 | Can paralytic poliomyelitis be eliminated? |
| Q37229865 | Candida and Aspergillus Infections in Immunocompromised Patients: An Overview |
| Q37696681 | Candida sepsis in pregnancy and the postpartum period |
| Q43855013 | Capnophilic and anaerobic bacteremia in neutropenic patients: an oral source. |
| Q40112336 | Capsular Polysaccharides of Cryptococcus neoformans |
| Q42255994 | Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis |
| Q40231874 | Cardiobacterium hominis: review of microbiologic and clinical features. |
| Q37935910 | Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review |
| Q36924036 | Catheter-Related Infections Caused by the Mycobacterium fortuitum Complex: 15 Cases and Review |
| Q44319462 | Catheter-related right-sided endocarditis in bone marrow transplant recipients |
| Q43858032 | Cefazolin-induced encephalopathy in uremic patients |
| Q70514538 | Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting |
| Q44625083 | Cefonicid: an overview of clinical studies in the United States. |
| Q72783354 | Cefoperazone Therapy for Obstetric and Gynecologic Infections |
| Q72783368 | Cefoperazone as a Prophylactic Agent in Abdominal Hysterectomy |
| Q48662985 | Cefoperazone for the treatment of acute urinary tract infection: multicentered comparative and noncomparative studies |
| Q40837833 | Cefoperazone for the treatment of infections in patients with cancer |
| Q54501608 | Cefoperazone sodium in the treatment of serious bacterial infections in 2,100 adults and children: multicentered trials in Europe, Latin America, and Australasia. |
| Q40114590 | Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro Characteristics |
| Q67250277 | Cefotaxime Therapy for Patients with Osteomyelitis and Septic Arthritis |
| Q33476905 | Cefotaxime and Cephalosporins: Adverse Reactions in Perspective |
| Q67250256 | Cefotaxime in the Treatment of Infections of the Skin and Skin Structure |
| Q40132630 | Cefotaxime toxicity studies: a review of preclinical studies and some clinical reports. |
| Q40132619 | Cefotaxime: A Review of in Vitro Antimicrobial Properties and Spectrum of Activity |
| Q40741271 | Cefoxitin Therapy for Bacterial Endocarditis |
| Q40741284 | Cefoxitin Therapy for Surgical Patients |
| Q41213205 | Cefoxitin and Cephamycins: Microbiological Studies |
| Q40741230 | Cefoxitin for Treatment of Infections Due to Anaerobic Bacteria |
| Q40741291 | Cefoxitin in Obstetric and Gynecologic Infections |
| Q40741297 | Cefoxitin in Treatment of Obstetric and Gynecologic Infections |
| Q41213153 | Cefoxitin: An Overview of Clinical Studies in the United States |
| Q39634878 | Cefoxitin: its role in treatment and prophylaxis of obstetric and gynecologic infections. |
| Q70521069 | Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns |
| Q70521063 | Cefsulodin therapy for osteomyelitis due to Pseudomonas aeruginosa |
| Q40749196 | Ceftazidime Plus Amikacin Versus Ceftazidime Plus Vancomycin as Empiric Therapy in Febrile Neutropenic Children with Cancer |
| Q68829918 | Ceftriaxone treatment of syphilis |
| Q45214383 | Cell-mediated immune response in rubella infections. |
| Q37897915 | Cell-mediated immunity in experimental cytomegalovirus infections: a perspective. |
| Q40286668 | Cell-mediated immunity to viral glycoproteins. |
| Q43575361 | Cellular strategies in receptor-mediated phagocytosis |
| Q33383507 | Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins |
| Q38744790 | Central nervous system infection caused by Pseudallescheria boydii: case report and review |
| Q40199646 | Central venous catheter-induced endocarditis: human correlate of the animal experimental model of endocarditis. |
| Q57479465 | Cephalosporins and Related Antibiotics: An Overview |
| Q33533505 | Cerebral sparganosis: case report and review |
| Q40079246 | Cerebrospinal Fluid Alterations in Herpes Simplex Virus Encephalitis |
| Q50568061 | Certain aspects of medical research and its support. |
| Q69736795 | Cervicovaginal opsonic activity, immunoglobulins, complement, and soluble fibronectin in healthy women randomly assigned to tampon or napkin use |
| Q45828088 | Challenge with rubella virus after loss of detectable vaccine-induced antibody |
| Q39577963 | Changes and Changing Concepts in the Biology of Group A Streptococci and in the Epidemiology of Streptococcal Infections |
| Q37229810 | Changing Pattern of Bone and Joint Infections Due to Staphylococcus aureus: Study of Cases of Bacteremia in Denmark, 1959-1988 |
| Q39830832 | Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections |
| Q39750231 | Characteristic features of neonatal sepsis due to Haemophilus influenzae |
| Q46244950 | Characteristics of group A streptococcal bacteremia in patients at the San Bernardino County Medical Center |
| Q68886285 | Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center |
| Q37696793 | Characteristics of the ideal antibiotic for prevention of wound sepsis among military forces in the field |
| Q54362014 | Characteristics of toxic shock syndrome toxin 1-induced lectin-like activity and inhibitor(s) in rabbit serum. |
| Q47355624 | Characterization of Plasmids from Strains of Mycobacterium avium-intracellulare |
| Q39681893 | Characterization of a nontoxic monophosphoryl lipid A. |
| Q70223964 | Characterization of mannoproteins from a virulent Candida albicans strain and its derived, avirulent strain |
| Q52531099 | Characterization of spiroplasmas by serology. |
| Q44306524 | Characterization of strains of Helicobacter pylori: one-dimensional SDS-PAGE as a molecular epidemiologic tool |
| Q39681899 | Chemical structure and biologic activity of bacterial and synthetic lipid A. |
| Q40310248 | Chemical structure of and immune response to polysaccharides of Streptococcus pneumoniae. |
| Q40315049 | Chemistry and immunochemistry of the pneumococcal polysaccharide vaccine with special reference to cross-reactions and immunologic factors |
| Q70140179 | Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections |
| Q39737839 | Chemotherapeutic approach to control of onchocerciasis. |
| Q39506395 | Chemotherapy for Chagas' disease: a perspective of current therapy and considerations for future research |
| Q71102039 | Chemotherapy for Pulmonary Disease Due to Mycobacterium kansasii: Efficacies of Some Individual Drugs |
| Q39652857 | Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies |
| Q40122771 | Chemotherapy for the Systemic Mycoses: The Prelude to Ketoconazole |
| Q39264522 | Child care practices with respect to acute respiratory tract infection in a poor, urban community in Nigeria |
| Q40261894 | Chloramphenicol: A review of its use in clinical practice. |
| Q50187822 | Choleriform Syndrome and Production of Labile Enterotoxin (CT/LT1)-like Antigen by Species of Salmonella infantis and Salmonella haardt Isolated from the Same Patient |
| Q72954319 | Cholesterol and Phospholipid Uptake by Mycoplasmas |
| Q67915634 | Chronic Fatigue Syndrome: Thoughts on Pathogenesis |
| Q40860591 | Chronic Mucocutaneous Candidosis and Other Superficial and Systemic Mycoses Successfully Treated with Ketoconazole |
| Q67994440 | Chronic Q fever hepatitis |
| Q72056245 | Chronic candida arthritis in leukemic patients |
| Q39737890 | Chronic diarrhea in travelers: diagnostic and therapeutic considerations |
| Q39656832 | Chronic enteroviral meningoencephalitis in agammaglobulinemic patients |
| Q37704067 | Chronic fatigue syndrome and depression: cause, effect, or covariate |
| Q34781965 | Chronic fatigue syndrome in northern Nevada |
| Q37704056 | Chronic fatigue syndrome: issues in the diagnosis and estimation of incidence |
| Q69583366 | Chronic hip pain and limp in a 3-year-old girl |
| Q70235956 | Chronic melioidosis in a Vietnamese immigrant |
| Q71083849 | Chronic staphylococcal osteomyelitis: treatment with regimens containing rifampin |
| Q44984853 | Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates |
| Q46390102 | Ciprofloxacin: In Vitro, Experimental, and Clinical Evaluation |
| Q39652843 | Ciprofloxacin: in vitro activity, mechanism of action, and resistance |
| Q34268701 | Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature |
| Q40848161 | Clarification of the cause of Fort Bragg fever (pretibial fever) - January 1982. |
| Q68920033 | Classics in infections diseases. Significance of hemolytic streptococcic bacteremia: a study of two hundred and forty-six patients. By Chester S. Keefer, Franz J. Ingelfinger, and Wesley W. Spink, 1937 |
| Q70335223 | Classics in infectious diseases. "On abscesses". Alexander Ogston (1844-1929) |
| Q71442023 | Classics in infectious diseases. A contribution to human helminthology: Theodore Bilharz (1825-1862) |
| Q70022393 | Classics in infectious diseases. A contribution to the chemotherapy of bacterial infections. Gerhard Domagk, 1935 |
| Q34198222 | Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as "Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus" in Zeitschrift für Hygiene und Infektionskra |
| Q70227882 | Classics in infectious diseases. Childbed fever by Ignaz Philipp Semmelweis |
| Q40859432 | Classics in infectious diseases. Concerning the epidemic of spotted fever in New England: Elisha North, 1811. |
| Q70398805 | Classics in infectious diseases. Concerning the relationship between phagocytes and anthrax bacilli. By Elie Metchnikoff. 1884 |
| Q71474009 | Classics in infectious diseases. Excerpts from the Natural History of Pliny |
| Q70358681 | Classics in infectious diseases. Letter from Theobald Smith to Edward Krumbhaar |
| Q68886651 | Classics in infectious diseases. Observations on the pathology and treatment of necrosis. By Nathan Smith. 1827 |
| Q69906586 | Classics in infectious diseases. Observations on the sites of removal of bacteria from the blood of patients with bacterial endocarditis. By Paul B. Beeson, Emmett S. Brannon, and James V. Warren |
| Q57116907 | Classics in infectious diseases. On continuous molecular changes, more particularly in their relation to epidemic diseases. By John Snow (1813-1858) |
| Q70342945 | Classics in infectious diseases. On the antiseptic principle of the practice of surgery. By Joseph Lister |
| Q70521075 | Classics in infectious diseases. On the blue and green coloration that appears on bandages. By Carle Gessard (1850-1925) |
| Q52105044 | Classics in infectious diseases. On the epidemiology of Heine-Medin's disease. Reprinted from Acute Poliomyelitis (Heine-Medin's disease), Chapter VIII, by Ivar Wickman, Trans. J. W. J. Maloney. The Journal of Nervous and Mental Disease Publishing C |
| Q40868845 | Classics in infectious diseases. Reprinted from The Journal of Infectious Diseases 1:31-57, 1904. Studies in Pyroplasmosis Hominis ("Spotted Fever" or "Tick Fever" of the Rocky Mountains). |
| Q66899572 | Classics in infectious diseases. Scarlatina by a. trousseau reprinted from Lectures on Cliical Medicine by A. Trousseau. Trans. J. R. Cormack and P. V. Bazire. 2 vols. Lindsay and Blakiston, Philadelphia, 1873 |
| Q40121846 | Classics in infectious diseases. The cultivation of the poliomyelitis viruses in tissue culture by John F. Enders, Frederick C. Robbins, and Thomas H. Weller. |
| Q52412419 | Classics in infectious diseases. The etiology of tuberculosis: Robert Koch. Berlin, Germany 1882. |
| Q40832890 | Classics in infectious diseases. The etiology of yellow fever: a preliminary note. Walter Reed, James Carroll, A. Agramonte, and Jesse W. Lazear, Surgeons, U.S. Army. The Philadelphia Medical Journal 1900 |
| Q52412880 | Classics in infectious diseases. The presence of heterophile antibodies in infectious mononucleosis by John R. Paul and W. W. Bunnell. American Journal of the Medical Sciences, 1932. |
| Q70377828 | Classics in infectious diseases. Toxic products of Bacterium enteritidis and of related micro-organisms. By Sara Elizabeth Branham. Journal of Infectious Diseases 1925 |
| Q34268227 | Classics in infectious diseases: A newly discovered parasite in the blood of patients suffering from malaria. Parasitic etiology of attacks of malaria: Charles Louis Alphonse Laveran (1845-1922). |
| Q34275053 | Classics in infectious diseases: on the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae by Alexander Fleming, Reprinted from the British Journal of Experimental Pathology [...] |
| Q52415772 | Classics in infectious diseases: the relationship of "atypical" acid-fast bacteria to human disease: a preliminary report by Alice Timpe and Ernest H. Runyon. |
| Q70163544 | Classics of infectious diseases. The significance of pneumococcal types by Fred. Griffith, M. B |
| Q37754420 | Classification of Acanthamoeba |
| Q40161669 | Classification of Pathogenic Escherichia coli According to Serotype and the Production of Virulence Factors, with Special Reference to Colonization-Factor Antigens |
| Q39753119 | Classification of beta-lactamases. |
| Q70140168 | Classification of group A streptococcal infection in children |
| Q40267340 | Clindamycin: a review of fifteen years of experience. |
| Q67936890 | Clinical Aspects of Miliary Tuberculosis in Adults |
| Q54513119 | Clinical Comparison of Cefotaxime with Gentamicin plus Clindamycin in the Treatment of Peritonitis and Other Soft-Tissue Infections |
| Q40741302 | Clinical Evaluation of Cefoxitin in Treatment of Infections in 47 Orthopedic Patients |
| Q40741260 | Clinical Evaluation of Cefoxitin in the Treatment of Respiratory Tract and Other Acute Bacterial Infections |
| Q40841575 | Clinical Evaluation of Moxalactam in the Treatment of Respiratory Tract Infections, Hepatobiliary Infections, and Septicemia |
| Q67250231 | Clinical Experience with Cefotaxime in the Treatment of Patients with Bacteremia |
| Q43483286 | Clinical Experience with Cefotaxime in the Treatment of Serious Bone and Joint Infections |
| Q67250177 | Clinical Pharmacokinetics of Cefotaxime in Patients with Normal and Reduced Renal Function |
| Q72775883 | Clinical Studies of Moxalactam in Complicated Urinary Tract Infections |
| Q70924167 | Clinical Studies of Pneumococcal Vaccines in Infants. I. Reactogenicity and Immunogenicity of Two Polyvalent Polysaccharide Vaccines |
| Q70924134 | Clinical Studies of Pneumococcal Vaccines in Infants. II. Efficacy and Effect on Nasopharyngeal Carriage |
| Q54495020 | Clinical Study of Combination Therapy with Oxacillin and Rifampin for Staphylococcal Infections |
| Q44688250 | Clinical Usefulness of Amikacin and Doxycycline in the Treatment of Infection Due to Mycobacterium fortuitum and Mycobacterium chelonei |
| Q70744627 | Clinical and economic impact of cefonicid. A symposium, San Francisco, California, November 18-19, 1982 |
| Q45113028 | Clinical and pharmacokinetic study of parenteral administration of cefsulodin in pediatric patients in Japan. |
| Q37557396 | Clinical applications of chemiluminescence of granulocytes |
| Q38250121 | Clinical aspects and spectrum of illness of toxic shock syndrome: overview |
| Q34504585 | Clinical aspects of African viral hemorrhagic fevers |
| Q39284327 | Clinical aspects of cytomegalovirus retinitis. |
| Q33420963 | Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases |
| Q70183200 | Clinical course of Acanthamoeba keratitis |
| Q53775752 | Clinical diagnosis and changing manifestations of treponemal infection. |
| Q39643604 | Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans |
| Q54773994 | Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms. |
| Q54441865 | Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria. |
| Q72113262 | Clinical evaluation of intravenous trimethoprim-sulfamethoxazole for serious infections |
| Q70742244 | Clinical evaluation of single-dose oral bacampicillin or ampicillin in therapy of uncomplicated gonorrhea |
| Q37777732 | Clinical experience with aztreonam for treatment of infections in children |
| Q52808393 | Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden. |
| Q69923776 | Clinical experience with aztreonam in Germany and Austria |
| Q38960478 | Clinical experience with aztreonam in four Mediterranean countries |
| Q54441868 | Clinical experience with aztreonam in the treatment of gram-negative bacteremia. |
| Q67250250 | Clinical experience with cefotaxime in obstetric and gynecologic infections |
| Q33458016 | Clinical experience with imipenem/cilastatin: analysis of a multicenter study. |
| Q39010248 | Clinical features of Lassa fever in Liberia |
| Q43692095 | Clinical infections and nonsurgical treatment of parapharyngeal space infections complicating throat infection |
| Q39592147 | Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature |
| Q38717699 | Clinical manifestations of Kingella kingae infections: case report and review |
| Q69796464 | Clinical pathologic correlations of Lyme disease |
| Q69842141 | Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function |
| Q39837969 | Clinical pharmacology of aztreonam in healthy recipients and patients: a review |
| Q39694738 | Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy |
| Q69923774 | Clinical studies of aztreonam in Japan |
| Q71309988 | Clinical studies of influenza vaccines: comment |
| Q44252316 | Clinical studies with herpes simplex virus type 2 Curtis strain vaccine |
| Q67250243 | Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract |
| Q38663817 | Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease |
| Q69557232 | Clinical-histologic-microbiologic analysis of 419 lymph node biopsy specimens |
| Q40815417 | Clinically benign fever of unknown origin: a personal retrospective |
| Q39296134 | Clinicopathologic studies of children who die of acute lower respiratory tract infections: mechanisms of death |
| Q39600992 | Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. |
| Q41200720 | Clostridium botulinum: Characteristics and Occurrence |
| Q34373464 | Clostridium difficile: clinical considerations. |
| Q43787286 | Clostridium septicum Bacteremia and Diffuse Spreading Cellulitis of the Head and Neck in a Leukemic Patient |
| Q33420480 | Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever). |
| Q38744808 | Coccidioidomycosis: clinical update |
| Q37174169 | Cognitive and Mood-State Changes in Patients with Chronic Fatigue Syndrome |
| Q44557362 | Colitis Induced by Clostridium difficile |
| Q54697085 | Colorectal surgery: short-term prophylaxis with clindamycin plus aztreonam or gentamicin. |
| Q46234479 | Combination Antifungal Chemotherapy for Experimental Disseminated Cendidiasis: Lack of Correlation Between in Vitro and in Vivo Observations with Amphotericin Band Rifampin |
| Q72873774 | Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band Ketoconazole |
| Q40337629 | Combination of trimethoprim with sulfonamides other than sulfamethoxazole |
| Q70744621 | Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis |
| Q68442204 | Community-Acquired Acinetobacter Pneumonia in Adults in Papua New Guinea |
| Q34542314 | Community-acquired pneumonia requiring hospitalization: 5-year prospective study |
| Q40254064 | Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976. |
| Q47421272 | Community-based action for the control of trachoma |
| Q67261008 | Comparative Pharmacokinetics of Moxalactam, Cefoperazone, and Cefotaxime in Normal Volunteers |
| Q41213073 | Comparative Studies of Cefoxitin and Cephalothin: An Overview |
| Q41532808 | Comparative Susceptibility of Yersinia enterocolitica, Eikenella corrodens, and Penicillin-Resistant and Penicillin-Susceptible Streptococcus pneumoniae to β-Lactam and Alternative Antimicrobial Agents |
| Q41532815 | Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli. |
| Q37900559 | Comparative activity of the 4-quinolones |
| Q68280072 | Comparative antibacterial activity of new quinolone-carboxylic acid derivatives |
| Q54795375 | Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections. |
| Q39837980 | Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis |
| Q67261003 | Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime |
| Q51656463 | Comparative pharmacokinetics of bacampicillin and ampicillin suspensions in infants and children. |
| Q50716085 | Comparative properties of spiroplasmas and emerging taxonomic concepts: a proposal. |
| Q39632241 | Comparative studies of fluoroquinolones in the treatment of urinary tract infections |
| Q70303771 | Comparative studies of impurities in intravenous immunoglobulin preparations |
| Q40304202 | Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria. |
| Q70410618 | Comparative studies of multiple-dose cefoxitin vs. single-dose cefonicid for surgical prophylaxis in patients undergoing biliary tract operations or hysterectomy |
| Q68372996 | Comparison between parental report and results of microbiologic agar assay for presence of antibiotic in urine of Argentinian children with acute lower respiratory tract infection |
| Q41200818 | Comparison of Several Wild-Type Influenza Viruses in the Ferret Tracheal Organ Culture System |
| Q44904344 | Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli |
| Q67294859 | Comparison of bacampicillin twice daily and ampicillin four times daily in treatment of acute exacerbations of chronic bronchitis |
| Q70410606 | Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract |
| Q43667434 | Comparison of cefonicid and cefazolin for treatment of soft-tissue infections |
| Q45996207 | Comparison of fluconazole and ketoconazole in experimental murine blastomycosis. |
| Q68763997 | Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice |
| Q39352311 | Comparison of inactivated poliovirus vaccine and oral poliovirus vaccine programs in Israel |
| Q40841564 | Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections |
| Q46162566 | Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. |
| Q71339961 | Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method |
| Q34177583 | Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly |
| Q70258110 | Comparison of trimethoprim-sulfamethoxazole with ampicillin in acute infectious exacerbations of chronic bronchitis: a double-blind crossover study |
| Q39538166 | Complement and infectious agents |
| Q70843518 | Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae |
| Q37937676 | Complement deficiency and neutrophil dysfunction as risk factors for bacterial infection in newborns and the role of granulocyte transfusion in therapy |
| Q40108867 | Composition and Structure of Lipopolysaccharides from Pseudomonas aeruginosa |
| Q34515128 | Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever |
| Q50207987 | Concepts of the chemical structure of lipid A. |
| Q39652852 | Condyloma acuminatum in the oral cavity: four cases and a review. |
| Q70843531 | Conference on the Pneumococcus: summary and comments |
| Q40121851 | Congenital Disorders of the Functions of Polymorphonuclear Neutrophils |
| Q37897929 | Congenital and perinatal cytomegalovirus infections |
| Q93561623 | Congenital rubella in the United Kingdom before 1970: the prevaccine era |
| Q41933226 | Congenital rubella syndrome and physical growth: a 17-year, prospective, longitudinal follow-up in the Ryukyu Islands |
| Q71598151 | Congenital toxoplasmosis associated with transient monoclonal IgGl-lambda gammopathy |
| Q70486839 | Consequences of the introduction of the new inactivated poliovirus vaccine into the Expanded Programme on Immunization |
| Q37947320 | Considerations for the evaluation of antiretroviral agents in infants and children infected with human immunodeficiency virus: a perspective from the National Cancer Institute. |
| Q38241186 | Considerations for the prevention of infectious complications in patients with cancer. |
| Q68297679 | Considerations in the design of studies of chronic fatigue syndrome. Pittsburgh, Pennsylvania, 15-16 September 1988 |
| Q40290525 | Considerations of the risk of influenza in children and indications for prophylaxis. |
| Q38663770 | Contact systems in infectious disease. |
| Q70227881 | Contaminated breast milk: A source of Klebsiella bacteremia in a newborn intensive care unit |
| Q40304209 | Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo |
| Q39742237 | Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria. |
| Q37214793 | Control of Acute Lower Respiratory Illness in the Developing World: An Assessment of Vaccine Intervention |
| Q54533296 | Control of Infection in the Hospital: Problems in Surgery and the Management of Burns |
| Q71810006 | Control of measles in Brazil |
| Q71809995 | Control of measles in Czechoslovakia (CSSR) |
| Q34267839 | Control of paralytic poliomyelitis in the United States |
| Q50588235 | Control of poliomyelitis by vaccination in Belgium. |
| Q39009259 | Control of poliomyelitis in Africa |
| Q40795772 | Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine |
| Q43317590 | Control of yaws and other endemic treponematoses: implementation of vertical and/or integrated programs |
| Q67294868 | Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract |
| Q39656854 | Controversial areas in antifungal chemotherapy: short-course and combination therapy with amphotericin B. |
| Q69091637 | Controversies in the diagnosis and management of infectious diseases. Implanted devices. Summary and discussion |
| Q68811668 | Controversies in the diagnosis and management of infectious diseases. Session III: AIDS. Summary and discussion |
| Q69091650 | Controversies in the diagnosis and management of infectious diseases: conclusions |
| Q39759532 | Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient. |
| Q39505978 | Controversies in viral diagnosis. |
| Q44013956 | Corneal ulcer caused by Pseudomonas pseudomallei: report of three cases. |
| Q39728875 | Corynebacterium JK: a cause of nosocomial device-related infection |
| Q40234623 | Corynebacterium equi: a review of 12 cases of human infection |
| Q36840051 | Cost and Benefit of Perioperative Antimicrobial Prophylaxis: Methods for Economic Analysis |
| Q71598137 | Cost and benefit in control of nosocomial infection: methods for analysis |
| Q70744653 | Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration |
| Q50167289 | Cost effectiveness of alternative strategies for poliomyelitis immunization in Brazil. |
| Q71631279 | Cost-benefit analysis of vaccines |
| Q39847100 | Cost-effectiveness of different strategies for prevention of congenital rubella infection: a practical example from Iceland |
| Q69796455 | Coxiella burnetii infection in prosthetic devices |
| Q38019131 | Creation of a research program to determine the etiology and epidemiology of acute respiratory tract infection among children in developing countries |
| Q71407505 | Criteria for assessing accomplishment of poliomyelitis control |
| Q71415760 | Criteria for evaluation of therapeutic response to antifungal drugs |
| Q54737215 | Cross-allergenicity and immunogenicity of aztreonam. |
| Q39315030 | Cross-sex transmission of infection and increased mortality due to measles |
| Q37918322 | Cryptococcal skeletal infections: case report and review |
| Q39302479 | Cryptogenic group A streptococcal bacteremia: experience at an urban general hospital and review of the literature |
| Q68074461 | Cryptosporidiosis in patients with hematologic malignancies |
| Q40181084 | Cryptosporidiosis: clinical, epidemiologic, and parasitologic review |
| Q68925444 | Cryptosporidium and cryptosporidiosis |
| Q70172365 | Cryptosporidium in asymptomatic children |
| Q71407457 | Cuba: mass polio vaccination program, 1962-1982 |
| Q39688311 | Cultural practices contributing to the transmission of human immunodeficiency virus in Africa |
| Q39550186 | Cunninghamella bertholletiae infection associated with deferoxamine therapy. |
| Q69493534 | Cure of bacille Calmette-Guérin vaccination abscesses with erythromycin |
| Q67006788 | Current Perspectives and Priorities for Research in Infant Botulism |
| Q68597870 | Current advances in the diagnosis and treatment of AIDS: an introduction |
| Q44325989 | Current advances in viral diagnostic technology applicable to polio vaccination and diagnosis |
| Q40167165 | Current approach to prevention and treatment of Pseudomonas aeruginosa infections in burned patients |
| Q39660501 | Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis |
| Q38488961 | Current impact of measles in Latin America. |
| Q50589268 | Current impact of measles in the United Kingdom. |
| Q39550241 | Current issues in human rabies immunization |
| Q41445600 | Current measles control in Tanzania |
| Q39830841 | Current needs in chemotherapy for bacterial and fungal infections. |
| Q67994456 | Current oral rabies vaccination in Europe: an interim balance |
| Q38580959 | Current poliovirus vaccines. |
| Q44278254 | Current practices for treatment of dysentery in rural Bangladesh. |
| Q40304180 | Current practices in antimicrobial dosing |
| Q39837990 | Current problems in antibiotic treatment in obstetrics and gynecology |
| Q70432299 | Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa |
| Q67250162 | Current status of cefotaxime sodium: a new cephalosporin. A symposium. Phoenix, Arizona, January 12 and 13, 1981 |
| Q30670246 | Current taxonomy of medically important nonsporing anaerobes. |
| Q70463738 | Current topics in mycoplasmology. Symposia and abstracts of papers presented at the third meeting of the International Organization for Mycoplasmology. Custer, South Dakota, September 3-9, 1980 |
| Q40181075 | Current trends in immunodiagnosis of candidiasis and aspergillosis. |
| Q54112966 | Cutaneoarticular mucormycosis due to Cunninghamella bertholletiae in a patient with AIDS. |
| Q46449829 | Cutaneous Mycobacterium thermoresistibile infection in a heart transplant recipient |
| Q40304151 | Cutaneous and soft-tissue manifestations of sepsis due to gram-negative enteric bacilli. |
| Q39550197 | Cutaneous manifestations of infection with Corynebacterium group JK. |
| Q46798523 | Cytomegaloviral Infections in the Guinea Pig: Experimental Models for Human Disease |
| Q40121832 | Cytomegalovirus Immunization: Status, Prospects, and Problems |
| Q68238559 | Cytomegalovirus Infection of the Submandibular Gland in a Patient with AIDS |
| Q40129412 | Cytomegalovirus Infections Following Renal Transplantation |
| Q37897920 | Cytomegalovirus antigenemia. |
| Q37897940 | Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. |
| Q37897938 | Cytomegalovirus in the setting of infection with human immunodeficiency virus |
| Q37897933 | Cytomegalovirus infection after liver transplantation: clinical manifestations and strategies for prevention |
| Q69842133 | Cytomegalovirus infection and treatment with ganciclovir. A conference. San Francisco, California, 21-22 May 1987. Proceedings |
| Q41931310 | Cytomegalovirus infection in children with AIDS. |
| Q37897935 | Cytomegalovirus infections after allogeneic bone marrow transplantation |
| Q68485414 | Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy |
| Q68161486 | Cytomegalovirus infections: epidemiology, diagnosis and treatment strategies. Proceedings of a symposium. Cambridge, Massachusetts. 10-12 November 1988 |
| Q37897910 | Cytomegalovirus: where have we been and where are we going? |
| Q36461245 | Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients |
| Q44038568 | Damaging effect of toxic shock syndrome toxin 1 on chick embryo cells in vitro |
| Q39742227 | Day care homes: the "silent majority" of child day care. |
| Q40143660 | Defective Responses to Lipid A in C3H/HeJ Mice: Approaches to an Understanding of Lipid A-Cell Interaction |
| Q41165777 | Defining the chronic fatigue syndrome |
| Q37704082 | Definition and measurement of fatigue |
| Q46817945 | Definition of polymicrobial bacteremia |
| Q70163490 | Degenerative changes in fungi after itraconazole treatment |
| Q40286653 | Degradation of microorganisms by phagocytic cells. |
| Q93561628 | Delayed manifestations of congenital rubella |
| Q39537992 | Delayed rupture of the radial artery caused by catheter-related sepsis. |
| Q40837442 | Delayed-type hypersensitivity: probable role in the pathogenesis of dengue hemorrhagic fever/dengue shock syndrome |
| Q39660479 | Delusions of parasitosis: a review. |
| Q39603023 | Depression of neutrophil function induced by viruses and its role in secondary microbial infections. |
| Q44634069 | Dermatologic manifestations of Lyme disease |
| Q48415147 | Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. |
| Q52413773 | Derrick Graham ff. Edward: a pioneer in mycoplasmology. |
| Q43316938 | Design and modification of the day care environment |
| Q39538006 | Detached ciliary tufts mistaken for peritoneal parasites: a warning. |
| Q37174090 | Detection of Epstein-Barr Virus with Molecular Hybridization Techniques |
| Q46916749 | Detection of Streptococcus pneumoniae and Haemophilus influenzae type b antigens in the serum and urine of patients with pneumonia in Papua New Guinea: comparison of latex agglutination and counterimmunoelectrophoresis. |
| Q68074478 | Detection of the source of recurrent Staphylococcus aureus bacteremia by ultrafast computerized tomography |
| Q40210287 | Determinants of the biologic activity of surface slime in experimental Pseudomonas aeruginosa infections |
| Q69058587 | Determination of biologically active region in toxic shock syndrome toxin 1 |
| Q40836462 | Development and characteristics of live AIK-C measles virus vaccine: a brief report |
| Q44711469 | Development and evaluation of the spiral gradient endpoint method for susceptibility testing of anaerobic gram-negative bacilli |
| Q38675505 | Development and strategies of the Colombian vaccination program |
| Q68303264 | Development of Acanthamoeba-cornea coincubation assays |
| Q54293637 | Development of Resistance to Ciprofloxacin During Therapy for a Pseudomonas aeruginosa Lung Abscess |
| Q45861023 | Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. |
| Q45094717 | Development of animal recombinant DNA vaccine and its efficacy in foxes |
| Q93653092 | Development of trachoma control programs and the involvement of national resources |
| Q34162499 | Development of vaccines against hepatitis A and hepatitis B. |
| Q50549445 | Dexamethasone for the treatment of children and adults with bacterial meningitis. |
| Q69894423 | Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome |
| Q68647608 | Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan |
| Q40148406 | Diagnosis and Empiric Therapy of Urinary Tract Infection in the Seriously Ill Patient |
| Q38143693 | Diagnosis of Campylobacter pylori infections: the "gold standard" and the alternatives. |
| Q69842136 | Diagnosis of cytomegalovirus infection |
| Q68021118 | Diagnosis of gastritis caused by Helicobacter pylori in children by means of an ELISA |
| Q69493530 | Diagnostic value of serum antibody and antigen detection in heroin addicts with systemic candidiasis |
| Q40266021 | Dialysis-associated hepatitis in Edinburgh; 1969-1978. |
| Q30457020 | Diarrhea in developed and developing countries: magnitude, special settings, and etiologies |
| Q40756785 | Diarrhea, fever, hypoxia, and rash in a house officer |
| Q34672575 | Did scarlet fever and rheumatic fever exist in Hippocrates' time? |
| Q67261000 | Differences Among Moxalactam, Cefoperazone, and Cefotaxime in Activity Against Multiple-Antibiotic-Resistant Gram-Negative Bacteria |
| Q71407434 | Different secretory IgA antibody responses after immunization with inactivated and live poliovirus vaccines |
| Q40298555 | Differential Diagnosis of Infant Botulism |
| Q37754374 | Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli |
| Q40315011 | Direct effects of hyperthermia on pathogenic microorganisms: Teleologic implications with regard to fever. |
| Q69971124 | Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria |
| Q39837964 | Discovery and development of the monobactams |
| Q37918350 | Discovery of fluconazole, a novel antifungal agent |
| Q71102050 | Disease Due to Mycobacterium intracellulare: Its Possible Association with Human Leukocyte Antigens |
| Q38663813 | Disease exacerbation caused by sequential dengue infections: myth or reality? |
| Q33428269 | Disorders associated with antibodies to endothelial cells |
| Q36924033 | Disseminated Infection with Fusarium in Recipients of Bone Marrow Transplants |
| Q43560534 | Disseminated Pelvic Actinomycosis Presenting as Metastatic Carcinoma: Association with the Progestasert Intrauterine Device |
| Q38717696 | Disseminated Phialophora parasitica infection in humans: case report and review |
| Q40764659 | Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states |
| Q68703380 | Disseminated fusarial infection |
| Q39550172 | Disseminated fusarial infection in the immunocompromised host |
| Q44693553 | Disseminated fusarial infection. |
| Q68597876 | Disseminated infection due to Mycobacterium fortuitum in a patient with AIDS |
| Q68779471 | Disseminated infection with Trichosporon beigelii |
| Q38717683 | Disseminated zygomycosis: report of four cases and review |
| Q69971133 | Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin |
| Q72775859 | Distribution of Moxalactam in Serum, Bone, Tissue Fluid, and Peritoneal Fluid |
| Q46512149 | Diversity of outer membrane protein profiles of nontypable Haemophilus influenzae from children from Papua New Guinea and the Philippines |
| Q48545218 | Do You Practice What You Preach? |
| Q39652861 | Do the beta-hemolytic non-group A streptococci cause pharyngitis? |
| Q39303335 | Does Penicillin Kill Bacteria? |
| Q71155325 | Does epizootic lymphocytic choriomeningitis prime the pump for epidemic rickettsialpox? |
| Q39694729 | Does serum protein binding inhibit tissue penetration of antibiotics? |
| Q30386553 | Does vaccination with bacille Calmette-Guérin protect against AIDS? |
| Q39550220 | Dog ecology and dog rabies control. |
| Q39292679 | Domestic animal rabies control: an overview |
| Q40350770 | Dosage schedules of antimicrobial agents: a historical review. |
| Q30460025 | Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system |
| Q68764002 | Drug interactions with fluconazole |
| Q68128917 | Drug interactions with quinolones |
| Q38364042 | Drug interactions with quinolones. |
| Q39453485 | Drug therapy for diarrheal diseases: a look ahead |
| Q40293528 | Drug-Inactivating Enzymes of Bacteria Grown in Subminimal Inhibitory Concentrations of Antibiotics |
| Q40847856 | Drug-induced fever: cases seen in the evaluation of unexplained fever in a general hospital population |
| Q45170345 | Duration of immunity after rubella vaccination: a long-term study in Switzerland |
| Q39681828 | Dysgonic fermenter 2 septicemia |
| Q43209907 | Dysgonic fermenter 2 septicemia |
| Q70365311 | ELISA and RIA for serologic diagnosis of yersiniosis |
| Q37935914 | Early diagnosis of Nocardia asteroides endophthalmitis by retinal biopsy: case report and review. |
| Q70163502 | Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results |
| Q37988801 | Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review |
| Q34151434 | Eaton agent--science and scientific acceptance: a historical commentary |
| Q70172362 | Echinococcosis (Hydatid disease): lessons from experience with 59 patients |
| Q68074444 | Echinococcosis in the Middle East and Turkey |
| Q39550200 | Ecology and epidemiology of fox rabies |
| Q45077213 | Ecology and epidemiology of raccoon rabies |
| Q34115815 | Ecology of Acanthamoeba |
| Q51216709 | Ecology of toxic shock syndrome: amplification of toxic shock syndrome toxin 1 by materials of medical interest. |
| Q70514549 | Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin |
| Q30460082 | Economic benefits of an effective infection control program: case study and proposal |
| Q39660536 | Economic evaluations of antibiotic use and resistance--a perspective: report of Task Force 6. |
| Q44408667 | Editorial Response to Brook: Comparison of In Vivo Methods for Determination of Antimicrobial Efficacy |
| Q71809992 | Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia |
| Q68520673 | Edward H. Kass, M.D., eulogy |
| Q70296057 | Effect of Antibiotics on Production of Enzymes and Toxins By Microorganisms |
| Q40293522 | Effect of Serum and Blood on Enterobacteriaceae Grown in the Presence of Subminimal Inhibitory Concentrations of Ampicillin and Mecillinam |
| Q39590565 | Effect of Subminimal Inhibitory Concentrations of Mecillinam on the Synthesis of DNA, RNA, and Protein of Salmonella typhimurium: A Proposed Mechanism of Action* |
| Q50208043 | Effect of altered lipid A synthesis on the synthesis of major proteins of the Salmonella typhimurium outer membrane |
| Q39846500 | Effect of antibiotics on adherence of microorganisms to epithelial cell surfaces |
| Q40750986 | Effect of antibiotics on food intake and absorption of nutrients for children with diarrhea due to Shigella |
| Q68712132 | Effect of bismuth subsalicylate on Clostridium difficile colitis in hamsters |
| Q68712129 | Effect of bismuth subsalicylate on chronic diarrhea in childhood: a preliminary report |
| Q68712125 | Effect of bismuth subsalicylate on fecal microflora |
| Q39833197 | Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies |
| Q70183171 | Effect of contact lens disinfectants against Acanthamoeba cysts |
| Q40775855 | Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes. |
| Q54469331 | Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa. |
| Q40773244 | Effect of hospitalwide change in clindamycin dosing schedule on clinical outcome |
| Q70744647 | Effect of hydrogen ion and protein concentrations on the activity of beta-lactam antibiotics |
| Q54447959 | Effect of imipenem/cilastatin on the colonic microflora. |
| Q54381299 | Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria. |
| Q70303774 | Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats |
| Q46106077 | Effect of magainins on Acanthamoeba castellanii |
| Q39100217 | Effect of magnesium on in vitro production of toxic shock syndrome toxin 1. |
| Q39632248 | Effect of new quinolones on the human gastrointestinal microflora. |
| Q68930476 | Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer |
| Q70159395 | Effect of prophylactic administration of sulbactam/ampicillin on the rate of postoperative endometritis after first-trimester abortion |
| Q54494816 | Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus. |
| Q69971114 | Effect of tampon wraps on production of toxic shock syndrome toxin 1 |
| Q64129788 | Effect of trace metals on the synthesis of toxic shock syndrome toxin 1 |
| Q50551192 | Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. |
| Q70311118 | Effectiveness of immunization with multicomponent vaccines in protection against hemorrhagic pneumonia due to Pseudomonas aeruginosa infection in mink |
| Q72744241 | Effects of Lipid A on the Immunologic Properties of Liposomal Model Membranes |
| Q72775831 | Effects of Moxalactam on Blood Coagulation and Platelet function |
| Q40298576 | Effects of Murine Cytomegalovirus Infection on the Immune Response to a Tumor Allograft |
| Q39590569 | Effects of Subminimal Inhibitory Concentrations of Ampicillin, Chloramphenicol, and Nitrofurantoin on the Attachment of Escherichia coli to Human Uroepithelial Cells in Vitro |
| Q41182411 | Effects of Subminimal Inhibitory Concentrations of Antibiotics in Experimental Infections |
| Q41182400 | Effects of Subminimal Inhibitory Concentrations of Antibiotics on Adhesiveness of Escherichia coli in Vitro* |
| Q46718068 | Effects of antibiotic-diuretic interactions in the guinea pig model of ototoxicity |
| Q40244016 | Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte |
| Q39825883 | Effects of bacterial endotoxins on neutrophil function |
| Q45217654 | Effects of corticosteroids in experimental Acanthamoeba keratitis |
| Q40779142 | Effects of drugs on the pyrogenicity of toxic shock syndrome toxin 1 and its capacity to enhance susceptibility to the lethal effects of endotoxic shock in rabbits |
| Q69971127 | Effects of monoclonal antibody on biologic function of toxic shock syndrome toxin 1 in vitro and in vivo |
| Q54697076 | Efficacy and safety of aztreonam in the treatment of patients with renal failure. |
| Q39830861 | Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience. |
| Q70226012 | Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli |
| Q28287917 | Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children |
| Q72775873 | Efficacy of Moxalactam in an Animal Model of Subcutaneous Abscesses: Penetration into Infected Sites and in Vivo Activity Against Bacteroides fragilis |
| Q67005021 | Efficacy of Parenteral Antibiotics in the Treatment of Experimentally Induced Intraabdominal Sepsis |
| Q70924142 | Efficacy of Pneumococcal Polysaccharide Vaccine in Preventing Acute Otitis Media in Infants in Huntsville, Alabama |
| Q61446756 | Efficacy of Sulbactam plus Ampicillin in Gynecologic Infections |
| Q70183175 | Efficacy of a chlorhexidine tablet system for disinfection of soft contact lenses against Acanthamoeba species |
| Q45833285 | Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). |
| Q54494813 | Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. |
| Q70226002 | Efficacy of aztreonam in the treatment of neonatal sepsis |
| Q70226010 | Efficacy of aztreonam in the treatment of skeletal infections due to Pseudomonas aeruginosa |
| Q43514589 | Efficacy of cell wall Pseudomonas aeruginosa vaccines for protection against experimental pneumonia |
| Q70183167 | Efficacy of contact lens disinfecting solutions for prevention of Acanthamoeba keratitis |
| Q39825871 | Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans |
| Q43587499 | Efficacy of fluconazole in experimental invasive aspergillosis |
| Q68505806 | Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis |
| Q70178749 | Efficacy of pneumococcal polysaccharide vaccines |
| Q37900073 | Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections |
| Q46146686 | Elevation of meal-stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH. |
| Q70220548 | Elimination of Poliomyelitis in Finland |
| Q40836117 | Elimination of indigenous measles from the United States. |
| Q72677435 | Elucidation of the Antigenic Architecture of the Acholeplasma laidlawii Cell Membrane by Immunoabsorption in Combination with Crossed Immunoelectrophoresis |
| Q34212074 | Emergence of Antibiotic Resistance In Hospitals, 1935-1975 |
| Q40158888 | Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the Future |
| Q54494485 | Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases. |
| Q37988815 | Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora |
| Q48415155 | Emmy Klieneberger-Nobel Award Lecture: The protein fingerprints of mycoplasmas. |
| Q37988813 | Emphysematous gastritis: case report and review |
| Q40148434 | Empiric Antibiotic Therapy for Intraabdominal Infections |
| Q37229872 | Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients |
| Q39833202 | Empiric amphotericin B therapy in patients with acute leukemia |
| Q72783347 | Empiric therapy for bacterial infections. Evaluation of cefoperazone. A symposium. Geneva, Switzerland October 4-5, 1981 |
| Q40837751 | Empiric therapy for bacterial infections: the historical perspective |
| Q40148413 | Empiric therapy for bacterial meningitis. |
| Q40148395 | Empiric therapy for pneumonia. |
| Q37404707 | Empiric therapy for the immunocompromised host |
| Q40148383 | Empiric treatment of infections in neutropenic patients with cancer |
| Q67994436 | Empyema in pneumococcal bacteremia |
| Q39158213 | Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis. |
| Q37328308 | Endemic infectious diseases of the Middle East |
| Q39316735 | Endemic nonvenereal treponematosis (bejel) in Saudi Arabia |
| Q43568199 | Endemic treponematoses in Togo and other west African states |
| Q46691544 | Endemic treponematoses in the Sudan |
| Q37229827 | Endocarditis Due to Trichosporon beigelii: In Vitro Susceptibility of Isolates and Review |
| Q39694749 | Endocarditis caused by Kingella indologenes |
| Q37557381 | Endocarditis due to Corynebacterium pseudodiphtheriticum: five case reports, review, and antibiotic susceptibilities of nine strains. |
| Q43745446 | Endocarditis due to Kingella species |
| Q43651819 | Endocarditis due to Streptococcus faecalis with high-level resistance to gentamicin. |
| Q28331945 | Endocarditis due to ampicillin-resistant nontyphoid Salmonella: cure with a third-generation cephalosporin |
| Q39681840 | Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma |
| Q70317825 | Endogenous aspergillus endophthalmitis |
| Q37737175 | Endophthalmitis caused by non-albicans species of Candida |
| Q39728866 | Endophthalmitis following intraocular lens implantation: report of 30 cases and review of the literature |
| Q45423915 | Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole |
| Q44906709 | Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages |
| Q41352088 | Endotoxin is not an essential mediator in toxic shock syndrome |
| Q39158224 | Endotoxins, arachidonic acid, and superoxide formation |
| Q39538084 | Enhancement by calcium of the invasiveness of Salmonella for HeLa cell monolayers |
| Q70601391 | Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin |
| Q33399936 | Enterobacter bacteremia in pediatric patients |
| Q55062954 | Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance. |
| Q44096723 | Enterococcal Infections in Patients Treated with Moxalactam |
| Q37557350 | Enterococcal bacteremia in a pediatric institution: a four-year review. |
| Q69945197 | Enterococcal bacteremia: analysis of 75 episodes |
| Q68021089 | Enterococcal bacteremia: to treat or not to treat, a reappraisal |
| Q43991320 | Enterococcal endocarditis: a comparison of prosthetic and native valve disease |
| Q46148425 | Enterovirus Type 71 Infections: A Varied Clinical Pattern Sometimes Mimicking Paralytic Poliomyelitis |
| Q44534376 | Environmental Factors in Nosocomial Infection--A Selective Focus |
| Q39737860 | Environmental interventions for the prevention of travelers' diarrhea. |
| Q39660497 | Environmental nonhuman sources of leprosy |
| Q40264195 | Enzyme immunoassays for the detection of infectious antigens in body fluids: current limitations and future prospects |
| Q70159383 | Enzyme-mediated resistance to beta-lactam antibiotics: a symposium on sulbactam/ampicillin. Cairo, Egypt, April 18-19, 1985 |
| Q40141963 | Enzymes associated with the survival and virulence of gram-negative anaerobes. |
| Q40088619 | Epidemic hemorrhagic fever revisited |
| Q68118414 | Epidemic measles in a highly immunized rural West African (Gambian) village |
| Q40264188 | Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model. |
| Q68141899 | Epidemics and crowd-diseases: measles. By Major Greenwood, 1935 |
| Q45974308 | Epidemiologic Characteristics of Infant Botulism in the United States, 1975–1978 |
| Q36559533 | Epidemiologic Markers of Clostridium difficile |
| Q53162760 | Epidemiologic Studies of Lung Disease Due to Mycobacteria Other than Mycobacterium tuberculosis in Japan |
| Q50588210 | Epidemiologic aspects of poliomyelitis eradication. |
| Q37754322 | Epidemiologic aspects of shigellosis and other causes of dysentery in Thailand |
| Q68886299 | Epidemiologic characteristics and factors influencing the outcome of Pseudomonas aeruginosa bacteremia |
| Q70687757 | Epidemiologic designs for the study of acquired immunodeficiency disease: options and obstacles |
| Q68647592 | Epidemiologic risk factors for children with acute lower respiratory tract infection in Buenos Aires, Argentina: a matched case-control study |
| Q39488440 | Epidemiologic studies of travelers' diarrhea, severe gastrointestinal infections, and cholera |
| Q71240458 | Epidemiologic surveillance in the control of infectious disease |
| Q39356560 | Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America |
| Q44671009 | Epidemiological Spectrum and Current Treatment of Listeriosis |
| Q38717737 | Epidemiology and clinical similarities of human spirochetal diseases |
| Q39694767 | Epidemiology and ecology of rickettsial diseases in the People's Republic of China |
| Q38143758 | Epidemiology and pathophysiology of Campylobacter pylori infections |
| Q37937677 | Epidemiology and potential methods for prevention of neonatal intestinal viral infections |
| Q38675546 | Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries |
| Q44445606 | Epidemiology and specific prophylaxis of measles. |
| Q54478238 | Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics. |
| Q40176225 | Epidemiology of Clostridium difficile-Induced Intestinal Disease |
| Q39855754 | Epidemiology of Klebsiella and Hospital-Associated Infections |
| Q43411771 | Epidemiology of Mycobacteria Other than Tubercle Bacilli in South Africa |
| Q34795450 | Epidemiology of acute respiratory infections in children of developing countries |
| Q44842837 | Epidemiology of acute respiratory tract infections among Guatemalan ambulatory preschool children. |
| Q46549244 | Epidemiology of acute respiratory tract infections among young children in Kenya |
| Q70843506 | Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States |
| Q39821323 | Epidemiology of congenital rubella and results of rubella vaccination in Australia |
| Q39496189 | Epidemiology of cytomegaloviral infections: recommendations for prevention and control |
| Q37897911 | Epidemiology of cytomegalovirus infections |
| Q38280926 | Epidemiology of genital papillomaviruses and cervical cancer |
| Q38280956 | Epidemiology of hemorrhagic fever viruses |
| Q38919013 | Epidemiology of infection in pregnancy |
| Q39688294 | Epidemiology of infections caused by gentamicin-resistant enterobacteriaceae and Pseudomonas aeruginosa over 15 years at the Nashville Veterans Administration Medical Center |
| Q40216484 | Epidemiology of infections due to Pseudomonas aeruginosa |
| Q41456555 | Epidemiology of malaria in Malaysia |
| Q69493525 | Epidemiology of pertussis |
| Q34163463 | Epidemiology of rotaviral infection in adults |
| Q45155445 | Epidemiology of rubella and congenital rubella infection in Israel, a country with a selective immunization program |
| Q41499158 | Epidemiology of rubella and congenital rubella infection in Japan |
| Q37898669 | Epidemiology of sexually transmitted diseases in rape victims |
| Q38612214 | Epidemiology of toxic shock syndrome in the United States: overview. |
| Q38143742 | Epidemiology of travelers' diarrhea and relative importance of various pathogens. |
| Q39199474 | Epidemiology of travelers' diarrhea: current perspectives |
| Q37905377 | Epidemiology of venereal urethritis: comparison of gonorrhea and nongonococcal urethritis. |
| Q37696657 | Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center. |
| Q38349358 | Epitopes of the cholera family of enterotoxins. |
| Q38717732 | Epizootiology of Borrelia in Ixodes tick vectors and reservoir hosts |
| Q38264981 | Epstein-Barr virus and the elderly host |
| Q40132049 | Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. |
| Q39493493 | Equine infectious anemia virus: immunopathogenesis and persistence |
| Q39295703 | Eradication of poliomyelitis in the United States |
| Q40286694 | Eradication of poliomyelitis in the United States. I. Live virus vaccine-associated and wild poliovirus disease. |
| Q40257836 | Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine. |
| Q40286701 | Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations |
| Q71251423 | Eradication of poliomyelitis in the United States: a commentary on the Salk reviews |
| Q56780416 | Eradication, elimination, and control: which disease next? |
| Q67962445 | Erysipelothrix rhusiopathiae endocarditis |
| Q67994438 | Erysipelothrix rhusiopathiae endocarditis |
| Q39643608 | Erysipelothrix rhusiopathiae endocarditis: microbiologic, epidemiologic, and clinical features of an occupational disease |
| Q34497320 | Erythema migrans: a chronicle. |
| Q37557355 | Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: case report and review |
| Q64052097 | Esophageal tuberculosis: mimicry of gastrointestinal malignancy |
| Q40800276 | Esophagitis in the immunocompromised host: role of esophagoscopy in diagnosis. |
| Q39660515 | Estimating worldwide current antibiotic usage: report of Task Force 1. |
| Q36924039 | Estrogens and infection. |
| Q40141976 | Estrogens, Breast Cancer, and Intestinal Flora |
| Q72775834 | Ethanol-Moxalactam Interactions in Vivo |
| Q39688329 | Ethical dilemmas about intensive care for patients with AIDS. |
| Q43651851 | Etiologic and clinical evaluation of acute lower respiratory tract infections in young Argentinian children: an overview. |
| Q68647599 | Etiologic, clinical, and pathologic analysis of 31 fatal cases of acute respiratory tract infection in Argentinian children under 5 years of age |
| Q68164753 | Etiology and epidemiology of acute respiratory tract infection in children in developing countries. Irvine, California, 20-22 October 1988. Proceedings |
| Q39737855 | Etiology and epidemiology of travelers' diarrhea in Asia |
| Q30456145 | Etiology and mortality of bacterial meningitis in northeastern Brazil |
| Q34795460 | Etiology of Acute Respiratory Infections in Children in Tropical Southern India |
| Q39538065 | Etiology of acute lower respiratory tract infection in children from Alabang, Metro Manila. |
| Q39027662 | Etiology of infection and morphologic changes in the lungs of Filipino children who die of pneumonia |
| Q40358279 | Evaluation of Antibiotic Usage: A Comprehensive Look at Alternative Approaches |
| Q71108847 | Evaluation of antimicrobial agents in the rabbit model of endocarditis |
| Q36461166 | Evaluation of herpes simplex virus vaccines in animals: the guinea pig vaginal model |
| Q68898074 | Evaluation of new beta-lactam antibiotics |
| Q70453243 | Evaluation of rifampin and other antibiotics against Listeria monocytogenes in vitro and in vivo |
| Q28328527 | Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics |
| Q38621878 | Evaluation of the protective potency of new tuberculosis vaccines. |
| Q46921223 | Evaluation of the rabbit as a model of Acanthamoeba keratitis |
| Q38744934 | Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital |
| Q39756071 | Evolution of antifungal agents: past, present, and future |
| Q54333858 | Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain. |
| Q71810009 | Evolution of the measles vaccination program in Costa Rica |
| Q71407476 | Evolution of the poliomyelitis vaccination program in Costa Rica |
| Q39284300 | Evolution of therapy for cytomegalovirus infection |
| Q36431984 | Evolution of β-Lactamase Inhibitors |
| Q43769543 | Examination of neutrophil function in a rat model of decreased host resistance following burn trauma |
| Q70183196 | Examination of the contact lens with light microscopy: an aid in diagnosis of Acanthamoeba keratitis |
| Q38016835 | Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review |
| Q44423947 | Exchange transfusion for malaria: what are the indications? |
| Q46667294 | Expanded Programme on Immunization in Nigeria. |
| Q69685978 | Expanded Programme on Immunization in Thailand |
| Q38902339 | Experience in field rabies control programs |
| Q45270469 | Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia |
| Q39550234 | Experience with preexposure rabies vaccination |
| Q39538018 | Experience with trimethoprim-sulfamethoxazole in treatment of infective endocarditis |
| Q50588231 | Experiences associated with the use of live poliovirus vaccine in Hungary, 1959-1982. |
| Q38072032 | Experimental Animal Models for Anaerobic Infections |
| Q36924068 | Experimental Infection of Human Subjects with Strongyloides Species |
| Q50937883 | Experimental Infections with Mycobacterium intracellulare |
| Q72721265 | Experimental Studies of the Pathogenesis of Infections Due to Pseudomonas aeruginosa: Effect of Treatment with Protease Inhibitors |
| Q40835333 | Experimental Studies on the Virus of "Q" Fever |
| Q37918373 | Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts |
| Q54494494 | Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents. |
| Q37557227 | Experimental infection of humans with filariae. |
| Q40310253 | Experimental infections of animals in the study of Streptococcus pneumoniae |
| Q37557224 | Experimental leishmaniasis in humans: review |
| Q38684682 | Experimental models in drug development for helminthic diseases |
| Q38388982 | Experimental visna in Icelandic sheep: the prototype lentiviral infection |
| Q54380570 | Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. |
| Q40785225 | Extraction of protective components of Rickettsia rickettsii with n-octyl-beta-D-glucopyranoside |
| Q67936917 | Extrapulmonary Infection with Pneumocystis carinii in Patients Receiving Aerosolized Pentamidine |
| Q37935908 | Extrapulmonary Pneumocystis carinii infections |
| Q38016838 | Extrapulmonary pneumocystosis: the first 50 cases |
| Q53864617 | Extrapulmonary tuberculosis in an immigrant society: clinical and demographic aspects of 92 cases. |
| Q37935918 | Facial nerve paralysis and Kawasaki disease |
| Q40110154 | Factors Affecting the Clinical Value of Microscopy for Acid-Fast Bacilli |
| Q36443591 | Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review |
| Q64451676 | Factors influencing the adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells |
| Q71102090 | Factors that Affect the Cell Cycle of Mycobacterium avium |
| Q44753338 | Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. |
| Q39618245 | Failure to thrive, wasting syndrome, and immunodeficiency in rabies: a hypophyseal/hypothalamic/thymic axis effect of rabies virus |
| Q67830372 | Fatal Necrotizing Otitis Externa in a Patient with AIDS |
| Q39652873 | Fatal endocarditis due to Listeria monocytogenes |
| Q37229850 | Fatal varicella in an adult: case report and review of the gastrointestinal complications of chickenpox |
| Q50701117 | Feasibility of eradicating yaws. |
| Q38675518 | Feasible improvements in vaccines in the Expanded Programme on Immunization |
| Q45232718 | Federal funding for AIDS research: decision process and results in fiscal year 1986. |
| Q93561652 | Fetal risk associated with rubella vaccine: an update |
| Q40773240 | Fever and headache in a splenectomized woman |
| Q40811233 | Fever associated with repeated intramuscular injections of analgesics |
| Q40762357 | Fever, abdominal pain, and headache in an Iranian woman |
| Q40753176 | Fever, dyspnea, and slurred speech following lower extremity trauma |
| Q40760384 | Fever, hepatosplenomegaly, and pancytopenia in a 39-year-old hispanic woman. |
| Q40783588 | Fever, hypotension, and pulmonary infiltrates in a young Haitian man. |
| Q40743252 | Fever, leukopenia, and a cutaneous lesion in a man who had recently traveled in Africa |
| Q68676834 | Fibronectin and the pathogenesis of infection |
| Q39694809 | Fibronectin and viral pathogenesis |
| Q39694796 | Fibronectin in parasitic diseases |
| Q39485092 | Fibronectin-cell surface interactions |
| Q39694772 | Fibronectin: a brief overview of its structure, function, and physiology |
| Q39694816 | Fibronectin: an enhancer of phagocyte function. |
| Q69685985 | Field evaluation of a simplified unit-dose syringe for administration of measles vaccine |
| Q39381939 | Fimbrial adhesions of Escherichia coli. |
| Q70163451 | First International Symposium on Itraconazole. Oaxaca, Mexico, October 7-8, 1985. Proceedings |
| Q72873768 | First International symposium on ketoconazole. Medellín, Colombia, November 29 and 30, 1979 |
| Q40775211 | Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire |
| Q52420336 | Fleming's discovery. |
| Q38601905 | Flow cytometry for the study of phagocyte functions |
| Q37918356 | Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy |
| Q68764006 | Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents |
| Q39102368 | Fluconazole therapy for coccidioidomycosis in Japanese macaques |
| Q37918368 | Fluconazole therapy for experimental cryptococcosis and candidiasis in the rabbit |
| Q68763992 | Fluconazole: a novel advance in therapy for systemic fungal infections. Dorado Beach, Puerto Rico, 8-9 October 1988. Proceedings |
| Q40195160 | Focal hepatic candidiasis: a distinct clinical variant of candidiasis in immunocompromised patients. |
| Q43708159 | Folk terminology for diarrhea in rural Bangladesh |
| Q41200762 | Food and Environmental Aspects of Infant Botulism in California |
| Q39537984 | Formation and role of malaria pigment. |
| Q38486152 | Four decades of shigellosis in Israel: epidemiology of a growing public health problem |
| Q40142374 | Free Radical Metabolites in the Mode of Action of Chemotherapeutic Agents and Phagocytic Cells on Trypanosoma cruzi |
| Q70079064 | Frequency and characteristics of hyperbilirubinemia associated with bacteremia |
| Q40148420 | Frequency of occurrence and antimicrobial susceptibility of bacterial isolates from the intestinal and female genital tracts |
| Q38892008 | Frequency of rubella antibodies in the population of some tropical African countries |
| Q39307860 | From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view |
| Q38892391 | Functional consequences of malnutrition |
| Q39737810 | Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature |
| Q39537999 | Fungal prosthetic arthritis: presentation of two cases and review of the literature |
| Q39538144 | Fungal surfaces: effects of interactions with phagocytic cells |
| Q69659189 | Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome |
| Q43988777 | Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy |
| Q39297741 | Further community studies on the role of overcrowding and intensive exposure on measles mortality |
| Q45212374 | Further evidence for the existence of AIDS in the pre-AIDS era. |
| Q54488052 | Further studies on the genetic control of murine corneal response to Pseudomonas aeruginosa. |
| Q40836129 | Further-attenuated measles vaccine: characteristics and use. |
| Q37935941 | Gallbladder and biliary tract candidiasis: nine cases and review |
| Q33441615 | Ganciclovir therapy for cytomegalovirus disease associated with renal transplants |
| Q40785438 | Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients |
| Q69842147 | Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS |
| Q33441611 | Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients |
| Q33441617 | Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients. |
| Q43828782 | Gaps and excesses in the regulation of child day care: report of a panel |
| Q45844570 | Gastric Colonization of the Ferret with Helicobacter Species: Natural and Experimental Infections |
| Q68021120 | Gastritis associated with infection by Helicobacter pylori: comparative pathology in humans and swine |
| Q37404634 | Gastritis induced by Helicobacter pylori in gnotobiotic piglets |
| Q41213136 | General Mechanisms of Antimicrobial Resistance |
| Q70140162 | Generalized toxoplasmosis in two renal transplant recipients who received a kidney from the same donor |
| Q39310124 | Genetic Determinants of Microbial Resistance to Antibiotics |
| Q40161703 | Genetic Regulation of Host Resistance to Bacterial Infection |
| Q37754358 | Genetic and molecular basis of epithelial cell invasion by Shigella species |
| Q54520478 | Genetic aspects and epidemiologic implications of resistance to trimethoprim. |
| Q39537950 | Genetic basis of induction and overproduction of chromosomal class I beta-lactamase in nonfastidious gram-negative bacilli |
| Q70220579 | Genetic characterization of poliovirus isolates in Canada, 1962-1981 |
| Q68099574 | Genetic control of beta-lactamase production in Enterobacter cloacae |
| Q38223179 | Genetic control of susceptibility to mycobacterial infections. |
| Q36931833 | Genetically Engineered Attenuated Herpes Simplex Viruses |
| Q38612228 | Genetics and expression of toxic shock syndrome toxin 1: overview. |
| Q40141306 | Genital Herpes: Pathogenesis and Chemotherapy in the Guinea Pig Model |
| Q69411476 | Gentamicin-resistant enterococci and endocarditis |
| Q69796452 | Giant esophageal ulcer healed with steroid therapy in an AIDS patient |
| Q40244073 | Giardiasis: host-pathogen biology. |
| Q40244078 | Giardiasis: nutritional implications |
| Q41262632 | Glimpses into the future of rabies research |
| Q38255954 | Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization |
| Q69685988 | Global control of vaccine-preventable diseases: how progress can be evaluated |
| Q68083095 | Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae |
| Q38717687 | Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. |
| Q39514007 | Global priorities in the control of onchocerciasis |
| Q39681934 | Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanisms and dependence on the state of activation |
| Q36461214 | Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs |
| Q40091955 | Gonococcal Adherence: Selected Topics |
| Q41387472 | Gonococcal recidivism, diversity, and ecology |
| Q67830361 | Gonococcemia Associated with Adult Respiratory Distress Syndrome |
| Q93665183 | Gram-negative aerobic bacterial infections: a focus on directed therapy, with special reference to aztreonam |
| Q40315034 | Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera |
| Q40304170 | Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species |
| Q41372330 | Gram-negative bacterial infections: a look at the past, a view of the present, and a glance at the future |
| Q38717706 | Gram-negative bacterial pyomyositis: unique case and review |
| Q39538097 | Gram-positive bacteria: an overview and summary of session |
| Q38140276 | Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness |
| Q66999117 | Granulomatous Synovitis: The Role of Atypical Mycobacteria |
| Q40844703 | Granulomatous hepatitis. |
| Q44074706 | Group A and group B beta-hemolytic streptococcal bacteremia |
| Q72751808 | Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program |
| Q40139585 | Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness |
| Q68925454 | Group B streptococcal bacteremia in men |
| Q39732650 | Group B streptococcal endocarditis: report of seven cases and review of the literature, 1962-1985. |
| Q39828266 | Group B streptococcal vaccines |
| Q38601910 | Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review |
| Q37988807 | Group C streptococcal arthritis: case report and review |
| Q70172370 | Group C streptococcal bacteremia: analysis of 88 cases |
| Q68703366 | Group C streptococcal meningitis in adults |
| Q40304164 | Group C streptococcal pneumonia: report of a fatal case and review of the literature |
| Q40270691 | Group G streptococcal bacteremia: clinical study and review of the literature. |
| Q39504500 | Group day care and cytomegaloviral infections of mothers and children |
| Q69971112 | Growth of Staphylococcus aureus and synthesis of toxic shock syndrome toxin 1 in different in vitro systems |
| Q64129872 | Growth of toxic shock syndrome toxin 1-producing, tryptophan-requiring strains of Staphylococcus aureus associated with the presence of Escherichia coli |
| Q46977238 | Guanine-plus-cytosine content, hybridization percentages, and EcoRI restriction enzyme profiles of spiroplasmal DNA. |
| Q39634869 | HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. |
| Q70215567 | HLA-Restricted Cytotoxic T Lymphocytes Are an Early Immune Response and Important Defense Mechanism in Cytomegalovirus Infections |
| Q37214776 | Haemophilus influenzae Disease and Immunization in Developing Countries |
| Q70140176 | Haemophilus influenzae polyarthritis in an adult: an analysis of serotype b strains |
| Q39742196 | Haemophilus influenzae type b infections in day care attendees: implications for management |
| Q37404529 | Haemophilus parainfluenzae as a rare cause of epidural abscess: case report and review |
| Q39643613 | Haemophilus parainfluenzae infections in children, with the report of a unique case. |
| Q70303780 | Half-life and clearance of pH 6.8 and pH 4.25 immunoglobulin G intravenous preparations in patients with primary disorders of humoral immunity |
| Q39550178 | Hansenula anomala fungemia. |
| Q69214192 | Hansenula anomala infection |
| Q37591384 | Hantavirus infection in the United States: epizootiology and epidemiology. |
| Q46162992 | Headache and transient blindness in a 53-year-old woman |
| Q39688288 | Health and economic impacts of antimicrobial resistance |
| Q37404669 | Helicobacter pylori in patients with nonulcer dyspepsia. |
| Q44353554 | Hematogenous Dissemination of Mycobacterium tuberculosis in Patients with AIDS |
| Q36924043 | Hemolysis and Infection: Categories and Mechanisms of Their Interrelationship |
| Q41200799 | Hemolytic Activity of Plasma and Urine from Rabbits Experimentally Infected with Legionella pneumophila |
| Q33420483 | Hemorrhage in hemorrhagic fever with renal syndrome in China |
| Q33459471 | Hemorrhagic Fevers, with Special Reference to Recent Outbreaks in Southern Africa |
| Q33420487 | Hemorrhagic fever with renal syndrome in Greece: clinical and laboratory characteristics. |
| Q34463162 | Hemorrhagic fever with renal syndrome in Korea. |
| Q33428271 | Hemostasis and the complement system in Argentine hemorrhagic fever. |
| Q33428274 | Hemostatic defects in dengue hemorrhagic fever |
| Q40775204 | Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys |
| Q39504482 | Hepatitis in day care centers: epidemiology and prevention. |
| Q45236057 | Herd immunity and measles. |
| Q40100046 | Herpes Simplex Virus Antigens and Antibodies: A Survey of Studies Based on Quantitative Immunoelectrophoresis |
| Q39773548 | Herpes simplex viral hepatitis in adults: two case reports and review of the literature. |
| Q68272331 | Herpes simplex virus vaccine workshop. Bethesda, Maryland, 31 July- 1 August 1989 |
| Q70460599 | Heterogeneity and reduction in pulmonary clearance of mucoid Pseudomonas aeruginosa |
| Q54745893 | Heterogeneity in ampR-ampC gene interaction in Enterobacter cloacae. |
| Q50921655 | Heterogeneity of lipid A. |
| Q43870435 | Heterosexual spread of HIV infection. |
| Q39681856 | Heterosexual transmission of acquired immunodeficiency syndrome: international perspectives and national projections |
| Q37822584 | High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology |
| Q71083835 | High-pressure liquid chromatographic quantitation of rifampin and its two major metabolites in urine and serum |
| Q40286682 | High-pressure liquid chromatography for quantitation of antimicrobial agents |
| Q36408120 | Histopathology of childhood pneumonia in developing countries |
| Q34193746 | History of RA27/3 rubella vaccine |
| Q34102530 | History of chronic fatigue syndrome |
| Q70234012 | History of rabies: advances in research towards rabies prevention during the last 30 years |
| Q34264998 | History of the development of rifampin |
| Q40244063 | Hookworm disease: host-pathogen biology. |
| Q40244069 | Hookworm disease: nutritional implications |
| Q69500514 | Hookworm infection |
| Q53867172 | Hospital charges for antibiotics. |
| Q39759538 | Hospital hotel services as risk factors for infection among immunocompromised patients |
| Q70843512 | Host defense against Streptococcus pneumoniae: the role of the spleen |
| Q53909161 | Host defense mechanisms against pneumonia due to Pseudomonas aeruginosa. |
| Q71621913 | Host-pathogen interactions in experimental Mycoplasma pneumoniae disease studied by the freeze-fracture technique |
| Q39352304 | House-to-house and school lameness surveys in Cameroon: a comparison of two methods for estimating the prevalence and annual incidence of paralytic poliomyelitis |
| Q34954930 | Houseflies (Musca domestica) as mechanical vectors of shigellosis |
| Q39828259 | How does Toxoplasma gondii enter host cells? |
| Q70438691 | How important is bacteriuria? |
| Q70527495 | How should we assess the importance of an infection? |
| Q40161613 | Human Brucellosis |
| Q37066791 | Human Immunodeficiency Virus Infection in Patients with Solid-Organ Transplants: Report of Five Cases and Review |
| Q37229823 | Human Infection Caused by Exophiala pisciphila: Case Report and Review |
| Q45864316 | Human Infection with B Virus Following a Needlestick Injury |
| Q37904052 | Human immune response and Chlamydia trachomatis infection |
| Q36461201 | Human immune responses to live attenuated varicella vaccine |
| Q45849079 | Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3'-azido-3'-deoxythymidine. |
| Q38046091 | Human leukocyte antigen and leprosy: study in northern Louisiana and review |
| Q38616075 | Human microsporidiosis and AIDS. |
| Q38148186 | Human mycoplasmal infections: serologic observations. |
| Q39538172 | Human neutrophil antimicrobial activity |
| Q39284267 | Human parvovirus B19: historical and clinical review |
| Q39550223 | Human rabies and its prevention: an overview |
| Q39681919 | Human urine-derived inhibitors of interleukin 1. |
| Q41200754 | Human-Derived Immune Globulins for the Treatment of Botulism |
| Q34201087 | Humoral and cellular immune responses to Onchocerca volvulus infection in humans |
| Q40139596 | Hydrolytic enzymes of alveolar macrophages. |
| Q54381302 | Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins. |
| Q30455156 | Hypercalcitoninemia, hypocalcemia, and toxic shock syndrome. |
| Q67936899 | Hypoprothrombinemia During Therapy with Cefotiam |
| Q39493488 | Hypothesis on the molecular basis of nononcogenic retroviral diseases |
| Q44228701 | Hypothyroidism due to destruction of the thyroid by Kaposi's sarcoma |
| Q69971100 | Identification of a new toxin from a strain of Staphylococcus aureus isolated from a patient with nonmenstrual toxic shock syndrome |
| Q38353818 | Identification of an Antigenic Site in the Neutralization of Type 3 Poliovirus |
| Q70183147 | Identification of cyclic AMP-dependent protein kinase activity in Acanthamoeba |
| Q38201242 | Identification of mycobacterial antigens recognized by T lymphocytes. |
| Q46112034 | Identification of procedure-related nosocomial infections in high-risk patients. |
| Q39264561 | Identification of viruses in a study of acute respiratory tract infection in children from Uruguay |
| Q39538129 | Identification, cloning, and purification of protein antigens of Treponema pallidum |
| Q40178769 | Identifying Infectious Etiologies of Chronic Disease |
| Q39590789 | IgG subclass composition of intravenous immunoglobulin preparations: clinical relevance |
| Q44274507 | Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis |
| Q39830851 | Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience |
| Q39830855 | Imipenem/cilastatin in the treatment of obstetric and gynecologic infections: a review of worldwide experience |
| Q40816832 | Imipenem/cilastatin in the treatment of serious bacterial infections |
| Q44603924 | Imipenem/cilastatin therapy for serious bacterial infections. |
| Q54447773 | Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients. |
| Q45011718 | Imipenem/cilastatin: rationale for a fixed combination |
| Q69845934 | Imipenem: the first thienamycin antibiotic |
| Q93558387 | Imipenem: the first thienamycin antibiotic |
| Q93653095 | Immediate hypersensitivity responses in the immunopathogenesis of human onchocerciasis |
| Q44786458 | Immune complex glomerulonephritis associated with Staphylococcus aureus bacteremia: response to corticosteroid therapy |
| Q38223178 | Immune mechanisms in the pathogenesis of pulmonary tuberculosis |
| Q38744945 | Immune response to fungal infection |
| Q40266031 | Immune responses in parasitic diseases. Part A: general concepts |
| Q40244030 | Immune responses in parasitic diseases. Part B: mechanisms. |
| Q70569187 | Immune responses to atypical mycobacterial lung infections |
| Q36461176 | Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D. |
| Q40310223 | Immune responses to pneumococcal polysaccharide antigens: a comparison of the murine model and the response in humans. |
| Q45796315 | Immunity Induced by Inactivated Poliovirus Vaccine and Excretion of Virus |
| Q41526788 | Immunity as a factor in the epidemiology of medieval plague. |
| Q52399360 | Immunity in infective diseases. By Il'ia Il'ich Mechnikov, 1905. |
| Q37754449 | Immunity to Acanthamoeba. |
| Q70272393 | Immunization Against Measles by Aerosol |
| Q40831185 | Immunization and Military Medicine |
| Q70924148 | Immunization of Immunosuppressed Patients with Pneumococcal Polysaccharide Vaccine |
| Q70460605 | Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi |
| Q41863451 | Immunization opportunities taken and missed |
| Q45843239 | Immunization programs and human immunodeficiency virus |
| Q50588243 | Immunization with oral poliovirus vaccine in China. |
| Q39306540 | Immunochemical Characterization of Surface Antigens of Bacteroides melaninogenicus |
| Q39606860 | Immunochemical characterization of the polysaccharide antigens of group B streptococci |
| Q47248905 | Immunochemistry of Pseudomonas aeruginosa Lipopolysaccharides and High-Molecular-Weight Polysaccharides |
| Q39688321 | Immunodeficiency of the elderly. |
| Q46210001 | Immunogenic Properties of Lipid A |
| Q70303777 | Immunoglobulin G: potentiation of tobramycin and azlocillin in the treatment of Pseudomonas aeruginosa sepsis in neutropenic mice and neutralization of exotoxin A in vivo |
| Q37174095 | Immunologic Abnormalities Accompanying Acute and Chronic Viral Infections |
| Q38717757 | Immunologic aspects of Lyme borreliosis |
| Q38201243 | Immunologic aspects of mycobacterial infections |
| Q47248676 | Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa. |
| Q39439497 | Immunologic tools in the diagnosis of amebiasis: epidemiology in the United States |
| Q40244087 | Immunological interactions between host cells and mycoplasmas: an introduction |
| Q40133151 | Immunology of Entamoeba histolytica in Human and Animal Hosts |
| Q37903773 | Immunopathology and histopathology of experimental chlamydial salpingitis |
| Q37937681 | Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis. |
| Q68099579 | Immunosuppression by cell wall antigens of Coccidioides immitis |
| Q39506389 | Immunosuppression in viral infections |
| Q45042193 | Immunotherapy and immunoprophylaxis in the newborn infant: the need for definitive clinical trials |
| Q38663757 | Impact of atmospheric dispersion and transport of viral aerosols on the epidemiology of influenza. |
| Q37897931 | Impact of cytomegalovirus infection on organ transplant recipients |
| Q38684736 | Impact of fluoroquinolones on the gastrointestinal flora |
| Q50589278 | Impact of measles in Canada. |
| Q71809950 | Impact of measles in France |
| Q50589273 | Impact of measles in the United States. |
| Q38621853 | Impact of present control methods on the problem of tuberculosis |
| Q37229859 | Impact of temperature elevation on immunologic defenses |
| Q54745885 | Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae. |
| Q40818201 | Impact of the control of endemic treponemal diseases in Ghana on other diseases |
| Q38675551 | Impediments to the development of additional vaccines: vaccines against important diseases that will not be available in the next decade |
| Q69685971 | Implementation of vaccine programs in Ecuador |
| Q68505803 | Implications of the inoculum effect |
| Q93561636 | Implications of the international initiative against avoidable disablement ("impact") for rubella control |
| Q37903781 | Importance of reinfection in the pathogenesis of trachoma |
| Q38675499 | Importance of vaccines in child survival |
| Q38675554 | Improving the heat stability of vaccines: problems, needs, and approaches |
| Q46623709 | In Memoriam: Vera La Verne Sutter |
| Q39616032 | In Vitro Activity of Cefoxitin and Parenterally Administered Cephalosporins against Anaerobic Bacteria |
| Q70296080 | In Vitro Activity of Penicillin and Rifampin Against Group B Streptococci |
| Q36924051 | In Vitro Susceptibility vs. In Vivo Efficacy of Various Antimicrobial Agents against the Bacteroides fragilis Group |
| Q42271084 | In Vitro and In Vivo Susceptibility of Atypical Mycobacteria to Various Drugs |
| Q54510684 | In Vitro and in Vivo Antibacterial Activity of Moxalactam, an Oxa-β-Lactam Antibiotic |
| Q43900292 | In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections |
| Q39830847 | In vitro activity of imipenem against anaerobic bacteria |
| Q40114159 | In vitro activity of moxalactam against anaerobic bacteria |
| Q37906901 | In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis. |
| Q42264669 | In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria |
| Q69737863 | In vitro analysis of the cellular mechanisms involved in immunity to tuberculosis |
| Q43633056 | In vitro and in vivo antibody-dependent cellular cytotoxicity of intravenous immunoglobulin G preparations against herpes simplex virus. |
| Q33456066 | In vitro and in vivo effects of three bismuth compounds on fermentation by colonic bacteria. |
| Q44258908 | In vitro antibacterial activity of bismuth subsalicylate |
| Q39656844 | In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids. |
| Q41512336 | In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts |
| Q52623822 | In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus. |
| Q37754508 | In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba |
| Q70744629 | In vitro experience with cefonicid |
| Q72114957 | In vitro studies on the mitogenic activity of mycoplasmal species toward lymphocytes |
| Q71083852 | In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus |
| Q40304144 | In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. |
| Q52211120 | Inactivated Poliovirus Vaccine and Test Development at Connaught Laboratories Ltd |
| Q70220552 | Inactivated poliovirus vaccine in Finland |
| Q70486832 | Inactivated poliovirus vaccine: current production methods and new developments |
| Q64225683 | Inciting and etiologic agents of colitis |
| Q68380965 | Increased measles mortality in households with multiple cases in the Gambia, 1981 |
| Q68380970 | Increased risk of measles mortality for children with siblings among the Fula Bande, Senegal |
| Q68442208 | Increasing Evidence for the Pathogenic Role of DF-2 Organisms |
| Q46889334 | Increasing vaccine coverage through new delivery systems: a Sudan approach |
| Q37883303 | Incubation of poliomyelitis as calculated from the time of entry into the central nervous system via the peripheral nerve pathways |
| Q39537958 | Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins |
| Q39538158 | Induction of the mucosal immune response |
| Q44687154 | Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors |
| Q71407428 | Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier |
| Q39282434 | Infected false aneurysms of the femoral artery in intravenous drug addicts |
| Q43885217 | Infection and coding strategies of arenaviruses, phleboviruses, and nairoviruses. |
| Q38717664 | Infection and cyclosporine |
| Q38717670 | Infection and periodontal diseases |
| Q69411474 | Infection due to Actinobacillus actinomycetemcomitans |
| Q38601919 | Infection due to Actinobacillus actinomycetemcomitans: 15 cases and review |
| Q44446676 | Infection due to Leuconostoc species |
| Q37947310 | Infection due to Leuconostoc species: six cases and review |
| Q40841482 | Infection following renal transplantation: a changing pattern |
| Q44037897 | Infection in acute leukemia: an analysis of 433 episodes |
| Q38663776 | Infection of endothelial cells by common human viruses. |
| Q37754445 | Infection of the central nervous system due to Acanthamoeba |
| Q39504506 | Infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus: considerations for transmission in the child day care setting |
| Q41213087 | Infections Due to Endemic, Multiply Resistant Gram-Negative Rods: Sensitivity to and Therapy with Cefoxitin |
| Q36924027 | Infections Due to Stomatococcus mucilaginosus: 10 Cases and Review |
| Q43855531 | Infections associated with animal exposure in two infants |
| Q68021086 | Infections associated with biliary drainage procedures in patients with cancer |
| Q39828284 | Infections caused by Drechslera species: case report and review of the literature |
| Q34650687 | Infections caused by Moraxella, Moraxella urethralis, Moraxella-like groups M-5 and M-6, and Kingella kingae in the United States, 1953-1980. |
| Q39688318 | Infections caused by Mycobacterium szulgai in humans. |
| Q39652877 | Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases |
| Q45198014 | Infections caused by Propionibacterium species. |
| Q40207100 | Infections caused by Pseudomonas aeruginosa |
| Q40346598 | Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature |
| Q40251630 | Infections caused by nondiphtheria corynebacteria |
| Q68021104 | Infections due to Balantidium coli in primates |
| Q40232890 | Infections due to Wangiella dermatitidis in humans: report of the first documented case from the United States and a review of the literature |
| Q68021102 | Infections due to Xanthomonas maltophilia in patients with hematologic malignancy |
| Q38684672 | Infections due to Xylohypha bantiana (Cladosporium trichoides). |
| Q39838021 | Infections due to gram-negative bacteria: an overview |
| Q38745030 | Infections in immunocompromised patients in Mexico. |
| Q45304410 | Infections in patients in intensive care units: can the combination of a monobactam and a penicillin replace the classic combination of a beta-lactam agent and an aminoglycoside? |
| Q40254075 | Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients |
| Q45837066 | Infections in patients with cancer in Mexico |
| Q37737156 | Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients |
| Q44771298 | Infections with Eikenella corrodens in a general hospital: a report of 33 cases |
| Q36924029 | Infections with Pseudomonas paucimobilis: Report of Four Cases and Review |
| Q68238555 | Infectious Diseases Society of America and Centers for Disease Control: Summary of a Workshop on Surveillance for Congenital Cytomegalovirus Disease |
| Q37908763 | Infectious Diseases and Immunizations |
| Q40145720 | Infectious Diseases of the Thyroid Gland |
| Q93653084 | Infectious causes of blindness: trachoma and onchocerciasis |
| Q37557392 | Infectious causes of carpal tunnel syndrome: case report and review |
| Q38918510 | Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. |
| Q69945205 | Infectious complications of craniofacial surgery in children |
| Q41860553 | Infectious complications of hepatic artery catheterization procedures in patients with cancer. |
| Q39750225 | Infectious disease in the sella turcica |
| Q68300726 | Infectious disease rounds: deteriorating neurologic status in a young woman with schizophrenia |
| Q68522499 | Infectious disease rounds: fever and rash in a pregnant woman |
| Q69457392 | Infectious disease rounds: headache, diminished mentation, and leg pain |
| Q68676832 | Infectious disease rounds: headache, fever, and periorbital edema |
| Q68442197 | Infectious disease rounds: toxoplasmosis in a premature infant |
| Q39742179 | Infectious diseases and day care |
| Q37988817 | Infectious diseases as a Canadian subspecialty, with projections to the year 2000. |
| Q68074441 | Infectious diseases as a subspecialty in Canada: reply |
| Q43493554 | Infectious diseases as a subspecialty in Canada: status of the practice in Quebec |
| Q41330705 | Infectious diseases fellowship training: another viewpoint |
| Q69601597 | Infectious diseases in child day care: management and prevention. Minneapolis, Minnesota, June 21-23, 1984 |
| Q69601610 | Infectious diseases in child day care: management and prevention. Summary of the symposium and recommendations |
| Q39742174 | Infectious diseases in day care: parallels between psychologically and physically healthy care. |
| Q47435640 | Infectious diseases in persons of leadership |
| Q37947316 | Infectious diseases of geriatric inmates |
| Q71718248 | Infectious diseases update: 1982. Summary of a symposium |
| Q39728860 | Infective endocarditis complicating mitral valve prolapse: epidemiologic, clinical, and microbiologic aspects |
| Q67994444 | Influence of charcoal on ciprofloxacin activity |
| Q70064121 | Influence of cryptococcal antigens on cell-mediated immunity |
| Q38717709 | Influence of fever on pharmacokinetics |
| Q54447966 | Influence of imipenem on the serum resistance of enterobacteriaceae. |
| Q70460602 | Influence of nutrient limitation of growth on stability and production of virulence factors of mucoid and nonmucoid strains of Pseudomonas aeruginosa |
| Q40290501 | Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts |
| Q39694726 | Influence of subinhibitory concentrations of antibiotics on virulence of staphylococci |
| Q39660531 | Information and education as determinants of antibiotic use: report of Task Force 5. |
| Q71155336 | Inhibition of the activity of pseudomonas toxin by methylamine |
| Q70163506 | Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole |
| Q39493483 | Initiation and maintenance of latent herpes simplex virus infections: the paradox of perpetual immobility and continuous movement. |
| Q38663738 | Inoculum effect |
| Q41561127 | Integration of Selected Pharmacologic and Microbiologic Properties of Three New -Lactam Antibiotics: A Hypothesis for Rational Comparison |
| Q43632606 | Integration of yaws control and primary health care |
| Q39742244 | Interaction between beta-lactam and other antibiotics. |
| Q64451059 | Interaction between pap-encoded pilin and adhesin gene products of uropathogenic Escherichia coli |
| Q70296091 | Interaction of Rifampin with Other Antifungal Agents in Experimental Murine Candidiasis |
| Q52531102 | Interaction of spiroplasmas with plant, arthropod, and animal hosts. |
| Q40176255 | Interactions Among Microorganisms of the Indigenous Intestinal Flora and Their Influence on the Host |
| Q41182363 | Interactions Between Antibacterial Drugs Below the Minimal Inhibitory Concentration |
| Q61758410 | Interactions of Cyclosporine with Antimicrobial Agents |
| Q40176248 | Interactions of Polymorphonuclear Leukocytes with Anaerobic Bacteria |
| Q34675495 | Interactions of cyclosporine with antimicrobial agents. |
| Q39284283 | Interactions of cytomegalovirus with the human immune system |
| Q39694783 | Interactions of fibronectin with streptococci: the role of fibronectin as a receptor for Streptococcus pyogenes |
| Q36428394 | Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins |
| Q47589386 | Interactions of parasitic diseases and nutrition: some policy implications |
| Q44803467 | Interactions of rifampin and trimethoprim in vitro. |
| Q38621859 | Interactions of the human immunodeficiency virus and tuberculosis and the implications for BCG vaccination |
| Q71155329 | Interactions of thyroid hormones and catecholamines in severely burned patients |
| Q54131717 | Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS. |
| Q37557418 | Interferon-gamma in the management of chronic granulomatous disease. |
| Q34395571 | Interferons and their clinical value |
| Q40173633 | Interleukin-1. |
| Q70742260 | Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo |
| Q71102064 | International Conference on Atypical Mycobacteria. A symposium dedicated to the memory of Werner B. Schaefer. Denver, Colorado, September 5--8, 1979 |
| Q53438884 | International Conference on Atypical Mycobacteria. Introduction |
| Q68712135 | International Symposium on Anaerobic Bacteria and Bacterial Infections. Monte Carlo, Monaco, 25-28 September 1988. Proceedings |
| Q71339944 | International Symposium on Anaerobic Bacteria and Their Role in Disease. Los Angeles and Santa Monica, California, October 11-13, 1981 |
| Q71101981 | International Symposium on Control of Nosocomial Infection, Jerusalem, Israel, April 28-May 2, 1980 |
| Q69659202 | International Symposium on Hemostatic Impairment Associated with Hemorrhagic Fever Viruses. 26-28 May 1987, Leesburg, Virginia. Proceedings |
| Q71809937 | International Symposium on Measles Immunization. Pan American Health Association, Washington, D.C., March 16-19, 1982 |
| Q68280069 | International Symposium on New Quinolones. Geneva, Switzerland, July 17-19, 1986. Proceedings |
| Q68328047 | International Symposium on Perioperative Antibiotic Prophylaxis. San Juan, Puerto Rico, 4-7 March 1990 |
| Q69971097 | International Symposium on Toxic Shock Syndrome. Atlanta, Georgia, 15-18 November 1987. Proceedings |
| Q69685968 | International Symposium on Vaccine Development and Utilization. Washington, D.C., 9-10 June 1986. Proceedings |
| Q93584365 | International Symposium on Yaws and Other Endemic Treponematoses. Washington, D.C., April 16-18, 1984 |
| Q53413250 | International cooperation in rabies research. |
| Q68303258 | International symposium on Acanthamoeba and the Eye. Houston, Texas, 14-16 April 1989 |
| Q71407408 | International symposium on poliomyelitis control. Pan American Health Organization, Washington, D.C., March 14-17, 1983 |
| Q53431411 | International symposium on poliomyelitis control. Strategies for control: a discussion. |
| Q93561621 | International symposium on prevention of congenital rubella infection. Washington, D.C., March 13-15, 1984 |
| Q39828272 | Interpretation and comparison of treatment studies for uncomplicated urinary tract infections in women |
| Q37754383 | Intestinal manifestations of invasive diarrheas and their diagnosis |
| Q34193734 | Intestinal perforation in typhoid fever: a historical and state-of-the-art review. |
| Q40266038 | Intestinal physiology and parasitic diseases |
| Q39838009 | Intraabdominal infections: an overview. |
| Q40264181 | Intracellular parasites and phagocytic cells: cell biology and pathophysiology. |
| Q37935933 | Intramedullary tuberculomas of the spinal cord: case report and review |
| Q41213111 | Intramuscular Cefoxitin |
| Q47447320 | Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trial |
| Q72113291 | Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole |
| Q41437423 | Introduction to community studies of severe measles: comparative test of the crowding/exposure hypothesis |
| Q41445593 | Introduction to the control of measles by vaccination in the People's Republic of China. |
| Q38621872 | Introduction to the immunology of tuberculosis |
| Q34277056 | Introduction to vancomycin |
| Q36461149 | Introduction: objectives of herpes simplex virus vaccines seen from a historical perspective |
| Q36654702 | Introduction: the increasing importance of Acanthamoeba |
| Q40786678 | Invasive Fusarium solani infections in patients with acute leukemia |
| Q70311114 | Invasive aspergillosis |
| Q40751322 | Invasive aspergillus rhinosinusitis in patients with acute leukemia |
| Q40161674 | Invasive enteric pathogens |
| Q37918341 | Invasive external otitis caused by Aspergillus |
| Q37935922 | Invasive infection with Saccharomyces cerevisiae: report of three cases and review |
| Q39821276 | Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. |
| Q69557235 | Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts |
| Q41200432 | Is human immunodeficiency virus (HIV) rather than cytomegalovirus the cause of retinitis and colitis in HIV-infected patients? |
| Q39494484 | Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. |
| Q41566940 | Is renal function the only determinant in the elimination of ceftazidime? |
| Q39660492 | Is there a risk to contacts of patients with rabies? |
| Q40103404 | Isolation and Characterization of a Human Fibroblast Interferon Gene and Its Expression in Escherichia coli |
| Q41716289 | Isolation and identification of viral agents in Argentinian children with acute lower respiratory tract infection |
| Q38717773 | Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo |
| Q45021321 | Isoniazid-induced toxic fever |
| Q37704050 | Issues and problems in the conduct of epidemiologic research on chronic fatigue syndrome |
| Q42054309 | Itraconazole for deep mycoses: preliminary experience in Mexico |
| Q70163480 | Itraconazole in pityriasis versicolor |
| Q44685098 | Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment |
| Q70163460 | Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages |
| Q39507028 | Itraconazole in the treatment of human mycoses: review of three years of clinical experience |
| Q70163495 | Itraconazole in the treatment of paracoccidioidomycosis: a preliminary report |
| Q70163456 | Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases |
| Q70163471 | Itraconazole in the treatment of tinea corporis: a pilot study |
| Q70163487 | Itraconazole in the treatment of vaginal candidosis and the effect of treatment of the sexual partner |
| Q53883577 | Itraconazole: pharmacologic studies in animals and humans. |
| Q40176259 | Jejunoileal bypass: change in the flora of the small intestine and its clinical impact. |
| Q33481097 | John Keats: poet, patient, physician |
| Q39595696 | Joseph E. Smadel Memorial Lecture: neuroimmunologic diseases of animals and humans |
| Q68131363 | Kawasaki syndrome |
| Q68215480 | Kernig's and Brudzinski's signs revisited |
| Q72873771 | Ketoconazole in Early and Late Murine Coccidioidomycosis |
| Q46528255 | Ketoconazole in Experimental Candidosis |
| Q72873799 | Ketoconazole in Vulvovaginal Candidosis |
| Q34708094 | Ketoconazole in the Treatment of Paracoccidioidomycosis and Histoplasmosis |
| Q53532763 | Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. |
| Q72873805 | Ketoconazole: A New Drug for the Treatment of Paracoccidioidomycosis |
| Q70742229 | Killed and live poliovirus vaccines |
| Q70742253 | Kinetics of antimicrobial action |
| Q70894817 | Kinetics of cefsulodin in patients with renal impairment |
| Q39821283 | Klebsiella bacteremia: an analysis of 100 episodes |
| Q39537963 | Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. |
| Q37947315 | Klebsiella pulmonary infections: occurrence at one medical center and review |
| Q70358677 | Koch's Postulates and the Search for the AIDS Agent |
| Q39681930 | Kupffer cell function in host defense |
| Q41200726 | Laboratory Aspects of Infant Botulism in California |
| Q67006787 | Laboratory Procedures for Cases of Suspected Infant Botulism |
| Q37988823 | Laboratory methods in the diagnosis and prognostic staging of infection with human immunodeficiency virus type 1. |
| Q50214299 | Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides. |
| Q37898069 | Laboratory survey of fluoroquinolone activity |
| Q64380982 | Late Morphologic Consequences of Measles: A Lethal and Debilitating Lung Disease Among the Poor |
| Q43491754 | Late Postpoliomyelitis Muscular Atrophy: Clinical, Virologic, and Immunologic Studies |
| Q70220585 | Late Progression of Poliomyelitis Paralysis: Discussion of Pathogenesis |
| Q40134671 | Latent Infection and the Elusive Cytomegalovirus |
| Q40148379 | Legionella Infections: A Review of Five Years of Research |
| Q38616087 | Lemierre's disease: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum |
| Q39817230 | Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis |
| Q43657472 | Leprosy: cause, transmission, and a new theory of pathogenesis. |
| Q34112123 | Leptotrichia buccalis bacteremia in patients with cancer: report of four cases and review |
| Q39634875 | Lessons for human influenza from pathogenicity studies with ferrets |
| Q39634862 | Lessons learned from animal models of osteomyelitis |
| Q39158228 | Leukocyte activation by chemoattractant receptors: roles of a guanine nucleotide regulatory protein and polyphosphoinositide metabolism |
| Q40286711 | Leukocyte locomotion and chemotaxis: effects of bacteria and viruses. |
| Q48665167 | Levels of antibiotic in human blood and interstitial fluid after oral administration of bacampicillin or phenoxymethyl penicillin and intravenous administration of amoxicillin or ampicillin |
| Q40132625 | Levels of cefotaxime in body fluids and tissues: a review. |
| Q39479641 | Liability for infectious diseases in day care: legal and practical considerations |
| Q93561644 | Licensed vaccines |
| Q50555054 | Life-threatening Haemophilus influenzae infections in Scandinavia: a five-country analysis of the incidence and the main clinical and bacteriologic characteristics. |
| Q39742248 | Limitations of animal models in predicting beta-lactam efficacy for endocarditis and meningitis. |
| Q70601361 | Lipases specifically degrading lipopolysaccharide: fatty acyl amidases from Dictyostelium discoideum |
| Q46536381 | Lipid A and immunotherapy. |
| Q70601379 | Lipid A-dependent lymphocyte proliferation in "endotoxin-nonresponder" mice |
| Q40358292 | Lipid Analysis for the Identification of Mycobacteria: An Appraisal |
| Q70463765 | Lipid phase structure in the regulation of lipid composition in Acholeplasma laidlawii membranes |
| Q71840263 | Lipid-phase transition of phosphatidylglycerol in Acholeplasma laidlawii membranes studied with phospholipase A2 |
| Q34409045 | Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane |
| Q68833665 | Lipopolysaccharide-induced elaboration of interleukin 1 by human monocytes: use for detection of lipopolysaccharide in serum and the influence of serum-lipopolysaccharide interactions |
| Q70601349 | Lipopolysaccharides: structural principles and biologic activities |
| Q39550150 | Liposome-encapsulated amphotericin B: a promising new treatment for disseminated fungal infections |
| Q37229836 | Listeria monocytogenes infections in patients with AIDS: report of five cases and review. |
| Q44368848 | Listeria rhombencephalitis mimicking tuberculous meningitis |
| Q43866411 | Listerial endocarditis following coronary artery bypass surgery. |
| Q68597857 | Listerial myocarditis in cardiac transplantation |
| Q41172822 | Listeriosis following shigellosis. |
| Q40257832 | Listeriosis in adults: a changing pattern. Report of eight cases and review of the literature, 1968-1978. |
| Q37696655 | Listeriosis in patients infected with human immunodeficiency virus |
| Q40244013 | Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. |
| Q70220542 | Live Attenuated Oral Poliovirus Vaccine |
| Q40098566 | Live attenuated Varicella-Zoster vaccine |
| Q70486830 | Live attenuated oral poliovirus vaccine: problem areas in production |
| Q36461152 | Live vaccinia virus recombinants expressing herpes simplex virus genes |
| Q38616074 | Liver abscess caused by Streptococcus milleri |
| Q50153013 | Liver abscess due to Salmonella enteritidis 19 months after an episode of gastroenteritis in a man who underwent a cholecystectomy |
| Q70223957 | Localization of a lipoteichoic acid binding site to a 24-kilodalton NH2-terminal fragment of fibronectin |
| Q40771238 | Localized brucellosis: popliteal artery aneurysm, mediastinitis, dementia, and pneumonia |
| Q39773552 | Localized hypertrophic osteoarthropathy due to arterial graft sepsis from an enteroprosthetic fistula |
| Q72113264 | Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women |
| Q71407494 | Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus |
| Q39656828 | Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation. |
| Q44203690 | Long-term studies of the effect of rifampin on nasal carriage of coagulase-positive staphylococci. |
| Q43930008 | Long-term use of oral poliovirus vaccine from Sabin strains in the Soviet Union. |
| Q38684733 | Long-term use of quinolones and their safety |
| Q93525319 | Low back pain as the only presenting symptom in Streptococcus sanguis endocarditis |
| Q44260510 | Low mortality among patients with spinal cord injury and bacteremia |
| Q69796462 | Lyme disease and other spirochetal diseases. Proceedings of a symposium. Washington, D.C., 29 February-1 March 1988 |
| Q64129469 | Lyme disease surveillance in the United States, 1983-1986 |
| Q36583117 | Lymphokines: Enhancement by Granulocyte-Macrophage and Granulocyte Colony-Stimulating Factors of Neonatal Myeloid Kinetics and Functional Activation of Polymorphonuclear Leukocytes |
| Q46767765 | Macrophage toxicity and complement sensitivity of virulent and avirulent strains of Legionella pneumophila. |
| Q45226465 | Magnesium and the pathogenesis of toxic shock syndrome. |
| Q40244051 | Malaria: host-pathogen biology. |
| Q40266044 | Malaria: nutritional implications. |
| Q33447189 | Malassezia fungemia in neonates and adults: complication of hyperalimentation |
| Q39848750 | Male genital tuberculosis: a review of the literature with instructive case reports |
| Q37918318 | Malignant external otitis: report on therapy with ceftazidime and review of therapy and prognosis |
| Q39264534 | Malnutrition and acute respiratory tract infections in Filipino children |
| Q39295182 | Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies |
| Q33257218 | Management of Genital Infection Caused by Human Papillomavirus |
| Q37696789 | Management of children with occult bacteremia who are treated in the emergency department |
| Q37897944 | Management of cytomegalovirus disease with antiviral drugs |
| Q39837956 | Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations |
| Q37988824 | Management of the hematologic complications of human immunodeficiency virus infection |
| Q67936864 | Management of the immunocompromised patient: impact of fungal infections. Introduction |
| Q37696766 | Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome |
| Q43489468 | Mass treatment campaigns against the endemic treponematoses |
| Q41429721 | Mass vaccination against poliomyelitis in Mexico. |
| Q67994463 | Mass vaccination campaign against rabies: are dogs correctly protected? The Peruvian experience |
| Q39482248 | Maternal immunization and the immune response of neonates to pneumococcal polysaccharides |
| Q48548710 | Maxwell Finland lecture: the influenza viruses and the human respiratory tract |
| Q41200671 | Maxwell Finland lecture: viral vaccines and their ways |
| Q70272388 | Measles Immunization in Iran |
| Q49050545 | Measles control in the United Kingdom. |
| Q71810018 | Measles immunization: remaining needs for research |
| Q44028675 | Measles in India |
| Q33454529 | Measles in Israel, the West Bank, and Gaza: continuing incidence and the case for a new eradication strategy. |
| Q71809941 | Measles in Malaysia: a brief report of the 1981 Anti-Measles Pilot Study |
| Q39239854 | Measles in Mexico |
| Q69411478 | Measles vaccine |
| Q53923466 | Measles vaccine in the People's Republic of China. |
| Q40836122 | Measles vaccines used in Japan. |
| Q71809984 | Measles vaccines: discussion |
| Q39354962 | Measles: summary of worldwide impact |
| Q40295704 | Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. |
| Q54746048 | Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins. |
| Q54513126 | Mechanisms of Bacterial Resistance to Antimicrobial Agents, with Particular Reference to Cefotaxime and Other β-Lactam Compounds |
| Q40115864 | Mechanisms of Immune Regulation at Mucosal Surfaces |
| Q40141968 | Mechanisms of Resistance and Resistance Transfer in Anaerobic Bacteria: Factors Influencing Antimicrobial Therapy |
| Q39753138 | Mechanisms of beta-lactam resistance in anaerobic bacteria. |
| Q39215380 | Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses |
| Q36491726 | Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. |
| Q54488584 | Mechanisms of lipopolysaccharide-induced protection against pseudomonas sepsis in granulocytopenic mice. |
| Q34193727 | Mechanisms of microbial synergy in polymicrobial surgical infections |
| Q40209352 | Mechanisms of mucosal invasion by pathogenic Neisseria |
| Q40337561 | Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole |
| Q40833761 | Mediastinitis after cardiovascular surgery |
| Q43715604 | Mediastinitis complicating cardiac operations: evidence of postoperative causation |
| Q38612219 | Mediators in the pathogenesis of toxic shock syndrome: overview. |
| Q70142749 | Medical aspects of delayed convalescence |
| Q39833217 | Mediterranean spotted fever: a cooperative study of 227 cases |
| Q38663743 | Melioidosis: review and update |
| Q36461161 | Membrane-associated antigens of herpes simplex virus |
| Q50568410 | Meningitis Caused by Streptococcus suis in Humans |
| Q38616088 | Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol |
| Q37557341 | Meningitis due to Neisseria mucosa: case report and review |
| Q70140170 | Meningitis due to Pasteurella multocida |
| Q43408828 | Meningitis due to penicillin-resistant Streptococcus pneumoniae in adults. |
| Q43708394 | Meningitis due to pneumococcus |
| Q40145726 | Meningococcal Disease: Still with Us |
| Q39538063 | Mesophilic aeromonads in human disease: current taxonomy, laboratory identification, and infectious disease spectrum. |
| Q28264984 | Metabolism of Cefotaxime in Animals and Humans |
| Q38286329 | Metabolism of gyrase inhibitors |
| Q43621458 | Methodologic Aspects of Clinical Studies of Perioperative Antibiotic Prophylaxis |
| Q71101989 | Methodologic Issues in Hospital Epidemiology. I. Rates, Case-Finding, and Interpretation |
| Q52736110 | Methodologic Issues in Hospital Epidemiology. II. Time and Accuracy in Estimation |
| Q37704041 | Methodologic considerations in assessment of cognitive function in chronic fatigue syndrome |
| Q40181067 | Methodologic issues in hospital epidemiology. III. Investigating the modifying effects of time and severity of underlying illness on estimates of cost of nosocomial infection. |
| Q39550162 | Methodologic issues in hospital epidemiology. IV. Risk ratios, confounding, effect modification, and the analysis of multiple variables. |
| Q39742252 | Methods for evaluating the penetration of beta-lactam antibiotics into tissues |
| Q93561637 | Methods of assessing the impact of congenital rubella infection |
| Q36924061 | Metronidazole-Induced Acute Pancreatitis |
| Q40138287 | Microbial Interactions with Neutrophils |
| Q43511987 | Microbial agents associated with pneumonia in children from Uruguay. |
| Q37905391 | Microbial latency. |
| Q39732663 | Microbial ribosomal vaccines |
| Q67962447 | Microbial surfaces: determinants of virulence and host responsiveness. A symposium. Oakland, California, 18-20 October 1986. Proceedings |
| Q69675599 | Microbial synergy |
| Q54765381 | Microbial synergy. |
| Q37754318 | Microbiology and diagnosis of infections with Shigella and enteroinvasive Escherichia coli |
| Q38612224 | Microbiology of toxic shock syndrome: overview |
| Q40760390 | Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome |
| Q44015217 | Minocycline as an alternative antistaphylococcal agent |
| Q72744235 | Mitogenic activities of lipid A and liposome-associated lipid A: effects of epitope density |
| Q54472178 | Mitogenic response of lymphocytes from C3H/HeJ mice in the presence of lipid A and lipid A fractions. |
| Q53810472 | Mixed Mycobacterial Infections |
| Q39694718 | Mixed bacterial meningitis |
| Q68597883 | Mixed staphylococcal and cryptococcal epidural abscess in a patient with AIDS |
| Q43643272 | Mobilization for an Expanded Programme on Immunization in Somalia |
| Q66899959 | Mode of Action of -Lactam Antibiotics |
| Q39186227 | Mode of action of the quinolone antimicrobial agents. |
| Q38286334 | Mode of action of the quinolone antimicrobial agents: review of recent information |
| Q40161654 | Models for Studying the Role of Bacterial Attachment in Virulence and Pathogenesis |
| Q38016833 | Modern chemotherapy for brucellosis in humans |
| Q41200805 | Modes of Action of Enterotoxins from Vibrio cholerae and Escherichia coli |
| Q43843033 | Modes of action of poliovirus vaccines and relation to resulting immunity. |
| Q39488397 | Modulation of immune responses by surface polysaccharides of Candida albicans |
| Q46661257 | Moist-heat disinfection of Acanthamoeba cysts |
| Q67915633 | Molecular Approaches to Epidemiologic Evaluation of Viruses as Risk Factors for Patients Who Have Chronic Fatigue Syndrome |
| Q70220566 | Molecular Epidemiology of Polioviruses |
| Q34164339 | Molecular Koch's postulates applied to microbial pathogenicity |
| Q45799668 | Molecular Organization and Selective Solubilization of Lipids and Proteins In the Envelope of Mycoplasmal Virus L2 |
| Q72766069 | Molecular Properties of Membrane Lipids and Activity of a Membrane Adenosine Triphosphatase from Acholeplasma laidlawii B |
| Q54401612 | Molecular analysis of bacterial cytolysins. |
| Q43501610 | Molecular and antigenic characteristics and synthesis of rubella virus structural proteins |
| Q37754424 | Molecular aspects of the cell cycle and encystment of Acanthamoeba |
| Q39465209 | Molecular basis of bacterial adhesion in the oral cavity. |
| Q36363542 | Molecular cloning and expression of the imipenem-hydrolyzing beta-lactamase gene from Pseudomonas maltophilia in Escherichia coli. |
| Q70601343 | Molecular concepts of lipid A. A symposium held at Walter Reed Army Institute of Research. Washington, D.C., April 6-8, 1983 |
| Q39505966 | Molecular epidemiology of antibiotic resistance plasmids of Haemophilus species and Neisseria gonorrhoeae |
| Q30403413 | Molecular epidemiology of bacterial infections: examples of methodology and of investigations of outbreaks |
| Q70220555 | Molecular genetics of poliovirus |
| Q39509529 | Molecular mechanisms for transposition of drug-resistance genes and other movable genetic elements |
| Q38016839 | Molecular mechanisms of action of ribavirin |
| Q54520484 | Molecular mechanisms of resistance to trimethoprim. |
| Q39550207 | Mongoose rabies. |
| Q40133641 | Monoclonal Antibodies of Hybridomas |
| Q45050309 | Monoclonal antibodies as investigative tools in onchocerciasis |
| Q38744904 | Monoclonal antibodies for treatment of gram-negative infections |
| Q64129960 | Monoclonal antibody studies of rabies in insectivorous bats of the United States |
| Q44809760 | Monocytes in HIV infection |
| Q70183204 | Morphological and isoenzymatic study of an ocular strain of Acanthamoeba |
| Q39224032 | Morphology of rectal mucosa of patients with shigellosis |
| Q57926684 | Mortality Among Primary and Secondary Cases of Measles in Bangladesh |
| Q33579264 | Mortality due to shigellosis: community and hospital data |
| Q54510677 | Moxalactam Therapy for Bacterial Pneumonia |
| Q72775856 | Moxalactam Therapy for Gram-Negative Bacillary Meningitis |
| Q54510665 | Moxalactam Therapy for Obstetric and Gynecologic Infections |
| Q40841570 | Moxalactam Therapy vs. Standard Antimicrobial Therapy for Selected Serious Infections |
| Q54510671 | Moxalactam for Treatment of Nosocomial Infections |
| Q61840632 | Moxalactam for Treatment of Pelvic Infections After Cesarean Delivery |
| Q54510675 | Moxalactam in Serious Infections: Clinical, Bacteriologic, and Pharmacokinetic Studies |
| Q54510668 | Moxalactam in the Treatment of Intraabdominal Sepsis and Other Surgical Infections |
| Q72775808 | Moxalactam international symposium. London, England. May 7-8, 1981 |
| Q72775841 | Moxalactam--absorption, excretion, distribution, and metabolism |
| Q54510681 | Moxalactam: An Oxa-β-Lactam Antibiotic that Inactivates β-Lactamases |
| Q72775890 | Moxalactam: Clinical Summary of Efficacy and Safety |
| Q42244065 | Moxalactam: The First of a New Class of β-Lactam Antibiotics |
| Q45845683 | Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. |
| Q71407437 | Mucosal immune response to poliovirus vaccines in childhood |
| Q48659517 | Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections |
| Q40748512 | Multicenter trial of prophylaxis with clindamycin plus aztreonam or cefotaxime in gynecologic surgery |
| Q45262369 | Multicentered Clinical Evaluation of Cefoperazone for the Treatment of Lower Respiratory Tract Infections |
| Q53986660 | Multicentered study of cefoperazone for treatment of intraabdominal infections and comparison of cefoperazone with cefamandole and clindamycin plus gentamicin for treatment of appendicitis and peritonitis. |
| Q40744784 | Multidrug-resistant typhoid in children: presentation and clinical features |
| Q68930516 | Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria |
| Q45233755 | Multiple antibiotic resistance in South African strains of Streptococcus pneumoniae: mechanism of resistance to beta-lactam antibiotics |
| Q41853046 | Multiple hepatic abscesses caused by Streptococcus milleri in association with an intrauterine device |
| Q40744803 | Multisystem group A beta-hemolytic streptococcal disease in children |
| Q71101992 | Multivariate Analysis of Determinants of Postoperative Wound Infection: A Possible Basis for Intervention |
| Q40181092 | Mumps arthritis: a review of the literature |
| Q37918334 | Musculoskeletal manifestations of infection with human immunodeficiency virus |
| Q36446115 | Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects |
| Q71102069 | Mycobacteria: An Overview |
| Q71102098 | Mycobacterial Infections in Animals |
| Q40148375 | Mycobacterial Infections in Renal Transplant Recipients: Report of Five Cases and Review of the Literature |
| Q40358296 | Mycobacterial Sensitins: Where Are We Now? |
| Q39753086 | Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. |
| Q38621869 | Mycobacteriophage vector systems. |
| Q69710768 | Mycobacterium avium-Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS |
| Q71102030 | Mycobacterium avium-intracellulare Complex Serovars Isolated in South Africa from Humans, Swine, and the Environment |
| Q37557387 | Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature |
| Q71102035 | Mycobacterium kansasii Infections in The Netherlands: A Brief Sum |
| Q45853864 | Mycobacterium kansasii infections in patients positive for human immunodeficiency virus |
| Q54531728 | Mycobacterium simiae and related mycobacteria. |
| Q44244173 | Mycobacterium szulgai: an unusual pathogen |
| Q72535966 | Mycoplasma-Lymphocyte Interactions and Their Possible Role in Immunopathologic Manifestations of Mycoplasmal Disease |
| Q39681816 | Mycoses caused by Candida lusitaniae. |
| Q37935942 | Naegleria and Acanthamoeba infections: review |
| Q39643641 | Nasal septal abscess due to Staphylococcus aureus in a patient with AIDS. |
| Q34295283 | Native valve endocarditis due to Pseudallescheria boydii in a patient with AIDS: case report and review. |
| Q68074439 | Natural history of recurrent urinary tract infections in women |
| Q70140178 | Natural history of recurrent urinary tract infections in women |
| Q38663749 | Nature of protective immunity to Francisella tularensis. |
| Q37696768 | Necrotizing tracheitis caused by Corynebacterium pseudodiphtheriticum: unique case and review |
| Q47989295 | Needed research on the interactions of certain parasitic diseases and nutrition in humans. |
| Q35980673 | Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries |
| Q45147387 | Neisseria lactamica meningitis following skull trauma |
| Q36443596 | Neonatal Rotavirus Infections |
| Q33449544 | Neonatal herpes simplex pneumonitis. |
| Q69945200 | Neonatal meningitis due to Streptococcus mitis |
| Q68837236 | Neonatal sepsis and the role of immunotherapy. Proceedings of a symposium. Huron, Ohio, 18-20 July 1988 |
| Q37937675 | Neonatal susceptibility and immunity to major bacterial pathogens |
| Q33371815 | Nephropathia Epidemica (Hemorrhagic Fever with Renal Syndrome) in Scandinavia |
| Q70142748 | Nervous system-immune system communication |
| Q39681861 | Neurocysticercosis in the United States: 35 cases and a review |
| Q70233987 | Neurocysticercosis: an update |
| Q39215372 | Neurologic disorders associated with AIDS retroviral infection |
| Q28272745 | Neurologic manifestations of Lyme disease, the new "great imitator" |
| Q38206628 | Neutrophil activation by recombinant cytokines |
| Q39825881 | Neutrophil killing of bacteria by oxygen-independent mechanisms: a historical summary |
| Q40286705 | Neutrophil kinetics and the regulation of granulopoiesis. |
| Q40337621 | New analogs of trimethoprim. |
| Q37988828 | New antiretroviral agents in the clinic. |
| Q38269059 | New approaches to vaccine development |
| Q38186814 | New concepts on the pathogenesis of fever |
| Q67962442 | New developments in resistance to beta-lactam antibiotics among nonfastidious gram-negative organisms. Proceedings of a symposium. Bowness-on-Windermere, U.K., 14-16 September 1987 |
| Q70514546 | New drugs and clinical economics: analysis of cost effectiveness in the assessment of pharmaceutical innovations |
| Q38223187 | New experimental drugs for the treatment of tuberculosis |
| Q38744989 | New methods for delivery of antifungal agents |
| Q38143764 | New methods for identification of obligate anaerobes |
| Q38595022 | New quinolones in the treatment of joint and bone infections |
| Q38286332 | New quinolones: in vitro effects as a potential source of clinical toxicity |
| Q39632216 | New quinolones: pharmacology, pharmacokinetics, and dosing in patients with renal insufficiency |
| Q69659186 | New spectrum of fungal infections in patients with cancer |
| Q36488935 | New technologies for use in the surveillance and control of yaws |
| Q70296278 | New ways of managing under prospective payment and their impact on the principles and practice of infectious diseases |
| Q37897919 | Newer methods for diagnosis of cytomegalovirus infection |
| Q68165892 | Nocardia asteroides meningitis |
| Q48235248 | Nocardia asteroides meningitis without brain abscess. |
| Q48694568 | Nocardial brain abscesses in a pregnant woman |
| Q37404545 | Nocardial infection as a complication of AIDS: report of six cases and review |
| Q69659191 | Nocardial infection in patients with neoplastic disease |
| Q40315004 | Nocardial infections in the immunocompromised host: A detailed study in a defined population. |
| Q37696691 | Nocardial meningitis: case reports and review |
| Q69472427 | Non-O:1 Vibrio cholerae bacteremia |
| Q39537974 | Non-O:1 Vibrio cholerae bacteremia: case report and review |
| Q39543887 | Nonantibiotic therapy for travelers' diarrhea |
| Q40133145 | Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' Experience |
| Q47921442 | Noncardiogenic pulmonary edema and pulmonary fibrosis in falciparum malaria |
| Q39759556 | Nonenteric infections acquired through contact with water |
| Q39652866 | Nongenitourinary infections caused by Mycoplasma hominis in adults |
| Q64129784 | Nonmenstrual toxic shock syndrome associated with barrier contraceptives: report of a case-control study |
| Q51843470 | Nonpolio causes of polio-like paralytic syndromes. |
| Q70983368 | Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen |
| Q39759511 | Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. |
| Q39753108 | Nontyphoid salmonellosis in patients with total hip replacement: report of four cases and review of the literature. |
| Q39737825 | Nontyphoid salmonellosis in renal transplant recipients: report of five cases and review of the literature |
| Q39476080 | Normal vaginal microflora during use of various forms of catamenial protection |
| Q71102019 | Nosocomial Infection Control: Role of the Hospital Administrator |
| Q43774878 | Nosocomial Infection Due to Pseudomonas pseudomallei: Two Cases and an Epidemiologic Study |
| Q40167160 | Nosocomial Infections Due to Pseudomonas aeruginosa: Review of Recent Trends |
| Q67994433 | Nosocomial bacteremia and sinusitis in nasotracheally intubated patients in intensive care |
| Q54754733 | Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. |
| Q72927794 | Nosocomial infection control: an overview |
| Q68643648 | Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer |
| Q39837953 | Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy. |
| Q30447951 | Nosocomial pneumonia: pathogenesis and recent advances in diagnosis and therapy |
| Q70220558 | Nucleotide sequence from neurovirulent and attenuated strains of type 3 poliovirus |
| Q41641711 | Numerical Taxonomy and Cooperative Studies: Roles and Limits |
| Q37346642 | Nutritional effects on response of children in developing countries to respiratory tract pathogens: implications for vaccine development |
| Q38892385 | Nutritional requirements in parasitic diseases |
| Q37754416 | O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseases. |
| Q39482544 | Observations on the use of oral poliovirus vaccines in the Caribbean and Canada. |
| Q34172422 | Occurrence and pathogenicity of the Streptococcus milleri group. |
| Q39407418 | Occurrence of congenital, cardiovascular, visceral, neurologic, and neuro-ophthalmologic complications in late yaws: a theme for future research |
| Q37903778 | Ocular models of chlamydial infection |
| Q39515442 | Ocular parasitic infection in Thailand. |
| Q70410074 | On a unique tribute to Theobald Smith, 1915 |
| Q68763989 | On group C beta-hemolytic streptococcal infections in children |
| Q44471502 | On murder by tropical infection |
| Q44543453 | On new concepts on the pathogenesis of fever |
| Q47344878 | On the obligation of physicians to treat AIDS: is there a historical basis? |
| Q39681883 | On the pathogenesis of toxic shock syndrome. |
| Q54404221 | On the restriction of antibiotic use. |
| Q41507201 | Onchocerciasis: experimental models of ocular disease |
| Q52210888 | One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine. |
| Q54447768 | Open trial of imipenem/cilastatin therapy for serious bacterial infections. |
| Q53431733 | Opening address: International Congress for Infectious Diseases. |
| Q69945194 | Opportunistic infections in "normal hosts" |
| Q38911757 | Opportunistic infections in patients with AIDS: clues to the epidemiology of AIDS and the relative virulence of pathogens |
| Q37947313 | Opportunistic infections with Strongyloides stercoralis in renal transplantation |
| Q72873776 | Oral Therapy with Ketoconazole for Dermatophyte Infections Unresponsive to Griseofulvin |
| Q40173636 | Oral candidiasis: pathogenesis and host defense |
| Q56779521 | Oral immunization of wildlife against rabies: concept and first field experiments |
| Q40279961 | Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis |
| Q43209921 | Oral rabies vaccination: an overview. |
| Q37754388 | Oral rehydration therapy for invasive diarrhea |
| Q44368175 | Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans |
| Q68092259 | Oral trimethoprim as follow-up treatment of meningitis caused by Listeria monocytogenes |
| Q39292690 | Organization of mass vaccination for dog rabies in Brazil |
| Q69601606 | Organizational approach to medication administration in day care |
| Q40797418 | Osteoarticular complications of brucellosis: a study of 169 cases. |
| Q39742189 | Otitis media among children in day care: epidemiology and pathogenesis. |
| Q68099562 | Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants |
| Q67962448 | Outer-membrane antigens of gram-negative pathogens: summary of session |
| Q69923770 | Overall clinical experience with aztreonam in the treatment of intraabdominal infections |
| Q54152009 | Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections. |
| Q38621833 | Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries |
| Q37903838 | Overview of Chlamydia trachomatis infection and the requirements for a vaccine |
| Q40814328 | Overview of empiric antibiotic therapy for the febrile neutropenic patient |
| Q28330617 | Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients |
| Q37918379 | Overview of studies of fluconazole in oropharyngeal candidiasis |
| Q37822586 | Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine |
| Q44996364 | Overview of the symposium |
| Q37918381 | Overview: treatment of cryptococcal meningitis |
| Q64942788 | Paragonimiasis: diagnosis and the use of praziquantel in treatment. |
| Q39417923 | Paralytic Poliomyelitis: Old Dogmas and New Perspectives |
| Q71407448 | Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland |
| Q38488728 | Paralytic poliomyelitis can be eliminated. |
| Q39606852 | Parasite-directed endocytosis |
| Q37329757 | Parenteral antibiotic therapy for patients in nursing homes. |
| Q43454224 | Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer. |
| Q39643636 | Parotitis due to anaerobic bacteria |
| Q45984993 | Partial Purification and Characterization of a Cytotoxin from Clostridium difficile |
| Q67005023 | Participation of Immunoglobulin and the Alternative Complement Pathway in Opsonization of Bacteroides fragilis and Bacteroides thetaiotaomicron |
| Q39504512 | Passive immunotherapy for encephalitis caused by herpes simplex virus |
| Q44344517 | Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1. |
| Q37935936 | Pasteurella multocida meningitis in an adult: case report and review |
| Q39550156 | Pathobiology of infection in prosthetic devices |
| Q67928378 | Pathogenesis and Prevention of Childhood Pneumonia in Developing Countries: Recommendations |
| Q37214738 | Pathogenesis and Sequelae of Respiratory Infections |
| Q37903776 | Pathogenesis and immunology of chlamydial infections of the genital tract |
| Q39753091 | Pathogenesis and treatment of acute hematogenous osteomyelitis: evaluation of current views with reference to an animal model. |
| Q67928370 | Pathogenesis of Pneumococcal Pneumonia |
| Q40210281 | Pathogenesis of Pseudomonas aeruginosa ocular diseases. |
| Q37214744 | Pathogenesis of Respiratory Infections Due to Influenza Virus: Implications for Developing Countries |
| Q45863493 | Pathogenesis of Severe Acute Respiratory Infections in the Developing World: Respiratory Syncytial Virus and Parainfluenza Viruses |
| Q39439515 | Pathogenesis of disease caused by Entamoeba histolytica: studies of adherence, secreted toxins, and contact-dependent cytolysis |
| Q38663751 | Pathogenesis of experimental endocarditis |
| Q40347973 | Pathogenesis of nephrotoxicity of cephalosporins and aminoglycosides: a review of current concepts. |
| Q45016685 | Pathogenesis of rabies virus infection in dogs |
| Q44049058 | Pathogenesis of tuberculosis: clinical and epidemiologic perspective. |
| Q38663795 | Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted |
| Q70183135 | Pathogenic Acanthamoeba isolated during an atmospheric survey in Mexico City |
| Q64450764 | Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae |
| Q71102101 | Pathogenicity and immunogenicity of atypical mycobacteria for calves: a short summary |
| Q54477704 | Pathogenicity of anaerobic gram-negative rods: possible mechanisms. |
| Q38910945 | Pathogens that cause travelers' diarrhea in Latin America and Africa. |
| Q41371822 | Pathologic changes of human onchocerciasis: implications for future research |
| Q38143715 | Pathophysiology of diarrheal disorders. |
| Q68712120 | Pathophysiology of gastrointestinal infections: the role of bismuth subsalicylate. Scottsdale, Arizona, 11-14 February 1988. Proceedings |
| Q38717723 | Pathophysiology of the Lyme disease spirochete, Borrelia burgdorferi, in ixodid ticks |
| Q68703362 | Pattern of antibiotic use in medical wards of a university hospital, Bangkok, Thailand |
| Q40769916 | Pattern of infection in hematologic malignancies: an Indian experience |
| Q39264538 | Patterns of acute respiratory tract infection in children: a longitudinal study in a depressed community in Metro Manila |
| Q37696771 | Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalized patients with diarrhea |
| Q38943483 | Paul de Kruif's Microbe Hunters and an outraged Ronald Ross |
| Q53751238 | Pediatric acute respiratory infections in developing countries. |
| Q37903656 | Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy. |
| Q37947330 | Pelvic inflammatory disease: review of treatment options |
| Q48906888 | Penetration of Cefotaxime and Moxalactam into Cerebrospinal Fluid of Rabbits with Experimentally Induced Escherichia coli Meningitis |
| Q44263132 | Penetration of Cefotaxime into Bronchial Secretions |
| Q41213064 | Penetration of Cefoxitin into Cerebrospinal Fluid and Treatment of Meningitis Caused by Gram-Negative Bacteria |
| Q40741245 | Penetration of Cefoxitin into Cerebrospinal Fluid of Dogs with and without Experimental Meningitis |
| Q40741240 | Penetration of Cefoxitin into Human Cerebrospinal Fluid: Comparison with Cefamandole, Ampicillin, and Penicillin |
| Q40741224 | Penetration of Cephalothin and Cefoxitin into Experimental Infections with Bacteroides fragilis |
| Q71083842 | Penetration of antibiotics into human leukocytes and dermal suction blisters |
| Q40304195 | Penetration of antibiotics into respiratory secretions. |
| Q70744640 | Penetration of cefonicid into human breast milk and various body fluids and tissues |
| Q38684676 | Penetration of newer cephalosporins into cerebrospinal fluid |
| Q70159410 | Penetration of sulbactam into cerebrospinal fluid of patients with viral meningitis or without meningitis |
| Q43735538 | Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy |
| Q39634866 | Penicillin prophylaxis for streptococcal infections in United States Navy and Marine Corps recruit camps, 1951-1985. |
| Q39590783 | Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics |
| Q39537937 | Penicillin-binding proteins of gram-negative bacteria |
| Q45230314 | Penicillium marneffei: another pathogen to consider in patients infected with human immunodeficiency virus |
| Q58846629 | Pentamidine: a review |
| Q38977685 | Pentastomiasis |
| Q70220569 | Peptide Priming of a Poliovirus Neutralizing Antibody Response |
| Q37696663 | Pericardial actinomycosis: case report and review |
| Q68021110 | Pericarditis due to Bacillus cereus in an intravenous drug user |
| Q39753095 | Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries |
| Q38684680 | Perinephric abscess in renal transplant recipients: report of seven cases and review |
| Q36839988 | Perioperative Antibiotic Prophylaxis of Wound and Foreign Body Infections: Microbial Factors Affecting Efficacy |
| Q67785678 | Perioperative antimicrobial prophylaxis in middle Tennessee, 1989-1990 |
| Q69945203 | Periprosthetic candidal infections following arthroplasty |
| Q44624648 | Peritonitis Due to Prototheca wickerhamii in a Patient Undergoing Chronic Ambulatory Peritoneal Dialysis |
| Q34024740 | Peritonitis due to Kluyvera ascorbata: case report and review |
| Q43613305 | Peritonitis due to Rhizopus in a patient undergoing continuous ambulatory peritoneal dialysis. |
| Q37696672 | Perivalvular extension of infection in patients with infectious endocarditis |
| Q39606837 | Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteria. |
| Q93561649 | Persistence of rubella antibodies after vaccination: detection after experimental challenge |
| Q93561647 | Persistence of vaccine-induced immune responses to rubella: comparison with natural infection |
| Q40132044 | Persistent infection of humans with hepatitis B virus: mechanisms and consequences. |
| Q41608483 | Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis |
| Q44353807 | Persistent neutrophilic meningitis due to Pseudallescheria boydii. |
| Q68491572 | Persistent rectal ulcer associated with human papillomavirus type 33 in a patient with AIDS: successful treatment with isotretinoin |
| Q30384753 | Personal reflections on nosocomial staphylococcal infections and the development of hospital surveillance. |
| Q69457395 | Perspectives on bacterial pathogenesis and host defense. Proceedings of a symposium. April 21-23, 1986, Heidelberg, Federal Republic of Germany |
| Q36924022 | Pertussis Encephalopathy in an Adult: Case Report and Review |
| Q38073784 | Pertussis Toxin: The Cause of the Harmful Effects and Prolonged Immunity of Whooping Cough. A Hypothesis |
| Q37214758 | Pertussis in Developing Countries: Definition of the Problem and Prospects for Control |
| Q70261848 | Phagocyte strategy vs. microbial tactics |
| Q40244021 | Phagocytes and worms: David and Goliath revisited. |
| Q39302134 | Phagocytes, O2 reduction, and hydroxyl radical. |
| Q37908780 | Phagocytosis of Microorganisms |
| Q70744637 | Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis |
| Q44682882 | Pharmacokinetic study of sulbactam and ampicillin administered concomitantly by intraarterial or intravenous infusion in the newborn |
| Q72775878 | Pharmacokinetics and Clinical Efficacy of Moxalactam in Biliary Tract Infections |
| Q40741317 | Pharmacokinetics and Comparative Pharmacology of Cefoxitin and Cephalosporins |
| Q40161641 | Pharmacokinetics and Metabolism of Rifampin in Humans |
| Q38684748 | Pharmacokinetics and clinical results of parenterally administered new quinolones in humans |
| Q39632273 | Pharmacokinetics and efficacy of the new quinolones in infections of the eye, ear, nose, and throat |
| Q52430183 | Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsis. |
| Q39825867 | Pharmacokinetics and safety of antimicrobial agents during pregnancy |
| Q37918375 | Pharmacokinetics and tissue penetration of fluconazole in humans |
| Q40741235 | Pharmacokinetics of Cefoxitin in Normal Subjects and In Patients with Renal Insufficiency |
| Q54541500 | Pharmacokinetics of ampicillin in serum and in dermal suction blisters after oral administration of bacampicillin. |
| Q39656822 | Pharmacokinetics of antimicrobial agents in the elderly |
| Q40114597 | Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function |
| Q38684688 | Pharmacokinetics of fluorinated 4-quinolones in the aged |
| Q45245144 | Pharmacokinetics of imipenem and cilastatin in volunteers. |
| Q33483249 | Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function |
| Q72775847 | Pharmacokinetics of moxalactam in neonates and young infants |
| Q39506400 | Pharmacokinetics of sulbactam/ampicillin in humans: a review |
| Q67918988 | Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule |
| Q40304185 | Pharmacokinetics of tissue penetration of antibiotics |
| Q71108851 | Pharmacokinetics of vancomycin in anuria |
| Q71108839 | Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function |
| Q72775850 | Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations |
| Q71108855 | Pharmacology and efficacy of vancomycin for staphylococcal infections in children |
| Q37404655 | Pharmacology of bismuth-containing compounds. |
| Q28334251 | Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center |
| Q39742235 | Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria |
| Q39550192 | Phialophora richardsiae infection in humans |
| Q68829908 | Phthirus pubis infestation of the scalp: report of three cases |
| Q70601371 | Physical interaction between lipid A and phospholipids: a study with spin-labeled phospholipids |
| Q70463761 | Physical state of membrane lipids of Mycoplasma capricolum |
| Q37704085 | Physiologic measurement of exercise and fatigue with special reference to chronic fatigue syndrome. |
| Q54141565 | Pityriasis versicolor: efficacy of two five-day regimens of itraconazole. |
| Q38717717 | Plague in Vienna. |
| Q37404561 | Plagues--what's past is present: thoughts on the origin and history of new infectious diseases |
| Q39288997 | Planning for rabies control in Ontario |
| Q39694819 | Plasma fibronectin and fibronectin therapy in sepsis and critical illness. |
| Q54423351 | Plasmid analysis in molecular epidemiology: a summary and future directions. |
| Q39505961 | Plasmid analysis in the study of the epidemiology of nosocomial gram-positive cocci |
| Q44999458 | Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam |
| Q54381294 | Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. |
| Q39750219 | Plasmids as epidemiologic markers in nosocomial gram-negative bacilli: experience at a university and review of the literature |
| Q37404499 | Pleural fluid infection caused by Listeria monocytogenes: case report and review |
| Q36924058 | Pleuropulmonary Infections Caused by Eikenella corrodens |
| Q45256928 | Pneumococcal Antibodies in Patients with Chronic Obstructive Pulmonary Disease and Their Response to Pneumococcal Capsular Polysaccharides: Preliminary Results |
| Q37214764 | Pneumococcal Vaccine Trials in Papua New Guinea: Relationships Between Epidemiology of Pneumococcal Infection and Efficacy of Vaccine |
| Q72645828 | Pneumococcal Vaccine in Sickle Cell Disease: IgG and IgM Antibody Response |
| Q38537299 | Pneumococcal Vaccine in the Institutionalized Elderly: Design of a Nonrandomized Trial and Preliminary Results |
| Q40101279 | Pneumococcal Vaccine in the Institutionalized Elderly: Review of Past and Recent Studies |
| Q44732014 | Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden |
| Q39750236 | Pneumococcal endocarditis: report of a series and review of the literature. |
| Q37988802 | Pneumococcal endometritis and neonatal sepsis. |
| Q68643643 | Pneumococcal infections of the female genital tract |
| Q38675549 | Pneumococcal polysaccharide vaccines |
| Q40310211 | Pneumococcus: the first one hundred years. |
| Q39753079 | Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. |
| Q44115737 | Pneumocystis carinii infections in patients with AIDS. |
| Q39837985 | Pneumonia caused by gram-negative bacilli: an overview. |
| Q44928977 | Pneumonia due to Bordetella bronchiseptica in a Patient with AIDS |
| Q68021107 | Pneumonia due to Bordetella bronchiseptica in a patient with AIDS |
| Q68597860 | Pneumonia due to Legionella micdadei in bone marrow transplant recipients |
| Q39742213 | Policies for the exclusion of ill children from group day care: an unresolved dilemma |
| Q54407068 | Policies, laws, and regulations pertaining to antibiotics: report of Task Force 3. |
| Q51241947 | Policy for measles elimination in Canada and program implications. |
| Q71251420 | Polio vaccination in Sweden |
| Q71407469 | Poliomyelitis control in Japan |
| Q50588247 | Poliomyelitis in India: prospects and problems of control. |
| Q39239303 | Political, administrative, and economic resources for the control of poliomyelitis. |
| Q43936599 | Political, economic, and administrative resources available for the control of vaccine-preventable diseases |
| Q50716080 | Polyacrylamide gel analysis of spiroplasmas proteins and its contribution to the taxonomy of spiroplasmas. |
| Q71339958 | Polyacrylamide gel electrophoresis patterns produced by Clostridium difficile |
| Q69462350 | Polymicrobial bacteremia |
| Q38616070 | Polymicrobial bacteremia: clinical and microbiologic patterns |
| Q69583362 | Polymicrobial fungemia: microbiology, clinical features, and significance |
| Q71672811 | Polymicrobial infections in osteomyelitis |
| Q37557413 | Polymicrobial infective endocarditis in the 1980s |
| Q40340047 | Polymicrobial osteomyelitis: report of three cases and review of the literature. |
| Q30459416 | Polymorphonuclear neutrophils: an effective antimicrobial force |
| Q38181907 | Polysaccharide antigens of Escherichia coli |
| Q44671339 | Polysaccharide antigens of Pseudomonas aeruginosa |
| Q68522245 | Polyvalent group B streptococcal immune globulin for intravenous administration: overview |
| Q38601895 | Poncet's disease: tuberculous rheumatism |
| Q43581240 | Poncet's disease: tuberculous rheumatism |
| Q40079254 | Possible Viral Interactions in the Acquired Immunodeficiency Syndrome (AIDS) |
| Q71442044 | Possible adverse effects of antibiotic therapy in plants |
| Q70183142 | Possible environmental sources of Acanthamoeba species that cause keratitis in contact lens wearers |
| Q54401458 | Possible role of helper and cytolytic T lymphocytes in antibacterial defense: conclusions based on a murine model of listeriosis. |
| Q38684740 | Post-marketing surveillance of the quinolones: a view from Great Britain |
| Q40865909 | Post-streptococcal Glomerulonephritis Following Pyoderma |
| Q69845770 | Postanginal sepsis following infectious mononucleosis |
| Q67294880 | Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes |
| Q71543981 | Postantibiotic suppression of bacterial growth |
| Q68074481 | Postmenopausal pneumococcal tubo-ovarian abscess |
| Q40758876 | Postoperative pancreatic abscess due to Plesiomonas shigelloides |
| Q68505798 | Postpartum maternal group B streptococcal meningitis |
| Q38280933 | Postpartum uterine infection with Clostridium perfringens |
| Q39593495 | Posttraumatic endophthalmitis: the emerging role of Bacillus cereus infection |
| Q60222593 | Potential for Development of Antibiotic Resistance in Pathogenic Treponemes |
| Q69601608 | Potential health benefits of child day care attendance |
| Q43804796 | Potential metabolic targets in chemotherapy for Acanthamoeba infections: polyamine metabolism |
| Q38241182 | Potential role of fluoroquinolones in pediatric infections |
| Q39766106 | Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections |
| Q68522238 | Potential use of intravenous immune globulin for group B streptococcal infection |
| Q33389596 | Potentially lethal complications of shigellosis |
| Q43787218 | Pott's puffy tumor: a complication of intranasal cocaine abuse |
| Q44954481 | Practical guidelines for developing an office-based program for outpatient intravenous therapy. |
| Q71407522 | Practicalities of a global poliomyelitis control program |
| Q70349388 | Predictive value of amniotic-membrane cultures for the development of postcesarean endometritis |
| Q70894823 | Predictors of response to therapy for infections caused by Pseudomonas aeruginosa |
| Q40199650 | Pregnancy-associated depression of cell-mediated immunity. |
| Q69842130 | Preliminary physiologic characterization and genetic analysis of a new Escherichia coli mutant, lov, resistant to mecillinam |
| Q40173624 | Present Status of the Management of Patients with Defective Phagocyte Function |
| Q38621843 | Present status of chemotherapy for tuberculosis. |
| Q48412410 | Presentation of the Galen Medal to John Franklin Enders |
| Q39838014 | Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient |
| Q50569029 | Prevalence of methicillin-resistant Staphylococcus aureus in a Spanish hospital. |
| Q46037137 | Prevalence of rubella antibodies on the African continent. |
| Q45216130 | Preventing Nosocomial Infection through the Use of Effective Management Techniques |
| Q39656859 | Prevention and mycoses in immunocompromised patients |
| Q39742201 | Prevention of Haemophilus influenzae type b infections in day care: a public health perspective |
| Q38745091 | Prevention of Pneumocystis carinii pneumonia |
| Q40775763 | Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. |
| Q38313539 | Prevention of cytomegalovirus infection after marrow transplantation. |
| Q68930494 | Prevention of diarrhea caused by enterotoxigenic Escherichia coli: lessons learned with volunteers |
| Q69261308 | Prevention of infection in the neutropenic patient |
| Q38684707 | Prevention of infections in granulocytopenic patients by fluorinated quinolones |
| Q40290519 | Prevention of infections with respiratory syncytial virus: the hopes and hurdles ahead |
| Q39737865 | Prevention of travelers' diarrhea by nonantibiotic drugs |
| Q70258113 | Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole |
| Q39775184 | Primary actinomycosis of an extremity: a case report and review. |
| Q53434213 | Primary health care as a practical means for measles control. |
| Q37988810 | Primary meningococcal conjunctivitis: report of 21 patients and review. |
| Q40215044 | Primary meningococcal pericarditis: a disease of adults associated with serogroup C Neisseria meningitidis |
| Q71407519 | Priorities in health care: a discussion |
| Q40744791 | Probable neutropenic enterocolitis in patients with AIDS. |
| Q41432817 | Problems Encountered in Clinical Anaerobic Bacteriology |
| Q39688304 | Problems and benefits of an antibiotic compassionate therapy program |
| Q39837947 | Problems and changing patterns of resistance with gram-negative bacteria. |
| Q70258090 | Problems in determination of antibiotic synergism in vitro |
| Q39742259 | Problems in evaluation of adverse reactions to beta-lactam antibiotics. |
| Q38260951 | Problems in management of opportunistic fungal diseases |
| Q39439493 | Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality |
| Q39732658 | Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones |
| Q37229869 | Problems in the Diagnosis of Invasive Fungal Diseases |
| Q41945157 | Problems in the management of falciparum malaria |
| Q39742257 | Problems of studying infections in the compromised host |
| Q69261303 | Proceedings of a conference on controversies in the management of infectious complications of neoplastic diseases. New York, New York, 11-12 June 1987 |
| Q40298566 | Processes of Transport and Absorption in the Developing Infant Intestine |
| Q37404645 | Production of a cytotoxin by Helicobacter pylori |
| Q52876817 | Production of toxic shock syndrome toxin 1 by Staphylococcus aureus under aerobic and anaerobic conditions and the effect of magnesium ion limitation. |
| Q69971121 | Production of toxic shock syndrome toxin 1 in a mouse model of Staphylococcus aureus abscess formation |
| Q38744865 | Profound muscle weakness as the presenting feature of disseminated cryptococcal infection. |
| Q67830384 | Prognosis of enterococcal endocarditis |
| Q58001000 | Prognostic factors in Serratia bacteremia |
| Q41469383 | Program for Surveillance and Intervention in Specific Problem Areas of Nosocomial Infections |
| Q39292682 | Program for the elimination of urban rabies in Latin America |
| Q43747935 | Program planning for research on Acanthamoeba |
| Q38675526 | Progress in vaccines against typhoid fever |
| Q70303767 | Properties and characteristics of a new immunoglobulin G intravenous preparation. A symposium. Chicago, Illinois, June 7, 1985 |
| Q40158893 | Properties of Microorganisms Isolated from Human Leprosy Lesions |
| Q36840019 | Prophylactic Antibiotics in Gynecologic and Obstetric Surgery |
| Q70410622 | Prophylactic antibiotics for elective colorectal surgery or operation for obstruction of the small bowel: a comparison of cefonicid and cefoxitin |
| Q40176235 | Prophylaxis for Intraabdominal Surgery |
| Q36840027 | Prophylaxis in Otolaryngologic Surgery and Neurosurgery: A Critical Review |
| Q41818264 | Prophylaxis of oropharyngeal candidiasis with fluconazole. |
| Q39766131 | Prophylaxis with trimethoprim-sulfamethoxazole in abdominal, pelvic, and prostatic surgery |
| Q39538058 | Proposed mechanisms for the translocation of intestinal bacteria |
| Q43970361 | Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections |
| Q39681835 | Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. |
| Q70210235 | Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections |
| Q38284480 | Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children |
| Q43850464 | Prospects for development of a treponemal vaccine |
| Q41445610 | Prospects for future supplies of vaccines. |
| Q54797520 | Prospects for improved laboratory diagnoses of treponemal infections and species differentiation. |
| Q71315836 | Prospects for new viral vaccines: a symposium |
| Q39494673 | Prospects for the eradication of infectious diseases |
| Q39753114 | Prospects for the prevention and therapy of infections with the human immunodeficiency virus |
| Q28342747 | Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug |
| Q64129634 | Prospects for universal immunization: strategies for achievement |
| Q71407527 | Prospects for worldwide control of paralytic poliomyelitis: a discussion |
| Q39643596 | Prostatic abscess in the antibiotic era. |
| Q40337638 | Prostatitis: review of pharmacokinetics and therapy |
| Q44198153 | Prosthetic valve endocarditis and paravalvular abscess caused by Actinobacillus actinomycetemcomitans |
| Q39716642 | Prosthetic valve endocarditis due to small-colony staphylococcal variants |
| Q54778611 | Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens. |
| Q39538116 | Protein antigens of genital mycoplasmas |
| Q39800477 | Protothecal olecranon bursitis: treatment with intrabursal amphotericin B. |
| Q39530135 | Protracted outbreak of severe delta hepatitis: experience in an isolated Amerindian population of the Upper Orinoco basin. |
| Q39587775 | Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters |
| Q68442200 | Pseudomonas aeruginosa Bacteremia: Univariate and Multivariate Analyses of Factors Influencing the Prognosis in 133 Episodes |
| Q40210298 | Pseudomonas aeruginosa elastase and its role in pseudomonas infections. |
| Q70521040 | Pseudomonas aeruginosa--biology, immunology, and therapy: a cefsulodin symposium. Monterey, California, May 16-17, 1983 |
| Q69411481 | Pseudomonas bacteremia in a community teaching hospital, 1980-1984 |
| Q44831840 | Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. |
| Q46605517 | Pseudomonas cepacia: Implications and Control of Epidemic Nosocomial Colonization |
| Q40269076 | Pseudomonas folliculitis: an outbreak and review. |
| Q69945207 | Pseudomonas putrefaciens bacteremia |
| Q39804370 | Pseudomonas testosteroni infections: eighteen recent cases and a review of the literature |
| Q67994461 | Public health aspects of current oral rabies vaccines |
| Q71102061 | Pulmonary Disease Due to Atypical Mycobacteria: A Retrospective Study from South India |
| Q45036469 | Pulmonary Infection Caused by Atypical Mycobacteria: A Report of 24 Cases in Thailand |
| Q68597851 | Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience |
| Q38744838 | Pulmonary disease due to Mycobacterium xenopi in a renal allograft recipient: report of a case and review |
| Q71339950 | Pulmonary infection due to anaerobes in a hospital autopsy survey |
| Q37404568 | Pulmonary manifestations of leptospirosis |
| Q70742233 | Pulse dosing of antimicrobial drugs with special reference to bacampicillin. A symposium. Dorado Beach, Puerto Rico, May 8-9, 1980 |
| Q70742241 | Pulse dosing with bacampicillin in treatment of acute exacerbations of chronic bronchitis |
| Q50892285 | Purification and purity assessment of toxic shock syndrome toxin 1. |
| Q53972388 | Purulent pericarditis caused by Candida: report of three cases and identification of high-risk populations as an aid to early diagnosis. |
| Q40167149 | Pyogenic psoas abscesses: noninvasive diagnostic techniques and review of the literature. |
| Q40057303 | Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature |
| Q67830402 | Pyomyositis due to group C streptococci in a patient with AIDS |
| Q44685258 | Pyomyositis in children in the United States. |
| Q37557302 | Pyomyositis in patients with diabetes mellitus |
| Q40789463 | Q fever in Spain: acute and chronic cases, 1981-1985. |
| Q40815414 | Q fever in the Basque Country: 1981-1984. |
| Q39681851 | Q fever: current concepts |
| Q37988816 | Quinolone antibiotics in the treatment of Salmonella infections. |
| Q30459934 | Quinolone therapy for infections of the central nervous system |
| Q38286338 | Quinolone uptake by bacteria and bacterial killing |
| Q45172705 | Quinolones for the treatment of infections due to Salmonella |
| Q38684699 | Quinolones in the treatment of Salmonella carriers |
| Q39632264 | Quinolones in the treatment of bronchopulmonary infections |
| Q38684703 | Quinolones in the treatment of lower respiratory tract infections |
| Q39632269 | Quinolones in the treatment of serious infections. |
| Q40098575 | Rabies Vaccine Prepared in Human Cell Cultures: Progress and Perspectives |
| Q37404555 | Rabies in Thailand: 1990. |
| Q38195819 | Rabies in the Americas and remarks on global aspects. |
| Q46789096 | Rabies in the kudu antelope (Tragelaphus strepsiceros). |
| Q44792908 | Rabies virus infection of myotubes and neurons as elements of the neuromuscular junction |
| Q40358344 | Radiolabeled microorganisms: comparison of different radioisotopic labels. |
| Q69887580 | Radiology in the diagnosis of splenic abscess |
| Q70163476 | Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor |
| Q70163483 | Randomized comparative trial of three regimens of itraconazole for treatment of vaginal mycoses |
| Q39538053 | Randomized trials of aminoglycoside antibiotics: quantitative overview |
| Q41182370 | Range of Antibacterial Activity of Antibiotics at Subminimal Inhibitory Concentrations: The Ratio of Minimal Inhibitory Concentration to Minimal Antibiotic Concentration* |
| Q39656848 | Rapid diagnosis of candidiasis and aspergillosis |
| Q35828858 | Rapid diagnosis of tuberculosis: laboratory techniques applicable in developing countries |
| Q45174265 | Rates of infectious disease consultations in hospitals of different sizes and types, 1986-1987. |
| Q40358276 | Rationale and Methods for a Statewide, Prospective Surveillance System for the Identification and Prevention of Nosocomial Infections |
| Q39750253 | Rationale for identification and susceptibility testing of anaerobic bacteria. |
| Q43509499 | Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein |
| Q38181911 | Reactivity of antibodies to core glycolipid with gram-negative bacteria |
| Q45795094 | Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. |
| Q72535968 | Recent Developments in the Study of Potassium Transport in Mycoplasma mycoides Subspecies capri |
| Q53162763 | Recent Experience in the Epidemiology of Disease Caused by Atypical Mycobacteria |
| Q39001498 | Recent advances in management of bacterial diarrhea |
| Q39537931 | Recent developments in beta-lactamase research and their implications for the future. |
| Q71718252 | Recent developments in the management of anaerobic infections |
| Q70601368 | Recent developments in the organic synthesis of lipid A in relation to biologic activities |
| Q38355492 | Receptor Sites for Mycoplasmal Viruses on Acholeplasma laidlawii |
| Q39737834 | Reciprocal relationships between undernutrition and the parasitic disease visceral leishmaniasis. |
| Q30410804 | Recombination as a Mechanism in the Evolution of Influenza Viruses: A Two-Year Study of Ducks in Hong Kong |
| Q53427294 | Recommendations for an international health organization in handling a future AIDS-like epidemic. |
| Q41182381 | Recovery Period and the Exposure of Bacteria to Subminimal Inhibitory Concentrations of Antibiotics* |
| Q38583562 | Recovery of Anaerobic Bacteria from Vented Blood-Culture Bottles |
| Q69741584 | Recurrent Haemophilus influenzae bacteremia in a 79-year-old woman |
| Q69659197 | Recurrent native-valve infective endocarditis |
| Q34690344 | Recurrent urinary tract infections in female patients: an overview of management and treatment |
| Q44857985 | Red Man Syndrome with Teicoplanin |
| Q39004794 | Reflections on the efficacy of pertussis vaccines |
| Q38612216 | Regulation and control of toxic shock syndrome toxin 1: overview. |
| Q38223181 | Regulation of T cell responsiveness against mycobacterial antigens by HLA class 2 immune response genes. |
| Q72092106 | Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells |
| Q44279304 | Regulatory mechanisms of a chemoattractant receptor on human polymorphonuclear leukocytes |
| Q46354529 | Reimbursement for health care. Training, cost containment, and practice: effect on infectious diseases |
| Q50874628 | Reimbursement for outpatient parenteral antibiotic therapy: update. |
| Q45854619 | Relapsing Systemic Infection Due to Rhodococcus equi in a Drug Abuser Seropositive for Human Immunodeficiency Virus |
| Q37737177 | Relation of the pathogenesis of human immunodeficiency virus infection to various strategies for its control |
| Q38347001 | Relations between beta-lactamases and penicillin-binding proteins: beta-lactamase activity of penicillin-binding protein 5 from Escherichia coli |
| Q40118826 | Relationship Between Pathogenesis and Immune Regulation Mechanisms in Histoplasmosis: A Hypothetical Approach |
| Q45001249 | Relationship between acute myelomonoblastic leukemia and infection due to human immunodeficiency virus |
| Q44322036 | Relationship between day care and health care providers |
| Q36461193 | Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection |
| Q38663791 | Replication of hemorrhagic fever viruses in monocytic cells |
| Q38140274 | Report of a symposium on use and abuse of antibiotics worldwide. |
| Q69601612 | Requirements for pharmacokinetic evaluation of antibiotics in phase I studies |
| Q69593188 | Research towards global control and prevention of tuberculosis with an emphasis on vaccine development. A Fogarty International Center Workshop, Bethesda, Maryland, 3-5 November 1987. Proceedings |
| Q70234008 | Research towards rabies prevention. A symposium. Washington, D.C., 3-5 November 1986. Proceedings. Dedicated to the memory of Dr. Fakhry Assad and honors the contributions of Drs. Ernst Kuwert and Tadeusz Wiktor |
| Q39101365 | Research: the prerequisite for innovative strategies and technologies |
| Q39737874 | Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents |
| Q58405749 | Resistance of anaerobic bacteria to antimicrobial agents |
| Q39660520 | Resistance of bacteria to antibacterial agents: report of Task Force 2. |
| Q38143790 | Resistance to beta-lactam antibiotics in anaerobic bacteria. |
| Q39606840 | Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms |
| Q70438694 | Resistance to trimethoprim among urinary tract isolates in the United Kingdom |
| Q28335817 | Resolution of acute renal failure in toxoplasmic encephalitis despite continuance of sulfadiazine |
| Q68597848 | Resolution of lung abscess due to Pseudomonas aeruginosa with oral ciprofloxacin: case report |
| Q40195125 | Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials? |
| Q43635233 | Resources related to infectious illness for child care providers. |
| Q68094163 | Respiratory embarrassment and neurologic symptoms in a patient with AIDS |
| Q39192951 | Respiratory rate greater than 50 per minute as a clinical indicator of pneumonia in Filipino children with cough |
| Q36640330 | Response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella typhi to treatment with trimethoprim-sulfamethoxazole. |
| Q40778730 | Response of various animal species to experimental infection with different strains of Staphylococcus aureus. |
| Q37754400 | Response to antimicrobial therapy for shigellosis in Thailand |
| Q40746937 | Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia |
| Q64891823 | Response to pneumococcal vaccine among children with Hodgkin's disease. |
| Q42209688 | Responses of neurologic complications of AIDS to 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl) guanine. I. Clinical features |
| Q54447643 | Responsibility of the infectious disease community for optimal use of antibiotics: views of the membership of the Infectious Diseases Society of America. |
| Q38684718 | Results of treatment with quinolones of sexually transmitted diseases in the Far East: a brief summary |
| Q70226005 | Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses |
| Q93601001 | Retrospective commentary on the bacterial endocarditis study |
| Q39493498 | Retroviral spongiform polioencephalomyelopathy |
| Q34268428 | Retroviruses and cancer |
| Q39833191 | Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime |
| Q37331251 | Review of laboratory findings for patients with chronic fatigue syndrome |
| Q37918338 | Review of recent pneumococcal infections with attention to vaccine and nonvaccine serotypes. |
| Q39439540 | Review of the human immune mechanisms directed against Entamoeba histolytica. |
| Q39681888 | Review of the molecular requirements of endotoxic actions |
| Q40865899 | Rheumatic Fever, Rheumatic Heart Disease, and the Streptococcal Connection: The Role of Streptococcal Antigens Cross-Reactive with Heart Tissue |
| Q37404506 | Rheumatoid arthritis: new findings on the failure to isolate or detect mycoplasmas by multiple cultivation or serologic procedures and a review of the literature |
| Q39737830 | Rhinocerebral mucormycosis in renal transplant recipients: report of three cases and review of the literature |
| Q37696675 | Rhodococcus equi infection in patients with and without human immunodeficiency virus infection |
| Q37696778 | Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case |
| Q34515136 | Richard Pearson Strong and the iatrogenic plague disaster in Bilibid Prison, Manila, 1906. |
| Q39510145 | Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases |
| Q70996312 | Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b |
| Q54494861 | Rifampin and minocycline in meningococcal disease. |
| Q44994714 | Rifampin and pseudomembranous colitis |
| Q37906897 | Rifampin in chlamydial infections |
| Q54494495 | Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits. |
| Q54495015 | Rifampin in the Treatment of Leprosy |
| Q71083870 | Rifampin therapy for brucellosis, flavobacterium meningitis, and cutaneous leishmaniasis |
| Q42252243 | Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. |
| Q54495032 | Rifampin: Mechanisms of Action and Resistance |
| Q54494500 | Rifampin: spectrum of antibacterial activity. |
| Q43314354 | Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions. |
| Q40178775 | Risk Factors in Subacute Sclerosing Panencephalitis: Age- and Sex-Dependent Host Reactions or Intensive Exposure? |
| Q34102535 | Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases |
| Q40751044 | Risk factors for candidemia in patients with acute lymphocytic leukemia |
| Q46040133 | Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study. |
| Q44178096 | Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection |
| Q69561570 | Risk of infectious complications in patients taking glucocorticosteroids |
| Q57245175 | Risk-Factor Studies as an Epidemiologic Tool |
| Q45857165 | Role of Altered Drug Metabolism in Virus-Drug Interactions |
| Q36839992 | Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis |
| Q37906907 | Role of Chlamydia trachomatis in perinatal infection. |
| Q40161683 | Role of Iron in Microbe-Host Interactions |
| Q39837998 | Role of aerobic gram-negative bacilli in endometritis after cesarean section |
| Q69971110 | Role of air in growth and production of toxic shock syndrome toxin 1 by Staphylococcus aureus in experimental cotton and rayon tampons |
| Q40176189 | Role of anaerobic bacteria in bite-wound infections. |
| Q37404581 | Role of antibodies and antibiotics in aerobic gram-negative septicemia: possible synergism between antimicrobial treatment and immunotherapy |
| Q37696647 | Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections. |
| Q36461188 | Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus |
| Q39753126 | Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics |
| Q68021095 | Role of bronchoalveolar lavage in diagnosis of disseminated toxoplasmosis |
| Q37898667 | Role of ceftriaxone in sexually transmitted diseases |
| Q37903769 | Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity |
| Q54477832 | Role of complement in host resistance against members of the Bacteroidaceae. |
| Q51774681 | Role of drug-abuse treatment in limiting the spread of AIDS. |
| Q39643624 | Role of empiric parenteral antibiotics prior to lumbar puncture in suspected bacterial meningitis: state of the art. |
| Q37937680 | Role of fibronectin in diseases of newborn infants and children |
| Q39485102 | Role of fibronectin in infective endocarditis. |
| Q39694802 | Role of fibronectin in the pathogenesis of candidal infections |
| Q39601009 | Role of fibronectin in the pathogenesis of gram-negative bacillary pneumonia |
| Q39694791 | Role of fibronectin in the pathogenesis of syphilis |
| Q38143770 | Role of humoral factors in host resistance to the Bacteroides fragilis group |
| Q37817858 | Role of immunoglobulin therapy in neonatal infections: where we stand today |
| Q69765634 | Role of infectious disease specialists |
| Q37817865 | Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonates. The Neonatal IVIG Study Group |
| Q38596075 | Role of legionellae in acute infections of the lower respiratory tract |
| Q43209919 | Role of lesser developed nations in rabies research |
| Q39681914 | Role of leukotrienes in endotoxin action in vivo |
| Q70463770 | Role of membrane sterols in Mycoplasma capricolum |
| Q46534061 | Role of nongovernmental agencies in vaccine delivery |
| Q41274022 | Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. |
| Q43698166 | Role of serology in the diagnosis of toxoplasmic lymphadenopathy |
| Q36840002 | Role of the Environment of the Operating Suite in Surgical Wound Infection |
| Q39538152 | Role of the capsule in phagocytosis of Cryptococcus neoformans. |
| Q69557240 | Role of the infectious disease specialist in containing costs of antibiotics in the hospital |
| Q38745113 | Role of the microbiology laboratory in care of the immunosuppressed patient |
| Q45833288 | Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome |
| Q39825888 | Role of the neutrophil in oral disease: receptor deficiency in leukocytes from patients with juvenile periodontitis. |
| Q38612212 | Role of toxic shock syndrome toxin 1 in toxic shock syndrome: overview |
| Q38194445 | Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa |
| Q43882924 | Roles of the wolf and the raccoon dog in the ecology and epidemiology of rabies in the USSR. |
| Q54167002 | Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy. |
| Q93561633 | Rubella immunization strategies in Canada |
| Q50578866 | Rubella in the United Kingdom, 1970-1983. |
| Q93561642 | Rubella infection: the Indian scene |
| Q41388580 | Rubella vaccine in the People's Republic of China |
| Q93561640 | Rubella--world impact |
| Q44223847 | SI units and the clinical practice of infectious diseases: application to the usage of antimicrobial agents |
| Q70303783 | Safety and toxicity of a new serum immunoglobulin G intravenous preparation, IGIV pH 4.25 |
| Q36496256 | Safety of Cefoxitin: An Approach to the Analysis of Laboratory Data |
| Q93665185 | Safety of aztreonam and SQ 26,992 in elderly patients with renal insufficiency |
| Q40748519 | Safety of aztreonam in patients with cystic fibrosis and allergy to beta-lactam antibiotics |
| Q45123459 | Safety profile of aztreonam in clinical trials |
| Q45849077 | Salmonella arizonae bacteremia as the presenting manifestation of human immunodeficiency virus infection following rattlesnake meat ingestion |
| Q39728871 | Salmonella focal intracranial infections: review of the world literature (1884-1984) and report of an unusual case. |
| Q71718244 | Salmonella infections of the abdominal aorta |
| Q48308143 | Salmonella subdural empyema in a patient with brain metastasis. |
| Q39474909 | Salmonella typhi infections in the United States, 1975-1984: increasing role of foreign travel |
| Q39681845 | Salmonellosis during infection with human immunodeficiency virus |
| Q44740750 | Scanning electron microscopy of Acanthamoeba castellanii: adherence to surfaces of new and used contact lenses and to human corneal button epithelium |
| Q39598723 | Schistosomiasis in Malaysia |
| Q40131304 | Schistosomiasis: Nutritional Implications |
| Q70527501 | Schistosomiasis: eradication or control? |
| Q40244043 | Schistosomiasis: host-pathogen biology. |
| Q44199937 | Screening for chemical inhibitors of growth rate, encystment, and excystment in Acanthamoeba castellanii |
| Q40267850 | Screening to control infectious diseases: evaluation of control programs for gonorrhea and syphilis. |
| Q67020472 | Seal finger |
| Q41538138 | Seasonality of plague in early modern Europe: Swiss epidemic of 1628--1630. |
| Q69710784 | Second International Symposium on New Quinolones. Geneva, Switzerland, 25-27 August 1988 |
| Q34269770 | Secretory immunity and the bacterial IgA proteases. |
| Q41165865 | Selection and training of patients for outpatient intravenous antibiotic therapy |
| Q40148391 | Selection of Antimicrobial Agents for Initial Treatment of Suspected Septicemia in Infants and Children |
| Q40148401 | Selection of Antimicrobial Agents for Treatment of Neonatal Sepsis |
| Q40270698 | Selection of antimicrobial agents for treatment of infections of the female genital tract |
| Q45798511 | Selective Primary Health Care: Strategies for Control of Disease in the Developing World. III. Hepatitis B Virus and Its Related Diseases |
| Q38912125 | Selective Primary Health Care: Strategies for Control of Disease in the Developing World. V. Leprosy |
| Q40092717 | Selective Primary Health Care: Strategies for Control of Disease in the Developing World. X. Amebiasis |
| Q39217431 | Selective Primary Health Care: Strategies for Control of Disease in the Developing World. XIV. Leishmaniasis |
| Q41414961 | Selective Primary Health Care: Strategies for Control of Disease in the Developing World. XVI. Chagas' Disease |
| Q44164714 | Selective Primary Health Care: Strategies for the Control of Disease in the Developing World. VII. Filariasis |
| Q70224155 | Selective binding of lipid A to responder and nonresponder B lymphocyte subpopulations |
| Q39837973 | Selective decontamination of the digestive tract with oral aztreonam and temocillin |
| Q93561632 | Selective immunization: protection of the individual |
| Q70601377 | Selective interaction between lymphocytes and lipid A subunits in lipopolysaccharide macromolecular aggregates |
| Q39413289 | Selective primary health care. XXIV. Malaria |
| Q38488179 | Selective primary health care. XXV. Management priorities |
| Q43324900 | Selective primary health care: strategies for control of disease in the developing world. I. Schistosomiasis |
| Q36591112 | Selective primary health care: strategies for control of disease in the developing world. II. Tuberculosis |
| Q39353965 | Selective primary health care: strategies for control of disease in the developing world. IV. Measles. |
| Q39401351 | Selective primary health care: strategies for control of disease in the developing world. IX. Poliomyelitis |
| Q54494573 | Selective primary health care: strategies for control of disease in the developing world. VI. Onchocerciasis. |
| Q46429708 | Selective primary health care: strategies for control of disease in the developing world. VIII. African trypanosomiasis |
| Q40178783 | Selective primary health care: strategies for control of disease in the developing world. XI. Dengue |
| Q40181102 | Selective primary health care: strategies for control of disease in the developing world. XII. Ascariasis and trichuriasis |
| Q40212741 | Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis |
| Q39828289 | Selective primary health care: strategies for control of disease in the developing world. XIX. Giardiasis |
| Q40199655 | Selective primary health care: strategies for control of disease in the developing world. XV. Acute diarrhea |
| Q38479142 | Selective primary health care: strategies for control of disease in the developing world. XVII. Hookworm infection and anemia. |
| Q39825893 | Selective primary health care: strategies for control of disease in the developing world. XVII. Pertussis and diphtheria |
| Q38152332 | Selective primary health care: strategies for control of disease in the developing world. XX. Typhoid fever. |
| Q39833226 | Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections |
| Q44521121 | Selective primary health care: strategies for control of disease in the developing world. XXII. Tetanus: a preventable problem |
| Q39588780 | Selective primary health care: strategies for control of disease in the developing world. XXIII. Control of infection to reduce the prevalence of infantile and childhood malnutrition |
| Q68522503 | Semiautomated susceptibility systems |
| Q50207982 | Separation and characterization of toxic and nontoxic forms of lipid A. |
| Q43668305 | Septic Anaerobic Jugular Phlebitis with Pulmonary Embolism: Problems in Management |
| Q40178752 | Septic Arthritis in Young Infants: Clinical and Microbiologic Correlations and Therapeutic Implications |
| Q38140275 | Septic arthritis caused by Bacteroides fragilis |
| Q68021078 | Septic arthritis caused by Corynebacterium xerosis following vascular surgery |
| Q40278093 | Septic arthritis due to Candida species on patients with cancer: report of five cases and review of the literature |
| Q68886295 | Septic arthritis due to Fusarium moniliforme |
| Q37404537 | Septic endarteritis of the femoral artery following angioplasty |
| Q39598726 | Septic lung |
| Q54362012 | Sequential assessment of vaginal microflora in healthy women randomly assigned to tampon or napkin use. |
| Q37737159 | Serious infections involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzihabitans |
| Q71810016 | Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age |
| Q67994447 | Serodiagnosis of neurocysticercosis |
| Q42048920 | Seroepidemiology of Pertussis in Italy |
| Q71407489 | Seroimmunity following vaccination in infants by an inactivated poliovirus vaccine prepared on Vero cells |
| Q37229812 | Serologic Diagnosis of Human Brucellosis: Analysis of 214 Cases by Agglutination Tests and Review of the Literature |
| Q34781954 | Serologic and Immunologic Responses in Chronic Fatigue Syndrome with Emphasis on the Epstein-Barr Virus |
| Q37174131 | Serologic and Virologic Epidemiology of Epstein-Barr Virus: Relevance to Chronic Fatigue Syndrome |
| Q40835064 | Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. |
| Q69894419 | Serologic test combinations for safe detection of rubella infections |
| Q38223185 | Serology of mycobacteria: characterization of antigens recognized by monoclonal antibodies |
| Q38152331 | Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes |
| Q70140175 | Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989 |
| Q38509316 | Serratia bacteremia: review of 118 cases |
| Q54538230 | Serum antibody responses of high-risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae. |
| Q52050580 | Severe Hypomagnesemia Associated with Pentamidine Therapy |
| Q47382667 | Severe measles in Copenhagen, 1915-1925. |
| Q71809957 | Severe measles: some unanswered questions |
| Q40756780 | Severity of meningococcal disease: assessment by factors and scores and implications for patient management |
| Q37896401 | Sexual assault and sexually transmitted diseases: detection and management in adults and children |
| Q68703372 | Sexually transmitted diseases in rape victims |
| Q37754378 | Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects |
| Q34115810 | Shiga toxin: purification, structure, and function |
| Q38675522 | Shigella vaccines |
| Q37754326 | Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays |
| Q53922175 | Short-Term Administration of Rifampin in the Prevention or Eradication of Infection Due to Foreign Bodies |
| Q46956755 | Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim. |
| Q37935937 | Short-term treatment of uncomplicated lower urinary tract infections in women |
| Q40751041 | Significance of elevated levels of serum creatine phosphokinase in febrile diseases: a prospective study |
| Q38181908 | Significance of histamine formation and release in the development of endotoxic shock: proof of current concepts by randomized controlled studies in rats |
| Q40275893 | Single-dose antimicrobial therapy for urinary tract infections in women. |
| Q70159386 | Single-dose pharmacokinetics of intravenous sulbactam in pediatric patients |
| Q70410603 | Single-dose regimen of cefonicid for the treatment of uncomplicated infections of the lower urinary tract |
| Q72113268 | Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women |
| Q70514542 | Single-dose treatment of uncomplicated gonorrhea: a comparison of cefonicid and penicillin |
| Q28261016 | Sir Patrick Manson's studies on the transmission and biology of filariasis |
| Q38943493 | Sir Patrick Manson: An Annotated Bibliography and a Note on a Collected Set of His Writings |
| Q34275057 | Sisomicin: a review of eight years' experience |
| Q42082121 | Six hundred years: Heidelberg University--crisis and achievements. |
| Q39728853 | Skin clues in the diagnosis of life-threatening infections. |
| Q45966287 | Skunk rabies. |
| Q37754350 | Social and behavioral factors in transmission and response to shigellosis |
| Q38717679 | Social context of human immunodeficiency virus transmission in Africa: historical and cultural bases of east and central African sexual relations |
| Q39660527 | Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4. |
| Q38489095 | Sociocultural Factors in the Control and Prevention of Parasitic Diseases |
| Q93653094 | Sociomedical contributions to trachoma research and intervention |
| Q40743247 | Some Aspects of Rocky Mountain Spotted Fever as Shown by Recent Investigations |
| Q38576899 | Some Considerations Regarding the Classification and Identification of Mycobacteria |
| Q41200703 | Some Evidence for Interhuman Transmission of Medieval Plague |
| Q46530770 | Some epidemiologic aspects of yaws in the Ivory Coast. |
| Q43567263 | Some historical notes on chlortetracycline |
| Q40241999 | Some observations on poliomyelitis lameness surveys. |
| Q40315042 | Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. |
| Q71407473 | Some problems of administering oral poliovirus vaccine |
| Q39537969 | Some properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with non-enzyme-dependent multiple resistance to beta-lactam antibiotics, aminoglycosides, and quinolones. |
| Q33537694 | Sources of confounding in immunologic data |
| Q67994431 | Species identification in haemophilus infection |
| Q41200677 | Specific Membrane Receptors: Pathogenetic and Therapeutic Implications in Infectious Diseases |
| Q39632230 | Specific toxicologic aspects of the quinolones. |
| Q70349419 | Specimen Collection and Transport, Anaerobic Culture Techniques, and Identification of Anaerobes |
| Q40358286 | Spectrum of Clinical Disease in Pulmonary Infection with Mycobacterium avium-intracellulare |
| Q40758889 | Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus |
| Q40158899 | Spectrum of Disease Due to Rapidly Growing Mycobacteria |
| Q36525458 | Spinal Sepsis Due to Streptococcus milleri: Two Cases and Review |
| Q38616072 | Spirochete-like organisms in the human gastrointestinal tract |
| Q54517627 | Spiroplasmal viruses: group 1 characteristics. |
| Q43653411 | Splenic Abscess Due to Fusobacterium necrophorum |
| Q40749202 | Splenic Abscesses Due to Mycobacterium tuberculosis in Patients with AIDS |
| Q40743257 | Splenic Tuberculosis in Patients with AIDS |
| Q68074450 | Splenic abscesses due to Mycobacterium tuberculosis in patients with AIDS: is splenectomy necessary? |
| Q72403965 | Spontaneous clostridial empyema and pyopneumothorax |
| Q39656841 | Spontaneous gangrenous myositis induced by Streptococcus pyogenes: case report and review of the literature |
| Q68886277 | Spontaneous pneumothorax complicating pulmonary mycetoma in patients with acute leukemia |
| Q68763984 | Spontaneous, nontraumatic gangrene due to Clostridium septicum |
| Q45853865 | Sporotrichosis in human immunodeficiency virus-infected patients: report of a case |
| Q68157722 | Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient |
| Q40866736 | Spotted fever and babesiosis |
| Q37557371 | Spotted fever group rickettsial infections in Australia. |
| Q71809966 | Stability of further-attenuated measles vaccines |
| Q45896738 | Stability of sulbactam/ampicillin in diluents for parenteral administration |
| Q71809974 | Stabilized measles vaccine in a novel single-dose delivery system: a practical reality for worldwide elimination of measles |
| Q70220582 | Standardization of Poliovirus Neutralizing Antibody Tests |
| Q70220575 | Standardization of safety and potency tests of vaccines against poliomyelitis |
| Q69894421 | Standardization of techniques and reagents for the study of rubella antibody |
| Q38717668 | Staphylococcus aureus meningitis: review of 28 cases |
| Q34257890 | Staphylococcus saprophyticus as a common cause of urinary tract infections |
| Q52633043 | Statistical aspects of clinical trials of antibiotics in acute infections. |
| Q46381792 | Status of measles in The Gambia, 1981. |
| Q69184930 | Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1 |
| Q39538044 | Stimulation of secretory antibody following oral administration of antigen |
| Q50208040 | Stimulation of spleen cells and macrophages of C3H/HeJ mice by a lipid A precursor derived from Salmonella typhimurium |
| Q37404710 | Strategic antibiotic decision-making at the formulary level |
| Q39417908 | Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine |
| Q45861053 | Strategies for the prevention of neonatal infection with herpes simplex virus: a decision analysis. |
| Q39598732 | Strategies for the treatment of endotoxemia: significance of the acute-phase response |
| Q93653090 | Strategies for treatment and control of blinding trachoma: cost-effectiveness of topical or systemic antibiotics |
| Q40161679 | Streptococcal Toxins |
| Q44514171 | Streptococcal endocarditis: single vs. combination antibiotic therapy and role of various species |
| Q39737816 | Streptococcal puerperal sepsis and obstetric infections: a historical perspective |
| Q69583364 | Streptococcus pneumoniae endocarditis presenting as an epidural abscess |
| Q37935929 | Streptococcus pneumoniae infections of the female genital tract and in the newborn child |
| Q34714546 | Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. |
| Q37404572 | Stress and pathogenesis of infectious disease |
| Q43671325 | Stroke due to Capnocytophaga endocarditis |
| Q72744237 | Structural Features of Binding of Lipopolysaccharides to Murine Lymphocytes |
| Q71108836 | Structural features of vancomycin |
| Q45828089 | Structure and function of the rubella virus proteins |
| Q38194446 | Structure and functions of the cell envelope of gram-negative bacteria |
| Q38201241 | Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. |
| Q39538105 | Structure, function, and genetics of streptococcal M protein |
| Q38143767 | Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis |
| Q69971103 | Structure-function analysis of toxic shock syndrome toxin 1 |
| Q40103081 | Structures of the typing antigens of atypical mycobacteria: a brief review of present knowledge |
| Q54145274 | Studies of beta-lactam antibiotics in systemic infections: some personal observations over 25 years. |
| Q40117528 | Studies on Low-Molecular-Weight Immunomodifiers Produced by Microorganisms: Results of Ten Years' Effort |
| Q39538094 | Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae |
| Q40101275 | Studies on Vaccine Control and Immunogenicity of Polysaccharides of Streptococcus pneumoniae |
| Q40848165 | Studies on a virus from a patient with Fort Bragg fever (pretibial fever) by Hugh Tatlock (The Journal of Clinical Investigation 26:287-297, 1947). |
| Q38172180 | Studies on antibiotics and enzyme inhibitors |
| Q38579192 | Study of rimantadine in the USSR: a review of the literature |
| Q70220571 | Studying Poliovirus with Infectious Cloned cDNA |
| Q50588251 | Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza. |
| Q68485419 | Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation |
| Q40819638 | Successful treatment of multiple brain abscesses with antibiotics alone |
| Q39506404 | Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use. |
| Q70159415 | Sulbactam/ampicillin in the treatment of acute epiglottitis in children |
| Q70159417 | Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children |
| Q54774005 | Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. |
| Q46410962 | Sulbactam: biochemical factors involved in its synergy with ampicillin |
| Q71102088 | Sulfonamide Activity Against Mycobacterium fortuitum and Mycobacterium chelonei |
| Q70924158 | Summarized vs. Type-Specific Analysis of Antibody to Pneumococcal Capsular Polysaccharides |
| Q70285873 | Summary of Clinical Trials of Inactivated Influenza Vaccine--1978 |
| Q36476621 | Summary of an international workshop on typhoid fever |
| Q69923765 | Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections |
| Q54441874 | Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections. |
| Q54447343 | Summary report of worldwide antibiotic resistance: international task forces on antibiotic use. |
| Q40297174 | Superoxide, Hydrogen Peroxide, and Oxygen Tolerance of Oxygen-Sensitive Mutants of Escherichia coli |
| Q41182391 | Suppression of Bacterial Adherence by Subminimal Inhibitory Concentrations of β-Lactam and Aminoglycoside Antibiotics |
| Q38663740 | Suppression of transmission of malaria through source reduction: antianopheline measures applied in Israel, the United States, and Italy. |
| Q67005019 | Surface Antigens as Virulence Factors in Infection with Bacteroides fragilis |
| Q57077309 | Surface Components of Streptococcus pneumoniae |
| Q39470905 | Surface proteins of Bordetella pertussis |
| Q52491136 | Surface proteins of Staphylococcus aureus. |
| Q39538110 | Surface-localized protein antigens of group B streptococci. |
| Q43519877 | Surgical Management of Pulmonary Disease Due to Mycobacterium avium-intracellulare |
| Q38684715 | Surgical prophylaxis and treatment of surgical infections with quinolones |
| Q70220545 | Surveillance and Control of Poliomyelitis in The Netherlands |
| Q43317587 | Surveillance and control of resurgent yaws in the African region |
| Q39742209 | Surveillance of communicable diseases in child day care settings. |
| Q37229853 | Survival and Disinfectant Inactivation of the Human Immunodeficiency Virus: A Critical Review |
| Q37229856 | Survival and Vehicular Spread of Human Rotaviruses: Possible Relation to Seasonality of Outbreaks |
| Q37918353 | Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies |
| Q42244066 | Susceptibility of moxalactam to beta-lactamase. |
| Q68320130 | Symposium on Helicobacter pylori: a cause of gastroduodenal disease. Cincinnati, Ohio, 9-10 October 1989 |
| Q71155327 | Symposium on Pseudomonas aeruginosa infections. Symposium, Washington, D.C., December 6-7, 1979 |
| Q68819858 | Symposium: Update and advances in intravenous therapy with trimethoprim-sulfamethoxazole. San Francisco, California, July 15, 1985. Proceedings |
| Q37704073 | Symptoms and signs of chronic fatigue syndrome |
| Q34276255 | Syndrome of hyperinfection with Strongyloides stercoralis |
| Q40266027 | Synergism and antagonism of parasitic diseases and malnutrition |
| Q70258073 | Synergism in the folate pathway |
| Q40337576 | Synergistic combinations of antibiotics in gram-negative bacillary infections. |
| Q38232982 | Synergy of fluoroquinolones with other antimicrobial agents |
| Q53578953 | Synthesis and maturation of glycoproteins of enveloped animal viruses. |
| Q37947317 | Syphilis serology in human immunodeficiency virus-infected patients with symptomatic neurosyphilis: case report and review |
| Q39302474 | Syphilis, historical and actual: cultural geography of a disease |
| Q37557311 | Systemic infection due to atypical mycobacteria in patients with chronic myelogenous leukemia. |
| Q36542540 | T Cell Responses to Herpes Simplex Viruses in Humans |
| Q40098180 | T Suppressor Cells: Role in Dengue Hemorrhagic Fever and Dengue Shock Syndrome |
| Q38143779 | T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. |
| Q68100834 | TMP-SMZ in the treatment of brucellar meningitis |
| Q39791427 | Taeniasis unresponsive to a single dose of niclosamide: case report of persistent infection with Taenia saginata and a review of therapy. |
| Q37817861 | Targeted immunoglobulin therapy for the prevention of neonatal infections |
| Q50716073 | Taxonomy and identification of spiroplasmas. |
| Q36592398 | Taxonomy of Anaerobes: Present State of the Art |
| Q39858750 | Taxonomy, Enzymes, and Clinical Relevance of Anaerobic Bacteria |
| Q38232977 | Tenosynovitis of the hand: a forgotten manifestation of tuberculosis |
| Q37704038 | Testing of vestibular function: an adjunct in the assessment of chronic fatigue syndrome |
| Q68643645 | The "toxic strep syndrome": severe group A streptococcal disease in the absence of bacteremia |
| Q40298560 | The Action of Botulinal Toxin |
| Q72873789 | The Activity of Ketoconazole in the Treatment of Onychomycosis |
| Q40173629 | The Acylampicillins: Mezlocillin, Piperacillin, and Azlocillin |
| Q54495030 | The Antimicrobial Activity of Rifampin: Emphasis on the Relation to Phagocytes |
| Q38621850 | The BCG story: lessons from the past and implications for the future |
| Q37214785 | The Burden of Acute Respiratory Infection Due to Measles in Developing Countries and the Potential Impact of Measles Vaccine |
| Q67005022 | The Chemotactic Effect of Bacteroides fragilis Lipopolysaccharide |
| Q67006786 | The Clinical Spectrum of Infant Botulism |
| Q40178758 | The Clinical Spectrum of Nocardia brasiliensis Infection in the United States |
| Q41493371 | The Complement System in Host Defense and Inflammation |
| Q41213193 | The Design of New Drugs That Resist Microbial Inactivation |
| Q36924047 | The Ecology of Cryptococcus neoformans and the Epidemiology of Cryptococcosis |
| Q41182354 | The Effects and Significance of Subminimal Inhibitory Concentrations of Antibiotics* |
| Q40751035 | The English sweating sickness, with particular reference to the 1551 outbreak in Chester. |
| Q71102032 | The Epidemiology of Opportunist Mycobacterial Infections in Wales, 1952-1978 |
| Q51233163 | The Expanded Programme on Immunization of the World Health Organization. |
| Q36437319 | The Fetid Foot: Lower-Extremity Infections In Patients with Diabetes Mellitus |
| Q70296076 | The First American Account of Cerebrospinal Meningitis |
| Q37229862 | The Growing Problem of Mycoses in Patients Infected with the Human Immunodeficiency Virus |
| Q68296821 | The Home Care Symposium. Snowbird, Utah, 10-11 January 1989 |
| Q41200742 | The Intestinal Flora and Infant Botulism |
| Q43774754 | The Israeli experience in the control of poliomyelitis during a quarter of a century, 1957-1982. |
| Q37737151 | The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review |
| Q39538078 | The K1 capsular polysaccharide of Escherichia coli |
| Q29543987 | The Life and Career of Howard Taylor Ricketts |
| Q39721738 | The Longitudinal Approach to the Pathogenesis of Respiratory Disease |
| Q49121107 | The Medical Research Council Common Cold Unit, Harvard Hospital, Salisbury, Wilts, England |
| Q28334247 | The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles |
| Q40789455 | The Nature of Human Brucellosis in Kuwait: Study of 379 Cases |
| Q67785682 | The Path to New FDA Guidelines for Clinical Evaluation of Anti-Infective Drugs |
| Q67239693 | The Paul-Bunnell Test Revisited |
| Q67250206 | The Pharmacokinetics of Cefotaxime and Its Metabolites in Subjects with Normal and Impaired Renal Function |
| Q72775853 | The Pharmacologic Basis for Moxalactam Therapy for Gram-Negative Enteric Bacillary Meningitis of Infancy |
| Q38073863 | The Possible Role of Epstein-Barr Virus in Rheumatoid Arthritis |
| Q40161697 | The Role of Antibody and Complement in the Reticuloendothelial Clearance of Pneumococci from the Bloodstream |
| Q30407995 | The Role of Bacteroides melaninogenicus and Other Anaerobes in Periodontal Infections |
| Q37214756 | The Role of Haemophilus influenzae in the Pathogenesis of Pneumonia |
| Q71102024 | The Role of the Hospital Administrator in the Control of Nosocomial Infections |
| Q71102078 | The Seroagglutination Test in the Study of Nontuberculous Mycobacteria |
| Q40178762 | The Significance of Nongonococcal, Nonmeningococcal Neisseria Isolates from Blood Cultures |
| Q41022774 | The Sudden Infant Death Syndrome and Infant Botulism |
| Q71102015 | The Usefulness of a Conceptual Model in the Study of the Efficacy of Infection Surveillance and Control Programs |
| Q53944644 | The Value of Animal Models for Study of Infection Due to Atypical Mycobacteria |
| Q28262738 | The Vwa+ virulence factor of yersiniae: the molecular basis of the attendant nutritional requirement for Ca++ |
| Q44325464 | The Willowbrook hepatitis studies revisited: ethical aspects |
| Q54529202 | The antibacterial action of vancomycin. |
| Q70178739 | The assessment of antimicrobial combinations |
| Q41200665 | The association of the temperature-sensitive phenotype with viral attenuation in animals and humans: implications for the development and use of live virus vaccines |
| Q70463730 | The biology of parasitic infection. Workshop on interactions of nutrition and parasitic diseases. An international symposium, Bellagio, Italy, September 27-October 1, 1980 |
| Q39317482 | The challenge of poliomyelitis in tropical Africa. |
| Q39505972 | The changing pattern of trimethoprim resistance in Paris, with a review of worldwide experience. |
| Q70521036 | The clinical challenge of infections due to Pseudomonas aeruginosa |
| Q33434350 | The clinical pathology of Crimean-Congo hemorrhagic fever |
| Q34713453 | The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. |
| Q71672817 | The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis |
| Q93653086 | The community epidemiology of trachoma |
| Q38596038 | The concept of immunofocusing illustrated by influenza virus infection |
| Q36496476 | The control of endemic treponematoses |
| Q38488954 | The control of measles in tropical Africa: a review of past and present efforts |
| Q71407454 | The control of poliomyelitis in Brazil |
| Q40254082 | The effect of aging on susceptibility to infection. |
| Q70463768 | The electrochemical potential across mycoplasmal membranes |
| Q40148427 | The emergence of bacterial resistance and its influence on empiric therapy. |
| Q36463709 | The enlarging spectrum of tick-borne spirochetoses: R. R. Parker Memorial Address. |
| Q42248062 | The enzymatic synthesis of lipid A: molecular structure and biologic function of monosaccharide precursors. |
| Q37754335 | The epidemiologic importance of dysentery in communities |
| Q34306565 | The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers. |
| Q40310229 | The epidemiology of pneumococcal disease in infants and children. |
| Q41573945 | The etiology and persistence of cryptic bacterial infections: a hypothesis. |
| Q41143321 | The evolving use of biologicals in the treatment and prevention of infectious diseases |
| Q50207979 | The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule |
| Q39681904 | The function of antibody and complement in the lysis of bacteria |
| Q41454535 | The future of beta-lactam antibiotics |
| Q39817223 | The global distribution of Lyme disease. |
| Q34193739 | The history and medical consequences of rubella |
| Q47603223 | The hospital in Jewish History |
| Q40310240 | The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis to tissue damage |
| Q37903810 | The humoral immune response to chlamydial infection in humans |
| Q40161630 | The immunobiology of leishmaniasis. |
| Q40314988 | The immunology of leprosy: speculations on the leprosy spectrum |
| Q71339964 | The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans |
| Q40314998 | The importance of lactic acid levels in body fluids in the detection of bacterial infections. |
| Q40828669 | The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. |
| Q44954474 | The infusion center: a model for outpatient parenteral antibiotic therapy |
| Q52397279 | The intestinal bacteria of the neonate and breast-fed infant. 1884. |
| Q49148800 | The intestinal bacteria of the neonate and breast-fed infant. 1885. |
| Q37872713 | The intestinal microflora and the colon cancer connection |
| Q70279557 | The link between viral infection and autoimmunity |
| Q36654698 | The lipopolysaccharide of Shigella bacteria as a virulence factor |
| Q70224160 | The membrane receptor complex regulating induction and clonal expansion of normal murine B lymphocytes |
| Q54432042 | The meningococcus: a twenty-year perspective. |
| Q49099284 | The microbe of pleuropneumonia. 1896. |
| Q40315026 | The microbicidal mechanisms of human neutrophils and eosinophils |
| Q38357387 | The minor problem of hemostatic impairment in nephropathia epidemica, the mild Scandinavian form of hemorrhagic fever with renal syndrome. |
| Q38717754 | The molecular biology of Borrelia |
| Q38195822 | The molecular biology of rabies viruses |
| Q36461184 | The mouse model and understanding immunity to herpes simplex virus. |
| Q39821317 | The multihandicapped child with congenital rubella: impact on family and community |
| Q40832467 | The nature of an infectious disease practice in a community hospital. |
| Q38684742 | The new quinolones: back to the future. |
| Q54469322 | The outlook for prevention and treatment of infections due to Pseudomonas aeruginosa. |
| Q70843525 | The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis |
| Q54506108 | The phagocytic cell: summary. |
| Q40304175 | The pharmacokinetics of bacampicillin. |
| Q39538089 | The plasmid-encoded outer-membrane proteins of Yersinia pestis |
| Q72484978 | The pneumococcus. A symposium held at the Kroc Foundation headquarters, Santa Ynez Valley, California, February 25-29, 1980 |
| Q37696693 | The polymerase chain reaction: amplifying our options |
| Q37903805 | The polymicrobial etiology of acute pelvic inflammatory disease and treatment regimens |
| Q70527503 | The present impossibility of eradicating of omnipresent worm |
| Q39246078 | The prevalence of Acanthamoeba in the human environment. |
| Q39660507 | The prevention of infection in total joint replacement surgery |
| Q38663815 | The reemergence of dengue in China |
| Q71309983 | The relation between clinical investigators and the pharmaceutical industry |
| Q70183150 | The relationship of Acanthamoeba to the external eye flora |
| Q40176169 | The role of anaerobic bacteria in intraabdominal infections |
| Q37754341 | The role of behavioral research in the prevention and management of invasive diarrheas |
| Q40195133 | The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. |
| Q40264494 | The role of cell-mediated immunity in bacterial infections. |
| Q40310244 | The role of complement in the host's defense against Streptococcus pneumoniae. |
| Q40210291 | The role of exotoxin A in pseudomonas disease and immunity. |
| Q71339953 | The role of gastrointestinal microflora in the pathogenesis of complications of mesenteric ischemia |
| Q54517625 | The role of industry in the development of a product for control of mycoplasmal plant diseases. |
| Q40210273 | The role of the microcolony mode of growth in the pathogenesis of Pseudomonas aeruginosa infections. |
| Q40286662 | The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. |
| Q39750247 | The serum bactericidal test. |
| Q40330818 | The significance of iron in infection |
| Q53431408 | The standardization of vaccines: a discussion. |
| Q39485097 | The staphylococcal fibronectin receptor: evidence for its importance in invasive infections |
| Q36461241 | The status of cytomegalovirus vaccine. |
| Q40266050 | The treatment and control of parasitic diseases. |
| Q39742217 | The unresolved child care dilemma: care for the acutely ill child. |
| Q51196891 | The use of amphotericin B in nosocomial fungal infection. |
| Q43471052 | The use of antimicrobial agents for noninfectious diseases |
| Q71083832 | The use of rifampin in the treatment of nontuberculous infections. Symposium held in San Francisco, California April 1982 |
| Q71083829 | The use of rifampin in the treatment of nontuberculous infections: an overview |
| Q39256262 | The use of soap and water in two Bangladeshi communities: implications for the transmission of diarrhea |
| Q40337649 | The use of trimethoprim-sulfamethoxazole in the treatment of chest infections |
| Q40216480 | The virulence of Pseudomonas aeruginosa |
| Q39759526 | The white cells: use of granulocyte transfusions |
| Q40118490 | Theoretical Interrelationships Among Immunologic and Hematologic Sequelae of Thermal Injury |
| Q44858280 | Theoretical aspects of rubella vaccination strategies |
| Q45140353 | Theory and applications of pulse dosing: a summary of the symposium |
| Q72873809 | Therapeutic Evaluation of Ketoconazole in Patients with Coccidioidomycosis |
| Q37988827 | Therapeutic approaches to neoplasms in AIDS. |
| Q40315018 | Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. |
| Q44672134 | Therapeutic potential of rifampin in enterococcal infections |
| Q39821294 | Therapeutic role of granulocyte transfusions |
| Q67936912 | Therapy for Human Brucellosis |
| Q44572596 | Therapy for experimental endocarditis due to Staphylococcus epidermidis. |
| Q37822587 | Therapy for gonococcal infections: options in 1989. |
| Q39849300 | Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience |
| Q93584375 | Therapy for nonvenereal treponematoses: review of the efficacy of penicillin and consideration of alternatives |
| Q44519547 | Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. |
| Q72873811 | Therapy of Disseminated or Pulmonary Coccidioidomycosis with Ketoconazole |
| Q40741266 | Therapy of Skin, Soft Tissue, and Bone Infections with Cefoxitin Sodium |
| Q40091959 | Thoughts on the Evolution of Strategies Used by Bacteria for Evasion of Host Defenses |
| Q41515362 | Three days in October of 1630: detailed examination of mortality during an early modern plague epidemic in Venice. |
| Q42207621 | Three generations of immunoglobulin G preparations for clinical use. |
| Q37404694 | Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections |
| Q37404705 | Ticarcillin/clavulanate for treatment of postpartum endometritis |
| Q67994466 | Tissue culture-based rabies vaccines: vaccine production technology transfer |
| Q70463725 | Tissue eosinophilia in human coccidioidomycosis |
| Q70744644 | Tissue penetration and half-life of cefonicid |
| Q38684685 | Tissue penetration of the new quinolones in humans |
| Q33891297 | Tn5030: a conjugative transposon conferring clindamycin resistance in Bacteroides species |
| Q70163509 | Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results |
| Q40832462 | Too few and too little: barricades to the pursuit of health |
| Q59807078 | Toxic Shock Syndrome Toxin 1 Is Encoded by a Variable Genetic Element |
| Q69971118 | Toxicity of staphylococcal toxic shock syndrome toxin 1 for germ-free and conventional piglets |
| Q42271152 | Toxicology of vancomycin in laboratory animals |
| Q40209357 | Toxins of Pseudomonas aeruginosa: new perspectives |
| Q70460619 | Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means |
| Q39759551 | Traditional enteropathogenic Escherichia coli of infantile diarrhea |
| Q39742223 | Training for child day care staff and for licensing and regulatory personnel in the prevention of infectious disease transmission |
| Q44948481 | Training of infectious disease specialists. |
| Q37737184 | Transfusion reactions due to bacterial contamination of blood and blood products |
| Q40139601 | Transfusion-associated cytomegalovirus infections |
| Q72535963 | Translocation of Thy-1 antigen and a fluorescent lipid probe during lymphoblastoid cell interaction with Mycoplasma hyorhinis |
| Q39494479 | Transmission of viral infections by the water route: implications for developing countries |
| Q69557242 | Travelers' diarrhea: National Institutes of Health Consensus Development Conference. Bethesda, Maryland, January 28-30, 1985 |
| Q39737846 | Travelers' diarrhea: an overview. |
| Q38143732 | Travelers' diarrhea: microbiologic bases for prevention and treatment |
| Q40257821 | Treatment failures secondary to in vivo development of drug resistance by microorganisms |
| Q28334255 | Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily |
| Q37896404 | Treatment of Chlamydia trachomatis genital infection |
| Q72873795 | Treatment of Chronic Mucocutaneous Candidosis with Ketoconazole: A Study of 12 Cases |
| Q72873792 | Treatment of Chronic Mucocutaneous Candidosis with Ketoconazole: Preliminary Results of a Controlled, Double-Blind Clinical Trial |
| Q72873815 | Treatment of Coccidioidomycosis with Ketoconazole: Clinical and Laboratory Studies of 18 Patients |
| Q72873779 | Treatment of Dermatomycoses with Ketoconazole |
| Q71102047 | Treatment of Disease Due to Mycobacterium intracellulare |
| Q67250269 | Treatment of Gram-Negative Bacillary Meningitis: Role of the New Cephalosporin Antibiotics |
| Q50175702 | Treatment of Intraabdominal Infection with Moxalactam |
| Q70140164 | Treatment of Listeria bacteremia with vancomycin |
| Q39737820 | Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature |
| Q71102042 | Treatment of Pulmonary Disease Due to Mycobacterium kansasii: Recent Experience with Rifampin |
| Q40741280 | Treatment of Septicemic Patients with Cefoxitin: Pharmacokinetics in Renal Insufficiency |
| Q40741253 | Treatment of Significant Bacterial Infections in Adults with Cefoxitin |
| Q41213097 | Treatment of Uncomplicated Gonococcal Urethritis with Cefoxitin: Comparison with Penicillin |
| Q67250264 | Treatment of Uncomplicated Gonorrhea with Cefotaxime |
| Q67250236 | Treatment of Urinary Tract Infections with Cefotaxime: Noncomparative and Prospective Comparative Trials |
| Q44074815 | Treatment of antibiotic-associated enterocolitis with vancomycin |
| Q40240150 | Treatment of antibiotic-associated pseudomembranous colitis. |
| Q40199662 | Treatment of bacterial osteomyelitis and Staphylococcus aureus endocarditis and single-dose therapy for uncomplicated Neisseria gonorrhoeae infections: an overview. |
| Q37947321 | Treatment of chancroid, 1989. |
| Q70163467 | Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole |
| Q46168761 | Treatment of coccidioidal meningitis with fluconazole. |
| Q37908269 | Treatment of concomitant Neisseria gonorrhoeae and Chlamydia trachomatis infections in women: comparison of trimethoprim-sulfamethoxazole with ampicillin-probenecid |
| Q72113272 | Treatment of cystitis in women with a single dose of trimethoprim-sulfamethoxazole |
| Q42001056 | Treatment of cytomegalovirus pneumonia |
| Q39284335 | Treatment of cytomegalovirus retinitis in patients with AIDS. |
| Q70163463 | Treatment of dermatophytoses and pityriasis versicolor with itraconazole |
| Q38140273 | Treatment of endocarditis caused by relatively resistant nonenterococcal streptococci: is penicillin enough? |
| Q70258117 | Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo |
| Q37888936 | Treatment of genital herpes. |
| Q44698790 | Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis |
| Q39837961 | Treatment of infections due to gram-negative bacilli: a perspective of past, present, and future |
| Q70159406 | Treatment of infections due to multiresistant Neisseria gonorrhoeae with sulbactam/ampicillin |
| Q69091628 | Treatment of infections of cerebrospinal fluid shunts |
| Q70521055 | Treatment of invasive external otitis with cefsulodin |
| Q44477552 | Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis |
| Q70521059 | Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis |
| Q28328071 | Treatment of meningitis and other infections due to ampicillin-resistant Haemophilus influenzae type b in children |
| Q44013516 | Treatment of paracoccidioidomycosis, candidosis, chromomycosis, lobomycosis, and mycetoma with ketoconazole: a brief summary. |
| Q68886280 | Treatment of peritonitis due to Curvularia and Trichosporon with amphotericin B |
| Q36595229 | Treatment of pityriasis versicolor with ketoconazole. |
| Q39694755 | Treatment of pulmonary sporotrichosis with ketoconazole. |
| Q68092256 | Treatment of respiratory failure in AIDS |
| Q37947332 | Treatment of sexually transmitted vaginosis/vaginitis |
| Q70422774 | Treatment of skin and soft-tissue infections with cefsulodin |
| Q37947322 | Treatment of syphilis, 1989. |
| Q38717776 | Treatment of syphilis: current recommendations, alternatives, and continuing problems |
| Q44273980 | Treatment of systemic sporotrichosis with ketoconazole. |
| Q39737878 | Treatment of travelers' diarrhea: fluid and dietary management. |
| Q34166920 | Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins |
| Q54469324 | Treatment of urinary tract infections due to Pseudomonas aeruginosa with cefsulodin. |
| Q70410598 | Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole |
| Q45022827 | Treatment options for infected knee arthroplasties |
| Q38140277 | Trends in the incidence and transmission patterns of trichinosis in humans in the United States: comparisons of the periods 1975-1981 and 1982-1986. |
| Q39753103 | Trichosporon beigelii infection: a review |
| Q68522507 | Trichosporon capitatum fungemia and intravenous drug abuse |
| Q68074493 | Tricuspid valve group B streptococcal endocarditis following elective abortion |
| Q72113256 | Trimethoprim - sulfamethoxazole revisited. Cambridge, Massachusetts, November 16-19, 1980 |
| Q40337614 | Trimethoprim alone for treatment of urinary tract infection |
| Q40337592 | Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland |
| Q70438687 | Trimethoprim and sulfisoxazole in the treatment of urinary tract infections, with special reference to antibody-coated bacteria and fecal flora |
| Q70680450 | Trimethoprim once daily vs. nitrofurantoin in treatment of acute urinary tract infections in young women, with special reference to periurethral, vaginal, and fecal flora |
| Q40846215 | Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients. |
| Q44633258 | Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection |
| Q72113319 | Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii |
| Q34714733 | Trimethoprim-sulfamethoxazole in the treatment of malaria, toxoplasmosis, and pediculosis |
| Q54520627 | Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae. |
| Q40337587 | Trimethoprim-sulfamethoxazole in treatment of severe infections |
| Q72113306 | Trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonitis in children |
| Q72113259 | Trimethoprim-sulfamethoxazole vs. ampicillin in the treatment of experimental meningitis due to Streptococcus pneumoniae |
| Q40337552 | Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use. |
| Q39510671 | Tropical disease in the immunocompromised host: melioidosis and pythiosis |
| Q39579440 | Tropical medicine or tropical health: the Heath Clark lectures, 1988. |
| Q37897908 | Tropical neuromyelopathies and retroviruses: a review |
| Q37737163 | Tuberculosis cutis miliaris disseminata as a manifestation of miliary tuberculosis: literature review and report of a case of recurrent skin lesions |
| Q43622322 | Tuberculosis in the native American: indigenous or introduced? |
| Q39589722 | Tuberculosis of the middle ear: review of the literature with an instructive case report |
| Q44941728 | Tuberculous psoas muscle abscess following chemoprophylaxis with isoniazid in a patient with human immunodeficiency virus infection |
| Q44994323 | Tubo-ovarian abscess: contemporary approach to management |
| Q67830369 | Tumor Necrosis Factor in Patients with Leptospirosis |
| Q39681924 | Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects |
| Q68833669 | Tumor necrosis factor: a cytokine involved in toxic effects of endotoxin |
| Q39550168 | Twelve-year review of recurrent native-valve infective endocarditis: a disease of the modern antibiotic era. |
| Q28306438 | Two errors in enteric epidemiology: the stories of Austin Flint and Max von Pettenkofer |
| Q40827401 | Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries |
| Q39470908 | Type 1 fimbriae of Escherichia coli: genetic regulation, morphogenesis, and role in pathogenesis |
| Q40290530 | Type B hepatitis: a review of current prospects for a safe and effective vaccine |
| Q54324577 | Type, frequency, and antimicrobial sensitivity pattern of bacteria in an Iranian hospital during the 1980s. |
| Q68643640 | Typhlitis due to Balantidium coli in captive lowland gorillas |
| Q39821299 | Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management |
| Q38863693 | Ultrasonography in the diagnosis and management of 52 patients with amebic liver abscess in Cairo |
| Q68851733 | Unbiased evidence on early treatment of suspected meningococcal disease |
| Q39688325 | Uncommonly encountered, motile, anaerobic gram-negative bacilli associated with infection |
| Q39470900 | Understanding the structure and antigenicity of gonococcal pili |
| Q93561631 | Universal immunization to interrupt rubella |
| Q44435632 | University of California/Davis Interdepartmental Conference on gram-negative septicemia. |
| Q39643619 | Unusual infections associated with colorectal cancer |
| Q50207976 | Unusual lipid A types in phototrophic bacteria and related species. |
| Q40762368 | Unusual pathogens in narcotic-associated endocarditis |
| Q45842783 | Unusual presentation of cat scratch disease in a patient positive for antibody to the human immunodeficiency virus. |
| Q68829914 | Update on rickettsiae and rickettsial diseases in China |
| Q39773542 | Update on spinal epidural abscess: 35 cases and review of the literature |
| Q46753356 | Update through 1985 on the incidence of toxic shock syndrome among members of a prepaid health plan |
| Q54520632 | Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control. |
| Q38016829 | Urinary tract infection caused by Corynebacterium group D2: report of 82 cases and review |
| Q40251624 | Urinary tract infections due to Candida albicans. |
| Q40743259 | Use of Ciprofloxacin for Successful Eradication of Bacteremia Due to Campylobacter cinaedi in a Human Immunodeficiency Virus-Infected Person |
| Q67936906 | Use of Granulocyte-Macrophage Colony Stimulating Factor for Treatment of Drug-Induced Agranulocytosis |
| Q39598740 | Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins |
| Q36700279 | Use of Recombinant Interferons and Hematopoietic Growth Factors in Patients Infected with Human Immunodeficiency Virus |
| Q40176268 | Use of a Model of Intraabdominal Sepsis for Studies of the Pathogenicity of Bacteroides fragilis |
| Q45140863 | Use of a new, low-pH immunoglobulin G preparation during episodes of bacteremia in the rat. |
| Q39632222 | Use of animal models in evaluation of the quinolones |
| Q39660482 | Use of antimicrobial agents in animal feeds: implications for human health |
| Q39590776 | Use of bacterial vaccines for prevention of pneumococcal and meningococcal disease in the day care setting |
| Q44358630 | Use of bismuth subsalicylate for the prevention of travelers' diarrhea. |
| Q68930487 | Use of bismuth subsalicylate in acute diarrhea in children |
| Q72783359 | Use of cefoperazone in the empiric treatment of serious skin infections |
| Q36700325 | Use of cytokines during prolonged neutropenia associated with autologous bone marrow transplantation |
| Q38684746 | Use of fluoroquinolones for intracellular pathogens |
| Q37557422 | Use of immunoglobulins in prevention and treatment of infection in critically ill patients: review and critique |
| Q40827233 | Use of killed poliovirus vaccine in a routine immunization program in West Africa |
| Q70140180 | Use of outpatient parenteral antibiotic therapy in a health maintenance organization |
| Q70924138 | Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group |
| Q38684711 | Use of quinolones for the treatment of osteomyelitis and septic arthritis |
| Q38684696 | Use of quinolones for the treatment of patients with bacteremia |
| Q37898074 | Use of quinolones in chlamydial infection |
| Q38684691 | Use of quinolones in pediatric patients |
| Q37898071 | Use of quinolones in urinary tract infections and prostatitis |
| Q54494489 | Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections. |
| Q71083866 | Use of rifampin for the treatment of urinary tract infections |
| Q67994469 | Use of serum and vaccine in combination for prophylaxis following exposure to rabies |
| Q37754346 | Use of social science research to improve epidemiologic studies of and interventions for diarrhea and dysentery |
| Q30414968 | Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease |
| Q46408709 | Use of the Polymerase Chain Reaction for the Specific and Direct Detection of Clostridium dijficile in Human Feces |
| Q38684710 | Use of the new quinolones in cystic fibrosis. |
| Q40337626 | Use of trimethoprim alone or in combination with drugs other than sulfonamides |
| Q54520635 | Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. |
| Q40846221 | Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer |
| Q42216562 | Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population. |
| Q39766109 | Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration. |
| Q39766123 | Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome |
| Q39766117 | Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients |
| Q38744781 | Vaccination against enteric bacterial diseases. |
| Q50554266 | Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark. |
| Q40290514 | Vaccine adjuvants. |
| Q38581087 | Vaccine delivery management |
| Q69685981 | Vaccine distribution: an operations research study |
| Q39742204 | Vaccine-preventable diseases and child day care. |
| Q70527506 | Vaccine-related issues |
| Q39759522 | Vaccines against encapsulated bacteria: a global agenda |
| Q37897939 | Vaccines for the prevention of human cytomegalovirus infection |
| Q69528266 | Vaccines: obstacles and opportunities from discovery to use |
| Q44959601 | Vaginal tampon model for toxic shock syndrome |
| Q24091395 | Validation of biologic markers for use in research on chronic fatigue syndrome |
| Q43470983 | Vampire bat-transmitted rabies in cattle |
| Q54529189 | Vancomycin for treatment of bacterial meningitis. |
| Q34284955 | Vancomycin therapy for infective endocarditis |
| Q71108843 | Vancomycin therapy in severe staphylococcal infections |
| Q50220956 | Variability of Immune Response Induced by Bacteria Treated with Subminimal Inhibitory Concentrations of Fosfomycin |
| Q54530343 | Variations in host responses and the pathogenesis of human onchocerciasis. |
| Q39504489 | Varicella in day care centers |
| Q37935947 | Varied presentations of sporadic group A streptococcal bacteremia: clinical experience and attempt at classification. |
| Q38222464 | Vascular endothelium in immunology and infectious disease |
| Q36924055 | Vertebral Osteomyelitis and Aortic Lesions: Case Report and Review |
| Q45278242 | Vertebral osteomyelitis due to Branhamella catarrhalis |
| Q40257826 | Vertebral osteomyelitis in intravenous drug abusers: report of three cases and review of the literature. |
| Q38675532 | Vibrio cholerae vaccines |
| Q47381027 | Vibrio vulnificus: did Hippocrates describe a fatal case? |
| Q36459077 | Viral etiology of cervical cancer: a critique of the evidence. |
| Q40286677 | Viral glycoproteins in infectious disease processes. |
| Q45328560 | Viral infection of endothelial cells |
| Q68074487 | Viral myocarditis |
| Q40290506 | Viral vaccination via the mucosal routes. |
| Q36408125 | Viral vaccines for the prevention of childhood pneumonia in developing nations: priorities and prospects |
| Q44444301 | Viridans Streptococcal Endocarditis: The Role of Various Species, Including Pyridoxal-Dependent Streptococci |
| Q37897913 | Virologic and pathogenetic aspects of cytomegalovirus infection. |
| Q67005018 | Virulence Factors of Anaerobic Bacteria: An Overview |
| Q39306548 | Virulence Factors of Anaerobic Bacteria: Summary of the Symposium |
| Q40297160 | Virulence Factors of Clostridium perfringens |
| Q38143782 | Virulence factors of Clostridium difficile. |
| Q37797134 | Virus-induced autoimmunity |
| Q33428265 | Viruses and hemostasis |
| Q71230337 | Viruses may be etiologic agents for non-insulin-dependent (type II) diabetes |
| Q45843836 | Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain |
| Q44925289 | Visceral protothecosis mimicking sclerosing cholangitis in an immunocompetent host: successful antifungal therapy |
| Q67657476 | Visual Materials for Lectures |
| Q38621865 | What animal models can teach us about the pathogenesis of tuberculosis in humans |
| Q38675509 | What biotechnology has to offer vaccine development. |
| Q70744625 | What do serum antibodies to Yersinia enterocolitica indicate? |
| Q71102037 | When is an infection disease? |
| Q40330826 | Who introduced typhoid vaccination: Almroth Write or Richard Pfeiffer? |
| Q51217016 | Wildlife rabies: overview of ecology and epidemiology. |
| Q68303253 | Workshop on invasive diarrheas, shigellosis, and dysentery. Bangkok, Thailand, 7-9 December 1988 |
| Q38882248 | World Overview of Poliomyelitis: Regional Patterns and Trends |
| Q41456145 | World eradication of measles. |
| Q39519738 | Worldwide efficacy of bismuth subsalicylate in the treatment of travelers' diarrhea |
| Q44482392 | Worldwide experience with bacampicillin administered twice a day. |
| Q44198555 | Wound Infection Surveillance |
| Q38592019 | Wounds caused by corn-harvesting machines: an unusual source of infection due to gram-negative bacilli |
| Q53161331 | Yaws in Colombia. |
| Q93584369 | Yaws in Ghana |
| Q50578985 | Yaws in Malaysia. |
| Q46800922 | Yaws in Papua New Guinea: extent of the problem and status of control programs |
| Q36496481 | Yaws in Southeast Asia: an overview |
| Q29354240 | Yaws in Suriname |
| Q29354241 | Yaws in the Americas |
| Q39759517 | Yellow fever: a medically neglected disease. Report on a seminar |
| Q39759560 | Yersinia enterocolitica, a primary model for bacterial invasiveness |
| Q41530411 | Yersinia enterocolitica: Guidelines for Serologic Diagnosis of Human Infections |
| Q37947318 | Zidovudine intolerance. |
| Q34225500 | Zidovudine resistance of human immunodeficiency virus |
| Q34256184 | Zinc and Infection |
| Q39742230 | beta-Lactam antibiotics: structural relationships affecting in vitro activity and pharmacologic properties |
| Q40269080 | beta-propiolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivatives |
| Q37222616 | Chlamydial infections and the quinolones |
| Q39950662 | Costa Rica: Moving toward “Health for All” |
| Q36495509 | Discrimination Between Intracellular Uptake and Surface Adhesion of Bacterial Pathogens |
| Q70175010 | Effects of subinhibitory concentrations of ketoconazole on in vitro adherence ofCandida albicans to vaginal epithelial cells |
| Q30446615 | Evaluation of quinolones in experimental animal models of infections |
| Q37222608 | Fluoroquinolones in the treatment of typhoid fever and the carrier state |
| Q37222571 | Newly documented antimicrobial activity of quinolones |
| Q37222580 | Pharmacokinetics of quinolones: Newer aspects |
| Q67930978 | Post-marketing surveillance of quinolones 1988–1990 |
| Q37222636 | Role of quinolones in surgical prophylaxis |
| Q37222596 | Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia |
| Q37793709 | Spondylodiscitis: update on diagnosis and management |
| Q28327424 | Synergy and antagonism of combinations with quinolones |
| Q36670132 | The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment |
| Q37222604 | Treatment of intra-abdominal infections with quinolones |
| Q37222592 | Use of quinolones for treatment of ear and eye infections |
| Q37222631 | Use of quinolones in the immunocompromised host |
| Q37222611 | Use of quinolones in treatment of prostatitis and lower urinary tract infections |
Search more.